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 The use of ozone for the transformation of alkenes to carbonyls has been well 
established.  The reaction of ozone with alkenes in this fashion generates either a 1,2,4-
trioxolane (ozonide) or a hydroperoxyacetal, either of which must undergo a separate 
reduction step to provide the desired carbonyl compound.  There is considerable interest 
in being able to perform a reductive ozonolysis to directly provide the carbonyl.  Previous 
reports from the Dussault lab have shown that amine N-oxides are able to perform a 
reductive ozonolysis.  In the course of efforts to expand this reaction to other oxyanions it 
was realized that water was also able to efficiently perform a net reductive ozonolysis via 
nucleophilic capture of the carbonyl oxide.  This transformation was investigated for a 
variety of substrates and was shown to offer a useful alternative to conventional 
ozonolysis conditions.  
 Malaria is a global health epidemic that affects between 300-500 million people 
annually, with the most deadly strain being P. falciparum.  The current treatment for 
malaria is artemisinin combination therapy, but the development of artemisinin-resistant 
strains of malaria has spurred the need for the development of new treatments.  1,2,4-
Trioxolanes exhibit high efficacy against malaria, but concerns remain about their 
 
 
thermal and serum stability.  Our analysis of the likely mechanism of action of ozonides 
guided our development of structurally related 3-alkoxy-1,2-dioxolanes as a potential 
treatment for malaria.  This class of compounds has shown to possess high levels of 
activity against P. falciparum in vitro.  The synthesis of these dioxolanes required the 
development of new synthetic routes, which will be discussed in detail, as will efforts to 
optimize the activity of 3-alkoxy-1,2-dioxolanes.  In addition, the synthesis and 
evaluation of 1,2,4-trioxepanes as potential antimalarials was explored. 
 In the course of our investigation into the synthesis of 3-alkoxy-1,2-dioxolanes, 
we found Re (VII) oxide to be an effective catalyst for the transetherification of 3-alkoxy-
1,2-dioxolanes.  Re (VII) oxide was briefly explored as a catalyst for allylation or 
etherification reactions that involve stabilized carbocations as intermediates. 
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Chapter 1 
Improved procedure for alkene ozonolysis 
 
 
This chapter discusses the mechanism of ozonolysis and the trapping of the 
carbonyl oxide by various nucleophiles.  In addition, the use of water in a reductive 
ozonolysis fashion will be discussed. 
 
Section 1: Mechanism of ozonolysis and previous work involving trapping of 
the carbonyl oxide 
Section 2: Trapping of the carbonyl oxide with water 
Section 3: References 
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Section 1 
Section 1.1: Mechanism of ozonolysis 
Section 1.2: Issues with O3 in synthesis 
Section 1.3: Reductive ozonolysis using N-oxides 
Section 1.4: Reductive ozonolysis using water 
 
Ozonolysis is a powerful synthetic tool for the cleavage of alkenes to their 
corresponding carbonyl compounds.  The use of ozonolysis in synthesis and as a 
synthetic tool has been extensively reviewed.1-5  In this chapter, I will review the 
mechanism of ozonolysis with a focus on trapping of the carbonyl oxide. 
Section 1.1 
 Mechanism of ozonolysis 
The postulated mechanism of ozonolysis has been extensively reviewed.6-10     
 The Criegee mechanism for ozonolysis is now widely accepted.  The first step of, 
the Criegee mechanism of ozonolysis is the cycloaddition of ozone to an alkene 
generating a 1,2,3-trioxolane (primary ozonide), 2.  The primary ozonide is a short lived 
species that undergoes fragmentation to the carbonyl oxide (3) and carbonyl.  The 
carbonyl oxide can undergo cyclization with a carbonyl group, either the co-generated 
species or an exogenously added reagent, to form a 1,2,4-trioxolane (secondary ozonide), 
4.  The rate of this cycloaddition is related to the dipolarophilicity of the carbonyl, with 
aldehyde and electron-poor ketones reacting most rapidly.9  Alternatively, in the presence 
of a nucleophile the carbonyl oxide will be trapped forming a hydroperoxy acetal (5).  
The best nucleophile for the trapping of the carbonyl oxide is a primary alcohol.6  The 
 
 
3 
ozonides and hydroperoxyacetals are often reduced in a separate step to furnish carbonyl 
products. 
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 Recent isotopic labeling studies directly support the Criegee mechanism.  In 1998, 
Berger reported NMR studies of the trapping of 17O-labeled benzaldehyde in ozonolysis.  
Isotopically labeled ozonide 8 with the 17O in the ether was the sole ozonide isolated and 
gives support for the intermediacy of the carbonyl oxide during ozonolysis.11  The lack of 
17O in the peroxide argues against some more complicated mechanisms, which have been 
proposed as an alternative to the Criegee mechanism.10,12,13   
 
Section 1.2 
 Issues with O3 in synthesis 
 The use of ozonolysis as a synthetic tool is to some degree limited by the need to 
employ a separate reduction step to convert the ozonide or peroxide intermediates to the 
desired carbonyl compound.  The use of powerful reducing agents such as BH3,14 
Zn/HOAc,15 and LiAlH416 can lead to compatibility issues with other functional groups.  
The use of a milder reducing agent such as Me2S17 can lead to incomplete reduction of 
 
 
4 
the ozonide.  The use of PPh3 usually leads to complete reduction of the ozonide, but the 
resulting O=PPh3 needs to be removed from the final product.18 
Section 1.3 
 Reductive ozonolysis using N-oxides 
 The development of a reductive ozonolysis approach is desired as it would 
eliminate the need for a separate reduction step.  A second advantage to this approach is 
that the reduction takes time, while with reductive ozonolysis the reduction is complete 
when the ozonolysis is complete.  The Dussault lab has an interest in affecting the 
outcome of ozonolysis through intercepting the carbonyl oxide.  It was postulated that 
since alcohols9 are capable of trapping the carbonyl oxide it possible that another oxygen 
nucleophile would also be successful.  The use of dimethyl sulfoxide had been previously 
reported and prompted the exploration of other oxyanions.19,20   
In the course of these explorations, our lab has shown that a variety of  N-oxides 
are able to trap the carbonyl oxide and produce the desired carbonyl in a one-pot 
manner.21,22  The postulated mechanism for this reaction involves addition of N-oxide to 
carbonyl oxide 3 to form tetrahedral intermediate 9.  Intermediate 9 then undergoes 
fragmentation to provide aldehyde 6.  The only byproducts of this reaction are oxygen 
and the corresponding amine. 
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Section 1.4 
 Reductive ozonolysis using water 
 These results, in conjunction with the known reactivity of alcohols and carbonyl 
oxides, made us wonder if water was able to trap the carbonyl oxide.  A literature search 
revealed that trapping of the carbonyl oxide with water has been mainly reported in the 
literature related to atmospheric (gas phase) ozonolysis reactions.23-26  There are a 
handful of relevant examples in solution.  Pryor and Church reported that the ozonolysis 
of fatty acids in emulsions produced aldehydes and a stoichiometric amount of hydrogen 
peroxide.27,28  In 1998, Von Sonntag explored the ozonolysis of ethene and its derivatives 
and found a similar result.29  In 1982, Niki explored the relative reactivity of various 
protic solvents towards the carbonyl oxide.30  The ozonolysis of tetramethylethylene with 
methanol and water revealed that methanol was a superior trap of the carbonyl oxide.  In 
all of the literature the proposed mechanism involves intermediate 11, which fragments to 
generate the aldehyde and one equivalent of hydrogen peroxide.  
 
In 2007, Molander reported the cleavage of alkene 13 to ketone 14.31  What is 
notable about this approach is the high yield obtained even at -70oC.  This substrate 
formed stable ozonides, that were difficult to reduce, and this procedure was one of 
several explored.  The use of this procedure on another alkene (styrene analog of 13) led 
to a mixture of products and this reaction was not explored. 
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Section 2 
This section describes my attempts to trap the short lived carbonyl oxide 
intermediate generated in ozonolysis to directly provide a carbonyl in a “reductive” 
ozonolysis. 
 
Section 2.1: Rationale 
Section 2.2: Initial phase transfer studies 
Section 2.3: Anhydrous tetrabutyl ammonium salts 
Section 2.4: Water as a trap 
Section 2.5: Substrate scope 
Section 2.6: Conclusions 
Section 2.7: Experimentals 
Section 2.8: References 
Section 2.1 
 Rationale 
Previous research in the Dussault lab had demonstrated that trapping of carbonyl 
oxides by nucleophilic amine oxides led to the direct formation of carbonyl groups by the 
formation and decomposition of an unstable tetrahedral intermediate containing a 
peroxyanion as well as an oxyammonium salt (Section 1.3).  I became interested in 
whether this process was limited to oxyammonium species or was general for species 
containing a nucleophilic oxygen connected weakly to another heteroatom (periodate for 
example).  As will be discussed below, my results suggest that the reductive 
fragmentation may be possible for other fragments combining a nucleophilic oxygen with 
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an easily cleaved oxygen-heteroatom bond.  However, in the course of this work I 
discovered conditions for the highly efficient trapping of water to afford the desired 
carbonyl compound. 
 
Initially, sodium periodate was chosen to test this hypothesis as it possess a 
nucleophilic oxyanion, is commercially available, and is cheap.  NaIO4 would be 
solubilized in water and the interaction with the carbonyl oxide of decene would be 
facilitated by a phase transfer agent.   
Section 2.2 
 Initial phase transfer studies 
As expected under aprotic ozonolysis conditions, the ozonide was formed as the 
major product (Table 1.1 entry 1).  To my delight, ozonolysis in the presence of water, 
CH2Cl2, a phase-transfer agent, and periodate switched the selectivity and aldehyde was 
isolated as the major product (Entry 2).  CCl4, a non-polar aprotic solvent, was not 
suitable and led to the ozonide being formed as the major product.  Commercial bleach 
(Entry 4) and oxone (Entry 5) could be used as additives to afford aldehyde 16.  To rule 
out periodate performing a Hon fragmentation32 (E1CB), pure ozonide was resubjected to 
the reaction conditions and no further reaction was observed. 
A control reaction which included water and a phase-transfer catalyst but which 
omitted the oxyanion nucleophile also produced aldehyde in good yield (Entry 6).  This 
suggests that water is able to trap the carbonyl oxide.  This result led me to question the 
relative contributions of water and the oxyanion nucleophile in promoting the apparent 
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fragmentation.  Water appears capable of trapping the carbonyl oxide and the resulting 
intermediate undergoes decomposition to the desired product.  When water and NaIO4 
are used together it is unclear which species is trapping the carbonyl oxide.  To answer 
this question two different approaches were taken. 
 
Entry Additive 
(eq) 
H2O 
(eq) 
TBABr 
(eq) 
Solvent Yield (%) 
16 
Yield (%) 
17 
1 None 0 0 CH2Cl2 13 72 
2 NaIO4 (1) 92 0.1 CH2Cl2 32 8 
3 NaIO4 (1) 92 0.1 CCl4 3 34 
4 NaOCl (1) 0 0.1 CH2Cl2 42 11 
5 Oxone (1) 92 0.1 CH2Cl2 30 9 
6 None 92 (0.3) CH2Cl2 42 9 
           Table 1.1 
           Initial screen of various additives and decene 
 
Section 2.3 
 Anhydrous tetrabutyl ammonium salts 
A variety of anhydrous oxyanions solubilized with a bulky quaternary ammonium 
salt were screened to determine if a oxyanion is capable of trapping the carbonyl oxide 
(Table 1.2).  It was found that various anhydrous oxyanions are able to trap the carbonyl 
oxide to form nonanal, 16, in a one pot manner (Entries 4-7).  For reasons of economy 
TBAIO4 was chosen to find optimal conditions.  Increasing the equivalents of O3 (Entry 2 
vs. 3) improved the yield of aldehyde.  The reason for this improvement is unclear as 
previous reactions all appeared to go to completion.  In the presence of super 
stoichiometric amounts of TBAIO4 the yield of aldehyde is tripled (Entry 4).  This 
method is capable of providing a synthetically useful yield of nonanal, but the need for a 
large excess of reagent complicates purification.  
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Entry Additive (eq) Ozone (eq)A Yield (%) 16 Yield (%) 17 
1 None 1.2 13 72 
2 TBAIO4 (1) 1.2 35 ND 
3 TBAIO4 (1) 1.7 55 ND 
4 TBAIO4 (3) 1.7 72 17 
5 TBANO2 (1) 1.2 38 13 
6 TBANO3 (1) 1.2 38 13 
7 TBAOCN (1) 1.2 32 25 
8 TEMPO (1) 1.2 None by TLC Present by TLC 
    Table 1.2     Screen of various anhydrous salts and their ability to influence the 
formation of aldehyde 
ABased upon calibration of delivery against a known substrate 
Section 2.4 
 Water as a trap 
 With the knowledge that water is able to trap the carbonyl oxide, it became 
necessary to determine the optimum trapping conditions (Table 1.3).  A screen was 
performed based upon monitoring (NMR) the relative yields of nonanal (16) vs. decene 
ozonide (17) derived upon ozonolysis of decene under a given set of conditions.  It was 
found the addition of water in the absence of a phase transfer agent led to a lower yield of 
both aldehyde and ozonide (Entry 2).  Widely varying results for the reaction in CH2Cl2 
vs. CCl4 suggests a key factor could be solvent polarity and/or the amount of solubilized 
water (Entries 3-5).    We therefore hypothesized that higher yields of aldehyde should be 
obtained in a water-miscible solvent such as acetone or acetonitrile.  This hypothesis was 
found to be true (Entries 7-9).  When water immiscible ethyl acetate was employed the 
yield of aldehyde decreased (Entry 10).  
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Entry Phase Transfer 
(eq) 
Water 
(eq) 
Solvent Yield (%) 
16 
Yield (%)  
17 
1 None None DCM 13a 72a 
2 None 18 DCM 8 21 
3 TBABr (1) 92 DCM 54  ND 
4 TBAHSO4 (.1) 92 DCM 33 9 
5 TBABr (0.1) 92 CCl4 12 59 
7 None 92 Acetone 46 2.9 
8 None 18 Acetone 67 6 
9 None 18 MeCN 42 8 
10 None 18 EtOAc 35 6 
   Table 1.3  a Isolated yields 
Yields determined by NMR 
The relative volatility of nonanal led to relatively low isolated yields, and we 
developed a screen based upon the oxidation of 9-decenyl acetate, which would generate 
a less volatile product.  This approach led to similar trends as those present in Table 1.4, 
namely, that the use of a non-polar solvent led to poor yields (Entry 4), while the use of 
more polar CH2Cl2  led to good yields (Entries 2-4) in the presence of a phase transfer 
agent.  As was expected the use of acetone led to good yield of aldehyde (Entry 6).   
CH2
HAcO(H2C)8
O
HAcO(H2C)8
O3
AcO(H2C)8 O
OO
+
18 19 20  
Entry Phase Transfer 
(eq) 
Water (eq) Solvent Yield (%) 
19 
Yield (%) 
20 
1 None None DCM 13 72 
2 TBABr (0.1) 92 DCM 42 9 
3 TBABr (1) 92 DCM 72 17 
4 TBABr (0.1) 92 CCl4 12 59 
5 TBABr (0.1)a 92 DCM 63 9 
6 None 18 Acetone 72 14 
  
Table 1.4 Use of 9-decenylacetate as an ozonolysis substrate 
 aNaHCO3 added 
 
 
 
11 
 It was unknown what effect varying amounts of solubilized water would have on 
the reaction.  To determine this, I investigated the ozonolysis of alkene 18 in acetonitrile 
and acetone containing varying amounts of solubilized water.  New bottles of solvent 
were utilized for this screen, but the solvent underwent no additional drying.  As little as 
0.6% added water led to a remarkable increase in the yield of aldehyde and this high 
yield was maintained up to 20% added water.  It is expected that at a certain point the 
solvent mixture is able to no longer solubilize both the alkene and water, resulting in a 
decline in yield of the aldehyde.  Based upon these results 5% added water (v/v) was used 
for all further experiments. 
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I wanted to verify that the consumption of the alkene was linearly related to the 
formation of aldehyde.  Thus 18 was subjected to ozonolysis and aliquots were taken 
every 33 seconds and filtered through a silica plug.  1H NMR was taken and showed 18 
and 19, but no ozonide.  A graph of the calculated relative amounts of the consumed 
alkene vs. the generated products shows a linear trend.   
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The hypothesis, which is supported by previous literature, is that solubilized water 
is able to trap the carbonyl forming hydroperoxyacetal intermediate, 23.  This type of 
trapping has been reported in the literature for atmospheric chemistry (gas phase) and has 
not been previously applied as a general synthetic method to solution chemistry.23,24  For 
more complete coverage of this field see Section 1.4.  Tetrahedral intermediate 23 
undergoes in situ fragmentation giving the desired carbonyl, 24, and hydrogen peroxide 
as a byproduct.  To test this hypothesis, I performed the ozonolysis of 18 in 95:5 
acetone/water (v/v) and collected the aqueous layer remaining after extraction with 
CH2Cl2.  Testing this layer with calibrated peroxide test strips indicated that hydrogen 
peroxide was present in stoichiometric amounts.   
R
O+
R
O-
O
R
OH
OH H2O2
O
R
21 22 23 24  
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Section 2.5 
 Substrate scope 
A variety of alkenes were subjected to ozonolysis under these conditions to 
determine substrate scope.  Some of the initial yields were in our opinion lower than 
would be expected.  It was thought that excess ozone might be problematic and as a 
solution to this indicator Sudan Red III was employed.33 As was expected from the 
screening studies the ozonolysis of 18 and 25 proceeded in good yield.  Likewise, 
ozonolysis of styrenes 26 and 27 proceeded in moderate to excellent yield.  Styrene 27 
was chosen as an alkene which undergoes ozonolysis to give the aldehyde and 
formaldehyde O-oxide.  Therefore, the quantitative yield indicates that the water is able 
to trap the formaldehyde carbonyl oxide before recombination with 27 can occur.  The 
ozonolysis of structurally more complicated terpene 29 proceeded in quantitative yield.  
Ozonolysis of β-pinene (30) produced the ozonide as the major product.   
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Substrate Structure 
No Sudan 
Red III 
(%) 
Sudan Red  
III (%) 
18 
 
72 NA 
25 
 
NA 72 
26 
 
NA 73 
27 
 
NA quant. 
28 
 
NA 52 
29 
 
76 quant. 
30 
 
NA 19 
31 
 
54 75 
 
Methyl oleate, 32, was used to determine if the two chemically different 
aldehydes could be isolated.  Both aldehydes 33 and 16 were isolated, however, the yield 
for 33 was depressed. 
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Section 2.6 
 Conclusions 
 This work has shown two new methodologies for the formation of aldehydes or 
ketones directly from alkenes.  The first is utilizing oxyanions as a new method for the 
“reductive” ozonolysis of alkenes.  This route requires a large excess of reagents that 
must be removed making this approach less than ideal.  The second is the use of water to 
directly trap the carbonyl oxide giving the desired carbonyl compound.  The advantage of 
this route is the need for no elaborate purification.  The disadvantage is the generation of 
a stoichiometric amount of hydrogen peroxide  
Section 2.7 
 Experimentals 
All reagents were used as received from commercial vendors, with the exception of 
CH2Cl2, which was distilled from calcium hydride, and THF, which was distilled from 
sodium/benzophenone.  All reactions were conducted under an atmosphere of N2 except 
where noted; “RBF” indicates round-bottom flask.  Thin layer chromatography (TLC) 
was performed on 0.25 mm hard-layer silica G plates; developed plates were visualized 
by staining: 1% ceric sulfate and 10% ammonium molybdate in 10% H2SO4 (general 
stain, after charring); 1% N,N’-dimethyl-p-phenylenediamine solution in 1:20:100 acetic 
acid/water/methanol (specific for peroxides);34 1% aq. KMnO4 (for unsaturated 
compounds);.  “Standard drying and purification” refers to drying of organic extracts 
over Na2SO4, removal of solvent under vacuum, and purification by flash 
chromatography using the indicated eluting solvent. 1H /13C NMR spectra were recorded 
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at 300 (75), 400(100), or 500(125) MHz in CDCl3 unless otherwise indicated; peaks are 
reported as: chemical shift (multiplicity, J couplings in Hz, number of protons).   
 
We experienced no safety issues in the course of performing this research.  Ozonides 
and peroxides can be explosive and dangerous and all prudent safety precautions 
should be taken.35,36 
 
 
Nonanal (16): 
Representative procedure for ozonolysis in CH2Cl2 in the presence of H2O, a phase 
transfer agent, and NaIO4 
To a flame-dried RBF containing a solution of decene (3 mmol) in CH2Cl2 (20 mL) was 
added sequentially NaIO4 (3 mmol) in H2O (5 mL) and phase transfer agent (0.1-1mmol) 
and cooled to 0oC.  A stream of O3/O2 was passed through the reaction for the allotted 
amount of time and the reaction flask was purged with a stream of O2 for 2 min.  H2O (25 
mL) was added and the resulting suspension was extracted with CH2Cl2 (2 x 25 mL).  
The combined organic layers were washed with brine (25 mL) and dried with NaSO4. 
The residue obtained upon concentration in vacuo was subjected to column 
chromatography with 10 % EA/hex to afford 16 as a colorless oil.  Rf (10 % EA/hex): 
0.56.  1H NMR (300 MHz): 9.71 (t, J = 1.8, 1H), 2.82 (dt, J = 1.7, 7.3, 2H), 1.6 (m, 2H), 
1.45-1.13 (10H), 0.83 (t, J = 6.9, 3H). 
Also formed is 3-octyl-1,2,4-trioxolane as a colorless oil.  1H NMR (300): 5.20 (s, 1H), 
5.13 (t, J = 3.2, 1H), 5.04 (s, 1H), 1.72 (m, 2H), 1.51-1.20 (12H), 0.89 (t, J = 6.8, 3H). 
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Representative procedure for the ozonolysis in CH2Cl2 /H2O in the presence of a 
phase transfer agent 
To a flame-dried RBF containing a solution of decene (3 mmol) in CH2Cl2 (20 mL) was 
added sequentially H2O (5 mL) and phase transfer agent (0.1-1 mmol).  The solution was 
cooled to 0oC and a stream of O3/O2 was passed through the reaction for the allotted 
amount, after which the reaction was purged with a stream of O2 for 2 min.  H2O (25 mL) 
was added and the resulting suspension was extracted with CH2Cl2 (2 x 25 mL).  The 
combined organic layers were washed with brine (25 mL) and subjected to standard 
drying and purification with 10 % EA/hex to afford 16 as a colorless oil.  For yields see 
Table 1.2. 
 
9-decenenyl acetate (18): 
To a flame-dried RBF containing a solution of 9-decen-1-ol (4.0135g, 26 mmol) in 
pyridine (40 mL) was added sequentially Ac2O (2.86 mL, 39 mmol) and DMAP (319.8 
mg, 2.6 mmol) and reaction was stirred overnight.  2 N HCl (80 mL) was added and the 
resulting suspension was extracted with Et2O (3 x 80 mL).  The combined organic layers 
were washed with sat. aq. NaHCO3 (2 x 80 mL), brine (80 mL),   and were subjected to 
standard drying and purification with 5% EA/hex to afford 18 (4.6201 g, 90%) as a 
colorless oil.  Rf (5 % EA/hex): 0.44. 1H NMR (300 MHz): 5.79 (ddt, J = 17.0, 10.2, 6.7, 
1H), 4.95 (m, 2H), 4.03 (t, J = 6.7, 2H), 2.08 – 1.97 (5H), 1.66 – 1.53 (2H), 1.43 – 1.22 
(10H).  13C (75 MHz): 171.3, 139.2, 114.3, 64.7, 33.9, 29.5, 29.3, 29.1, 29.0, 28.7, 26.0, 
21.1.  The NMR spectra matched those previously reported.37 
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8-(1,2,4-trioxolan-3-yl)octyl acetate (20): 
In a flame-dried RBF containing 18 (0.5281g, 2.6 mmol) was added in CH2Cl2 (20 mL).  
The solution was cooled to -78 oC and a stream of O3/O2 was passed through the solution 
until blue and the flask was purged with O2 for 2 min.  The solution was concentrated in 
vacuo and purified via flash chromatography with 10% EA/hex to afford 20 (416.6mg, 
63%) as a colorless oil.  Rf (10% EA/hex) = 0.4.  1H NMR (400 MHz):  5.043 (s, 1H), 
4.977 (t, J = 4.95, 1H), 4.871 (s, 1H), 3.908 (t, J = 6.74, 2H), 1.884 (s, 3H), 1.57 (m, 2H), 
1.49 (m, 2H), 1.31-1.19 (10H).  13C NMR (100 MHz): 170.6, 103.5, 93.8, 64.2, 31.4, 
30.9, 29.1, 28.9, 28.4, 25.7, 23.6, 20.6.  HRMS: calc for C12H23O5: 247.1546; found: 
247.1545. 
 
9-oxononyl acetate (19): 
Representative procedure for the ozonolysis in CH2Cl2 /H2O in the presence of a 
phase transfer agent 
To a flame-dried RBF containing a solution of 18 (3 mmol) in CH2Cl2 (20 mL) was 
added sequentially H2O (5 mL) and phase transfer agent (0.1-1 mmol).   The flask was 
cooled to 0oC and a stream of O3/O2 was passed through the reaction for the allotted 
amount of time.  The reaction flask was purged with a stream of O2 for 2 min.  H2O (25 
mL) was added and the resulting suspension was extracted with CH2Cl2 (2 x 25 mL).  
The combined organic layers were washed with brine (25 mL) and subjected to standard 
drying and purification with 10 % EA/hex to afford 19 as a colorless oil. Rf (10% 
EA/hex): 0.33.  1H NMR (300 MHz): 9.72 (t, J = 1.7, 1H), 4.0 (t, J = 4, 2H), 2.38 (dt, J = 
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1.7, 7.2, 2H), 2.0 (2, 3H), 1.65 – 1.49 (4H), 1.37 – 1.23 (8H).  13C (75 MHz): 202.9, 
171.3, 64.6, 43.9, 29.3, 29.1, 29.0, 28.6, 25.9, 22.1, 21.1. The NMR spectra matched 
those previously reported.38 
 
((dec-9-en-1-yloxy)methyl)benzene: 
 A suspension of NaH (630 mg, 15.8 mmol, 60% in mineral oil) in a flame-dried 
RBF was washed with THF (10 mL) and suspended in THF (20 mL).  9-decen-1-ol 
(2.074 g, 13.3 mmol) and benzyl bromide (2.44 g, 14.3 mmol) were added sequentially 
and the reaction was stirred overnight.  H2O (20 mL) was added and extracted with EA (2 
x 30 mL) and washed with brine (30 mL).  The combined organic layers were subjected 
to standard drying and purification with 5% EA/hex to afford ((dec-9-en-1-
yloxy)methyl)benzene (1.3305 g, 41%) as a yellow oil.  Rf (10 % EA/hex): 0.86. 1H 
NMR (400 MHz): 7.41 – 7.26 (5H), 5.84 (ddt, J = 17.0, 10.2, 6.7, 1H), 2.50 (m, 2H), 5.0 
(m, 2H), 4.53 (s, 2H), 3.49 (t, J = 6.8, 2H), 2.11- 2.02 (2H), 1.69 – 1.59 (2H), 1.45 – 1.26 
(10H).  13C (100 MHz): 139.3, 138.9, 128.5, 127.8, 127.6, 114.3, 73.0, 70.7, 33.9, 29.6, 
29.3, 29.1, 26.4.  The NMR spectra matched those previously reported.39 
 
9-(Benzyloxy)nonanal (25): 
 To a flame-dried RBF containing a solution of 9-dencenyl benzylether (748.5 mg, 
3.04 mmol) in acetone (20 mL) was added sequentially added H2O (1 mL, 56 mmol) and 
Sudan Red III (trace).  The solution was cooled to 0oC and mixture of O3/O2 was passed 
through the flask until the red color dissipated.  The reaction was purged with O2 for 2 
min.  H2O (25 mL) was added and the resulting suspension was extracted with CH2Cl2 (2 
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x 25 mL).  The combined organic layers were subjected to standard drying and 
purification with 10% EA/hex to EA to afford 25 (545.3 mg, 72%) as a yellow oil. Rf 
(10% EA/hex): 0.34.  1H NMR (400 MHz): 9.77 (t, J = 1.8, 1H), 7.40-7.26 (5H), 4.52 (s, 
2H), 3.48 (t, J = 6.6, 2H), 2.43 (dt, J = 1.9, 7.4, 2H), 1.66 – 1.58 (4H), 1.44 – 1.27 (9H).  
13C (100 MHz): 203.0, 138.8, 128.4, 127.7, 127.6, 72.9, 70.5, 44.0, 29.9, 29.4, 29.3, 29.2, 
26.2, 22.1.  The NMR spectra matched those previously reported.40 
 
4-Methyl-benzaldehyde (26): 
To a flame-dried RBF containing a solution of 4-methylstyrene (369.8 mg, 3.1 
mmol) in acetone (20 mL) was added H2O (1.0 mL, 56 mmol) and Sudan Red III (trace).  
The solution was cooled to 0oC and O3/O2 was passed through the flask until the red color 
dissipated.  H2O (25 mL) was added and the suspension was extracted with CH2Cl2 (2 x 
25 mL).  The combined organic layers were subjected to standard drying and purification 
with 10% EA/hex to afford 26 (275.9 mg, 73%) as a yellow oil. Rf (10% EA/hex): 0.52.  
1H NMR (400 MHz): 9.95 (s, 1H), 7.76 (d, J = 8.1, 2H), 7.32 (d, J = 8.1, 2H), 2.42 (s, 
3H).  NMR spectra matched commercially available samples. 
 
O2N
O
 
4-nitrobenzaldehdye (27): 
To a flame-dried RBF containing a solution of 4-nitrostyrene (307.5 mg, 2.1 mmol) in 
acetone (13 mL) was added H2O (0.66 mL, 37 mmol) and Sudan Red III (trace).   The 
solution was cooled to 0oC and O3/O2 was passed through the flask until the red color 
dissipated.  H2O (25 mL) was added and the suspension was extracted with CH2Cl2 (2 x 
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25 mL).  The combined organic layers were subjected to standard drying and purification 
with 30% Et2O/pent to afford 27 (312.3 mg, quantitative) as a white solid. Rf (30% 
Et2O/pent): 0.57.  1H NMR (400 MHz): 10.17 (s, 1H), 8.41 (d, J = 8.4, 2H), 8.09 (d, J = 
8.4, 2H).  13C (100 MHz): 190.5, 151.3, 140.2, 130.7, 124.5. The NMR spectra matched 
those previously reported. 41 
 
Benzophenone (28): 
To a flame-dried RBF containing a solution of 1,1-Diphenylethylene (578.7 mg, 3.2 
mmol) in acetone (20 mL) was added H2O (1.0 mL, 56 mmol) and Sudan Red III (trace).   
The solution was cooled to 0oC and O3/O2 was passed through the flask until the red color 
dissipated.  H2O (25 mL) was added and the resulting suspension was extracted with 
CH2Cl2 (2 x 25 mL).  The combined organic layers were subjected to standard drying and 
purification with 10% EA/hex to afford 28 (303.5 mg, 52%) as a white solid. Rf (10% 
EA/hex): 0.43.  1H NMR (300 MHz): 7.87 – 7.79 (4H), 7.64 – 7.56 (2H), 7.53 – 7.45 
(4H).  13C (75 MHz): 196.9, 137.7, 132.5, 130.2, 128.4.  The NMR spectra matched those 
previously reported.42 
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5-acetyl-2-methyl-cyclohexanone (29): 
Small Scale (3 mmol): 
To an oven dried RBF containing a solution of dihydrocarvone (396.3 mg, 3 
mmol) in acetone (17 mL) was added sequentially H2O (0.9 mL, 49.5 mmol) and Sudan 
Red III (trace).  The solution was cooled to 0oC and a stream of O3/O2 was passed 
through the flask until the red color dissipated.  The flask was purged with O2 for 2 min.  
H2O (25 mL) was added and the suspension was extracted with CH2Cl2 (2 x 25 mL).  The 
combined organic layers were subjected to standard drying and purification with 40 % 
Et2O/hex to afford 29 (401.9 mg, quant.) as a yellow oil.  1H NMR (300 MHz): 2.78 (m, 
1H), 2.43 (d, J = 9, 2H), 2.34 (apparent sextet, J = 6.3, 1H), 2.15 (s, 3H), 2.2-2.05 (2H), 
1.68 (apparent qd/ddd, J = 13.3, 3.4, 1H), 1.39 (apparent qd/ddd, J = 13.1, 3.4, 1H), 0.98 
(d, J = 9.5, 3H). 13C NMR (75 MHz): 211.5, 208.3, 52.0, 44.5, 42.7, 34.5, 28.3, 27.8, 
14.3. HRMS: calc for C9H15O2: 155.1072; found: 155.1066. 
Large Scale Procedure (Chromatographic purification): 
To an oven dried RBF containing a solution of  dihydrocarvone (3g, 20 mmol) in 
acetone (133 mL) was added H2O (6.8 mL, 378 mmol) and Sudan Red III (trace).  The 
solution was cooled to 0oC and O3/O2 was passed through the flask until the red color 
dissipated.  The flask was purged with O2 for 2 min.  H2O (150 mL) was added and the 
resulting suspension was extracted with CH2Cl2 (2 x 130 mL).  The combined organic 
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layers were subjected to standard drying and purification with 40 % Et2O/hex to afford 29 
(2.6249g, 86%) as a yellow oil. 
Large Scale procedure (purification by distillation): 
To a flame-dried RBF containing a solution of dihydrocarvone (4.9395g, 32 
mmol) in acetone (213 mL) was added H2O (10 mL, 556 mmol) and Sudan Red III 
(trace).  The solution was cooled to 0oC and O3/O2 was passed through the flask until the 
red color dissipated.  The flask was purged with O2 for 2 min.  H2O (100 mL) was added 
and extracted with CH2Cl2 (1 x 130 mL and 1 x 30 mL).  The combined organic layers 
were washed with H2O (30 mL) and dried with Na2SO4.  The residue obtained upon 
concentration in vacuo was purified by Kugelrohr (bulb-to-bulb) distillation (245 oC @ 
90 torr) to afford 29 as a yellow oil (3.9331g, 78%). 
 
Citronellyl benzoate: 
In a flame-dried RBF containing a solution of B-citronellol (2.1399g, 13.7 mmol) in 
pyridine (20 mL) was added benzoyl chloride (2.0705g, 14.1 mmol).  The reaction was 
stirred for 4 hours.  Et2O (40 mL) was added and the organic layer was washed 
sequentially with 1 N HCl (20 mL), sat. aq. NaHCO3 (40 mL), and brine (40 mL).  The 
combined organic layers were subjected to standard drying and purification with 5 % 
EA/hex to afford citronellyl benzoate (3.1784 g, 89%) as a yellow oil. Rf (10% EA/hex) = 
0.74.  1H NMR (300 MHz): 8.05 (d, J = 7.5, 2H), 7.62-7.39 (3H), 5.16-5.05 (1H), 4.37 
(m, 2H), 2.14-0.91 (16H).  13C (75 MHz):  166.8, 133.0, 131.6, 130.7, 129.7, 128.5, 
124.7, 63.6, 37.1, 35.7, 29.7, 25.9, 25.6, 19.7, 17.8. 
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3-Methyl-6-oxohexyl benzoate (33): 
To an oven-dried RBF containing citronellyl benzoate (762.6 mg, 2.93 mmol) in acetone 
(20 mL) was added H2O (1 mL, 56 mmol) and Sudan Red III (trace).  The solution was 
cooled to 0oC and O3/O2 was passed through the flask until the red color dissipated.  H2O 
(25 mL) was added and the suspension was extracted with CH2Cl2 (2 x 25 mL).  The 
combined organic layers were subjected to standard drying and purification with 30% 
Et2O/hex to afford 33 (515.5 mg, 75%) as a yellow oil. Rf (30% Et2O/pentane): 0.72.  1H 
(300 MHz): 9.74 (t, J = 1.7, 1H), 8.05-7.92 (2H), 7.58-7.33 (2H), 4.41-4.26 (2H), 2.54-
2.34 (2H), 1.88-0.76 (8H).  The NMR spectra matched those previously reported.43 
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Chapter 2 
3-Alkoxy-1,2-dioxolanes as potential antimalarials   
  
This chapter will discuss the disease malaria and current treatments using both 
synthetic and natural peroxides.  There is also an in depth discussion of 3-alkoxy-1,2-
dioxlanes as a new class of peroxides for the treatment of malaria. 
 
Section 1: Malaria and current antimalarial treatments 
Section 2: Previous synthesizes and reactivity of 3-alkoxy-1,2,-dioxolane 
Section 3: “First Generation” 3-alkoxy-1,2-dioxolanes 
Section 4: “Second Generation” 3-alkoxy-1,2-dioxolanes 
Section 5: “Third Generation” 3-alkoxy-1,2,-dioxolanes 
Section 6: Experimentals 
Section 7: References 
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Section 1 
  
Section 1.1: Malaria 
Section 1.2: Antimalarial Treatments 
Section 1.3: Artemisinin as a treatment for malaria 
Section 1.4: Mechanism of Fe-mediated artemisinin degradation 
Section 1.5: Artemisinin mechanism of action against malaria 
Section 1.6: Vennerstrom’s ozonides 
Section 1.7: Rationale for 3-alkoxy-1,2-dioxolanes 
 
Section 1.1 
 Malaria  
 Malaria is a global health epidemic affecting 300-500 million people and causing 
1-2 million deaths annually, predominately in children.1  Malaria infection occurs 
primarily in Africa and Southeast Asia.  There are five strains of malaria that infect 
humans; the most deadly strain of malaria is P. falciparum.1   
 The following is a very brief overview to provide a perspective on the challenges 
in treating this disease.  An excellent review on malaria infection was published by Miller 
in 2002.2  The life cycle of malaria is complex and occurs in both the transmitting 
mosquito and the infected host.  The multiplication of malaria in the infected mosquito 
occurs in the midgut and takes approximately 10 days for the salivary glands to become 
infected.3  Humans are infected by a bite from an infected mosquito.  Within one hour the 
transferred sporozites infect the cells of the liver.3  Over the next 5-15 days the infection 
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develops into exoerythrocytic shizonts that contain tens of thousands of merozoites.3  
Release of these merozoites into the blood stream leads to rapid infection of red blood 
cells.  The eventual rupture of the infected red blood cells leads to further infection.3  The 
presence of multiple stages makes treating malaria difficult. 
Section 1.2 
Antimalarial treatments  
 The ultimate goal for the treatment of malaria is the development of a vaccine; 
however, this goal has proved elusive.4  As such, a continued need exists for the 
development of novel chemotherapeutics.  Several reviews have been published on 
chemotherapeutic treatments of malaria.3,5-11 
 Malaria can be treated by non-peroxide means (quinine,6 chloroquine,6 
mefloqquine,6 ferrocene conjugates,12-14 peptides15-17).  Several classes of peroxide-
containing compounds have demonstrated activity against malaria: 1,2-dioxanes,18 1,2,4-
trioxepanes,18-20 1,2,4-trioxanes,21-24 tetraoxanes,25-27 artemisinin dimers,28-30 and 
artemisinin derivatives.31,32  However, only a few of these have demonstrated efficacy in 
humans.  Artemisinin combination therapy (ACT) is currently the prescribed treatment 
for malaria, but the development of artemisinin resistant malaria in Cambodia has 
spurned the interest in chemotherapeutics.33    This introduction will discuss artemisinin, 
along with 1,2,4-trixolanes (ozonides); several molecules of the later class are in clinical 
trials against malaria. 
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Section 1.3 
Artemisinin as treatment for malaria 
 Artemisinin (1) is a naturally occurring endoperoxide isolated from the Chinese 
wormwood.34  Isolation continues to be the primary source of artemisinin but synthetic 
approaches have been reported.5  The total synthesis of artemisinin was first reported by 
Schimd and Hofheinz in 1983.35  Semi-synthesis of artemisinin based upon biosynthesis 
of artemisinic acid has been reported by Keasling.36,37  Currently, artemisinin (1) is not 
used directly for treatment due to rapid metabolism.  Instead, the closely related 
artemether (2)38  and artesunate (3)38 are given as part of a combination therapy.39  
Artemisinin and analogs 2 and 3 demonstrate long shelf life40 as well as stability to many 
chemical transformations.41  However, artemisinin is degraded by Pd-catalyzed 
hydrogenation and treatment with strong acid or base.34 
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Section 1.4 
Mechanism of Fe-mediated artemisinin degradation 
In 1992, Posner undertook a study of an 18O-labeled artemisinin analog to 
elucidate a mechanism for the Fe (II)-mediated degradation of the endoperoxide.  The 
degradation can proceed by two pathways.  The first is by radical scission to provide 
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intermediate 5 with the alkoxy radical on O1.  This intermediate can undergo C-C 
cleavage via β-scission to generate the mixed acetal 6, which undergoes hydrolysis to 
provide aldehyde 7.  Alternatively, if the initial cleavage occurs to create an alkoxy 
radical on O2, intermediate 8 is obtained.  A subsequent 1,5-H shift provides intermediate 
9, which can undergo cyclization with loss of Fe(II) to furnish epoxide 10.  A later paper 
supports the transformation of 9 to 10 through the generation of a hydroxyl-epoxide and 
Fe(IV)=O.42  The combined yields of 7 and 10 (~2:1) were 60 – 70%, demonstrating that 
these are major pathways. 
 
 With a preliminary mechanism proposed, Posner explored the 1,5-H shift 
involved in the conversion of alkoxy radical 8 to carbon radical 9.  The hypothesis was 
that if the hydrogen was not in the correct spatial alignment to undergo a shift there 
would be no activity.43  Peroxides 11 and 12 were synthesized and activity against P. 
falciparum was measured test this hypothesis.  When no H is available to perform a shift 
(12), no activity is observed.  Likewise, when the H is in the wrong spatial alignment (11) 
to allow hydrogen abstraction, the peroxide is devoid of activity.  In contrast, control 
peroxide 4, which is similar to artemisinin in stereochemistry at the methyl-bearing 
center, possessed high activity. 
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Section 1.5 
Artemisinin mechanism of action against malaria 
Several reviews have been published on the mechanism of action (MOA) of 
artemisinin.44-46 
In 1991, Meshnick reported the alkylation of heme by artemisinin.47  However, 
Meshnick and subsequent researchers have struggled to understand the role that the 
alkylated heme plays in antimalarial activity.  More recently proposed MOAs have 
included artemisinin blocking PfATP6 (Plasmodium falciparum Ca2+ ATPase)48,49 and 
artemisinin causing parasite membrane damage.50  Although a MOA based upon Fe(II)-
mediated generation of reactive radicals is the most widely accepted.  A minority of 
research papers support the idea that activity is not derived from the formation of carbon 
centered radicals, but rather a result of reactive intermediates derived from an ionic 
opening of the peroxide.51-53  None of these MOAs are without debate and thus far no 
consensus is present in the literature.  Arguably, until the MOA of endoperoxide 
containing drugs is confirmed no truly rationale design of a potential treatment can be 
undertaken.  
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Section 1.6 
Vennerstrom’s ozonides 
 In 2004, Vennerstrom and coworkers reported the first example of a 1,2,4-
trioxolane (ozonide) as a potential treatment for malaria.54  Ozonide 13 was synthesized 
utilizing a Griesbaum co-ozonolysis of oxime 14 and ketone 15 to afford ozonide 16.55  
Saponification of ester 16 to the corresponding acid 17 followed by amine coupling 
produced arterolane (OZ-277), 13.  Arterolane exhibits high activity against both 
chloroquine sensitive (NF54) and chloroquine resistant (K1) strains of P. falciparum in 
vitro (2.5 nM).  Excellent activity is also observed in vivo with P. berghei infected mice 
(100% cure); this system is typically used as the standard mammalian model for malaria.  
Arterolane is now in phase III trials.56  Further structural optimizations led to the 
discovery of OZ-439, which is currently in a Phase I clinical trial.57,58  In an attempt to 
determine the MOA of arterolane, Vennerstrom investigated the reactivity of 1,2,4-
trioxolanes towards heme.  Vennerstrom reported that synthetic 1,2,4-trioxolanes can 
alkylate free heme,59 but not the protein bound heme that is abundant in healthy cells.60   
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 The postulated antimalarial activity of arterolane is derived from the formation of 
carbon centered free radicals.  (A discussion of this mechanism in the context of 1,2,4-
trioxolanes, 1,2,4-trioxanes, and 1,2,4-trioxpenaes will be discussed in section 5.)  To test 
this hypothesis, model ozonide 18 was treated with FeBr2 where iron can attack either O1 
or O2 of the peroxide bond. 23  Experimentally, it was found that attack on O1 is preferred 
and was rationalized by O1 being more accessible then O2.  The resulting alkoxy radical 
19 undergoes β-scission to afford carbon radical 20.  Intramolecular attack of the radical 
on the ester carbonyl and loss of Fe(II) forms products 23-25, with lactone 23 being the 
predominant product.  If iron attacks O2, the resulting alkoxy radical (21) would be 
expected to undergo β-scission to provide carbon radical 22.  The only isolated product 
related to 22 is bromo acid 26 which is formed in very low yield.      
18
O
O OFeIII
O
OO
O
OFeIII O
O
OFeIII O
Beta-Scission O
O
OFeIII
-FeIII
-FeIII
O
O
COOH
COOH
19 20
21 22
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64%
25
2%
24
6%
Br
HOOC
Br
26
3%
12
Beta-Scission
 
 It was unclear if the 1,2,4-trioxolane (ozonide) functionality was necessary or if 
the same level of antimalarial activity could be accomplished with a 1,2-dioxolane, a 
class of peroxide expected to have much greater stability.61  However, only limited 
investigations of 1,2-dioxolanes as antimalarials have been reported.62  To test the 
relative activity of 1,2-dioxolanes and 1,2,4-trioxolanes, Vennerstrom prepared and 
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screened 1,2-dioxolane 27 for in vitro activity against P. falciparum.63  The results reveal 
that 1,2-dioxolane 27 possesses virtually no activity when compared to ozonide 14.  
Reaction of 1,2-dioxolane 27 with FeBr2 did not lead to formation of carbon centered 
radicals through β-scission, as determined by trapping with 4-oxo TEMPO.63  This 
suggests that the fate of the intermediate alkoxy radicals may be a crucial factor in the 
antimalarial activities of ozonides. 
 
Section 1.7 
Rationale for 3-alkoxy-1,2-dioxolanes 
 We became interested in 3-alkoxy-1,2-dioxolanes as potential antimalarials 
because they are isosteric to ozonides and should possess similar activity. The oxygen 
alpha to the peroxide bond should facilitate β-scission of one of the derived 3-alkoxy-1,2-
dioxolane radicals, enhancing generation of a carbon centered radical.  This hypothesis is 
supported by theoretical and experimental work reported by Erhardt on a related 
system.22  Our hypothesis is illustrated for 3-alkoxy-1,2-dioxolane 28.  We postulated 
that 3-alkoxy-1,2-dioxolane 28 would undergo β-scission to provide radical intermediate 
29.  This intermediate could either undergo quenching to afford 30 or β-scission to 
provide the desired free radical 32. As can be seen, the alkoxydioxolanes undergoes 
reaction with FeBr2 to predominantly furnish the expected products from formation and 
scission of an α-alkoxy radical.    
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 The potential advantage of 3-alkoxy-1,2-dioxolanes relative to ozonides is their 
increased stability and the safety of their synthesis.  By design ozonides, such as 
arterolane, require the use of ozone which can lead to the buildup of unstable 
intermediates.  Although no stability issues have been reported by Vennerstrom, ozonides 
such as arterolane are high energy species that can undergo exothermic decomposistion.64  
In contrast, the synthesis of 3-alkoxy-1,2-dioxolanes can be done in the absence of ozone.  
Though the synthesises that follow do utilize some potentially hazardous reagents, the 
peroxide bond is always installed with molecular oxygen and not ozone.  As a class, 1,2-
dioxolanes exhibit increased stability over 1,2,4-trioxolanes, potentially making them a 
platform for development of drugs which are more field stable.61  
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Section 2 
Section 2.1 
Synthesis of 3-alkoxydioxolanes and 1,2-dioxolan-3-ols 
This section describes investigations of the synthesis and reactivity of 3-alkoxy-1,2-
dioxolanes and related species.  A review of the synthesis of cyclic peroxides has been 
written by Bachi.65 
Singlet oxygen 
   In 1980, Ensley studied the addition of 1O2 to α-β-unsaturated ketones and 
lactones.66  In the course of this work, he reported the reaction of 1O2 and (R)-(+)-
pulegone, 33, to form the 1,2-dioxolan-3-ol 34 in 75% yield.  The oxygenation of more 
sterically hindered cyclohexylidine analog 35 produced 1,2-dioxolan-3-ol 36 as the major 
product in comparable yield. 
O
R
R OO
R
RHO
1O2
33 R = Me
35 R = (CH2)5
34 75%
36 78%  
 Several groups have investigated the reaction of cholest-5-en-3-one, 37, with 1O2 
and reported the isolation of alcohols, after a reductive workup.67-70  Note that in the 
example as well as an additional example below, 1O2 is generated via dye-sensitized 
excitation of 3O2 in the presence of substrate.  From the location of the alcohols the 
authors extrapolated that they had been hydroperoxides before reduction.  Based upon the 
work below, we can suggest the precursors of the alcohols were in fact 1,2-dioxolan-3-
ols.  In 1990, Schiesser studied the reaction of 1O2 on cholest-5-en-3-one, 37, and 
reported the first isolation of a 1,2-dioxolan-3-ol.71  Schiesser reported that reaction of 37 
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with 1O2 in the absence of a reductive workup resulted in isolation of 1,2-dioxolan-3-ol 
38 after chromatography. 
 
 In the same report Schiesser disclosed that this reaction is not specific to cholest-
5-en-3-one, but is also successful on a much simpler system.  The treatment of 
octahydronaphthalenone 39 with 1O2 afforded 1,2-dioxolan-3-ol 40 as the major product 
and hydroperoxide 41 as a minor product. 
 
In 1999, Adam explored the reaction of 1O2 and adamantylidene alcohol 42.72  
The treatment of 42 with 1O2 led to formation of 43 and 44 in approximately equal 
amounts as judged by 1H NMR.  However, 44 was the major isolated product.  Dioxetane 
43 was isolated almost exclusively as the threo isomer (shown), a result rationalized on 
the basis of hydroxyl-directed addition of 1O2 to a single major conformer, which is 
favored by allylic 1,2-strain present in other conformations.  1,2-Dioxolan-3-ol 44 is 
presumably formed in situ cyclization of the initially generated hydroperoxide in the ene 
product.  When the oxygenation was performed in a polar protic solvent such as 
methanol, dioxetane 43 was formed almost exclusively. 
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In the course of efforts directed towards the synthesis of (+)-Premnalane A 
Vassilikogiamakis and coworkers investigated the oxygenation of 45.  The desired 
spiroendoperoxide 47 was formed but as a minor product with the spiroalkoxydioxolane 
48 formed as the major product.73  The synthesis of 45 was accomplished in six steps 
from commercially available (+)-sclareolide.  The authors found that 46 needs to be 
preformed via a oxygenation/fragmentation of the silylcyclopentadiene 45.  Subsequent 
addition of 1O2 to 46 leads to a mixture of 47 and 48.  The authors screened several 
conditions for this reaction and determined that 3-alkoxy-1,2-dioxolane 48 was the 
preferred product under all conditions.  Though desired product 47 was not formed 
exclusively, this route shows the power of 1O2 to quickly form very complex peroxide 
containing systems. 
H
SiMe3
H
O
O
O
O
H
O
O
O
O
1O2 +
45 46 47
Conditions 47:48 Yield
CDCl3, MB, 8oC 1:2 73%
MeOH, MB, 8oC 1:4 NR
Toluene, TPP, 8oC 1:1.3 NR
Toluene, TPP, 65oC 1:1.2 NR
H
O
OH
30 sec
1. 1O2, hv
conditions
2. PTSA or SiO2
48
DePuy ring expansion 
 In 1969, DePuy reported the oxidative expansion of cyclopropanols under O2 as a 
synthetic route to 1,2-dioxolan-3-ols.74  Cyclopropanol 49 underwent ring expansion to 
hydroperoxyalkenoate 51 presumably through intermediate 50.  The cyclization of 51 
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was accomplished under basic conditions to afford perlactone 52, but no yield was 
reported. 
 
 With this methodology established, DePuy showed that 1,2-dioxolan-3-ols can be 
synthesized via a similar approach.  The expansion of 53 was reported to give the desired 
1,2-dioxolan-3-ol 54; however, no yield was reported.     
 
Thermolysis 
 In 1992, Baumstark reported the thermolysis of azahydroperoxide 55 to generate 
1,2,-dioxolane-3-ol 58.75  He postulated that the reaction proceeded through radical 
intermediate 56, which rapidly trapped O2 forming hydroperoxide 57.  In situ cyclization 
of hydroperoxide 57 affords the desired 1,2-dioxolan-3-ol 58.  The reaction worked well 
with a variety of substitution patterns in 55, but the limiting factor in this methodology is 
the synthesis of the precursors, 55.  The reported synthesis of the azohydroperoxides is 
not general enough to make this a widely applicable reaction.76  
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Conjugate addition to α-β-unsaturated carbonyls 
 In 1958, Payne reported the first example of the addition of basic hydrogen 
peroxide to an enone, mesityl oxide.77  The reaction was further explored by Rieche in 
1960.78  Early work used alkaline bases but more recent work has used hydrotalcite79,80 or 
natural phosphate81.  In all of these systems the reaction proceeds through conjugate 
addition of hydroperoxy anion to the enone generate an enolate, which protonates to 
generate hydroperoxy ketone 61.  Subsequent cyclization affords 1,2-dioxolan-3-ol 62.  
However, the intermediate hydroperoxyenolate 60 can easily undergo a 3-exo cyclization 
to form an epoxide, which can often become the major product. 
 
 Attempts to use this methodology on more hydrophobic substrates have proved 
problematic.  Dussault reported that the conversion of 63 to 64 can be accomplished, but 
required highly optimized conditions to obtain even modest yields.82   
 
Ozonolysis of enol ethers 
 In 1984, Kuczkowski reported the first synthesis of 3-alkoxy-1,2-dioxolanes 
through ozonolysis.83  In this initial report, the ozonolysis of methyl vinyl ether, 65, in 
pentane afforded the desired 3-alkoxy-1,2-dioxolane 66.  The use of methyl formate or 
ethyl acetate as solvent led to lower yields, while the use of methanol resulted in the 
isolation of hydroperoxyacetal as the only product.   
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 In subsequent work, Kuczkowski expanded this reaction to methoxy and 
ethoxyethene,84 1- ethoxypropene,85 and 1,2-dimethoxyethene.86  This synthetic approach 
is limited to unsubstituted 3-alkoxy-1,2-dioxolanes as decreased yield occurs with 
aliphatic substitution at C5 in 65.  In addition, the substituents cannot contain ozone 
reactive groups (for example, alkenes) other than the enol ether.  
Radical cyclization 
 The 6-exo cyclization of a peroxyl radical onto an alkene for the synthesis of 1,2-
dioxanes has been established and will not be discussed in detail.87-90  To the best of my 
knowledge a radical cyclization has not been used for the synthesis of 3-alkoxy-1,2-
dioxolanes or 1,2-dioxolan-3-ols, but I will discuss radical cyclization in the synthesis of 
1,2-dioxolanes. 
 In 1976, Porter reported the synthesis of 1,2-dioxolanes through radical 
cyclization as part of a program towards the synthesis of prostaglandins.88  Porter 
reported that reaction of hydroperoxy alkenes 67 in the presence of a radical initiator, di-
tert-butyl-peroxyoxalate (DBPO), and O2 resulted in cyclization to afford 1,2-dioxolanes 
68.  No yields were reported other than to say that analytically pure samples were 
obtained. 
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 In 1989, Bloodworth undertook a study to determine the relative rate of 1,2-
dioxolane vs. 1,2-dioxane formation via free radical cyclization.91  Bloodworth found that 
radical cyclization of hydroperoxydiene 70 led to 1,2-dioxolane exclusively.  The 
reaction was completed successfully under two different sets of conditions to afford 
either 69 or 71 as the final 1,2-dioxolane products, though no yields were reported. 
 
 In 2002, Mayrargue undertook a study of peroxyl radical cyclizations in an effort 
to develop 7-exo-trig  cyclization.87  A 7-exo cyclization (not shown) was unsuccessful, 
but the 5-exo-trig cyclization of hydroperoxyalkene 72 proceeded in low yield. 
 
The ring opening of vinylcyclopropanes via a free radical process has been 
explored heavily in the literature92-95 and has formed the core of an approach towards 
plakortide E.96  The general mechanism is outlined below.  Addition of phenylselenide 
radical to alkene 74 forms an unstable cyclopropylcarbinal radical, 75.  The homoallyl 
radical derived from opening of 76 is rapidly trapped by O2, providing peroxide radical 
77, which after cyclization and loss of phenylselenyl radical affords the desired 1,2-
dioxolane 79. 
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Electrophilic cyclization 
  To the best of my knowledge, the use of electrophilic cyclization with iodine or 
mercury to afford 3-alkoxy-1,2-dioxolanes has not been previously reported.  The 
following section will discuss the synthesis of 1,2-dioxolanes via electrophilic 
cyclization.  
In 1978, Bloodworth reported the synthesis of 1,2-dioxolanes through 
peroxymercuration.97  Diene 80 was first subjected to intermolecular 
hydroperoxymercuration to afford hydroperoxide 81 as a transient intermediate that 
undergoes an intramolecular electrophilic peroxymercuration to the 1,2-dioxolane.  
Demercuration was accomplished with NaBH4 affording the desired 1,2-dioxolane 83.  A 
further study of this type of cyclization was reported by Bloodworth in 1980.98 
 
 Bloodworth later reported the relative rates of electrophilic cyclizations to form 
1,2-dioxolanes and 1,2-dioxanes.91  The major products of peroxymercuration were 1,2-
dioxanes, but 1,2-dioxolanes were isolated as the minor product.  The cyclization of 
hydroperoxide 84 was accomplished using Hg(NO3)2 to form 1,2-dioxolane 85. 
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OOH O O
BrHg
84 85
1. Hg(NO3)2
2. KBr
 
 The problem that has plagued the formation of 1,2-dioxolanes using electrophilic 
cyclization has been the final demercuration or dehalogenation.  As early as 1970 
Bloodworth reported that decomposition of the peroxide occurred when transforming a β-
peroxyorganomercurial to a halide.99  In 1972, Bloodworth reported an investigation of 
the demercuration of β-peroxyorganomercurial with NaBH4.100  Radical scission of the 
peroxide bond leads to epoxide 88 while trapping of the radical leads to peroxide 89. 
Bloodworth reported that this side reaction can be decreased through reduction at lower 
temperature, but cannot be eliminated.  In subsequent work, Bloodworth reported that 
increased substitution of the peroxide R = Me increases the rate of the scission.101 
O
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O
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R86 87
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 In 1978, Porter undertook a study of the SH scission reaction and concluded that 
the dihedral angle of the peroxide bond and the radical must be 180o for maximum 
reactivity.102  When bromides 90-93 were treated with Bu3SnH it was found that each of 
the bromides gave a different ratio of reduction (peroxide) vs. scission (epoxide).  
Bromide 91 is easily able to adopt the proper dihedral angle in a low-energy chair 
conformation and as a result undergoes predominantly scission.  For the bromoalkyl 
dioxolanes 90 and 92, the conformation allowing overlap of the radical with the backside 
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of the peroxide is disfavored, and reduction of the radical becomes the dominant reaction.  
In the case of a 4-bromo-1,2-dioxepane (93), the intermediate radical is unable to interact 
with the backside of the O-O and only reduction is observed. 
 
Section 2.2 
Reactions of 1,2-dioxolan-3-ols and 3-alkoxy-1,2-dioxolanes 
Acid-Mediated etherification 
 In 1994, Baumstark undertook an investigation of the etherification of 1,2-
dioxolan-3-ols under acidic conditions.103  Subjecting 1,2-dioxolan-3-ols 94-96 to acidic 
conditions led to decomposition at varying rates to the corresponding diketone.  
Qualitatively the order of decomposition was found to be 94>95>96.  Baumstark 
postulated the 1,2-dioxolan-3-ols underwent a Criegee-like decomposition with C-O 
migration to afford the diketone and a molecule of alcohol or phenol.   
O O
OH
RR1
R2
R1 R
O O
94 R=R1=R2=Ph
95 R=R1=Me; R2=Ph
96 R=Ph; R1=R2=Me
H+ + R2OH
 
 As 96 underwent decomposition the slowest, it was resubjected to the same 
conditions in the presence of methanol as a nucleophile.  The result was the synthesis of 
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the 3-methoxy-1,2-dioxolane in good yield.  This represented a new synthetic strategy 
that was later exploited by Dussault in his synthesis of 3-alkoxy-1,2-dioxolanes.82  
Base-Mediated etherification 
 In 1994, Baumstark reported a base mediated etherification of 1,2-dioxolan-3-
ols.103  Pentasubstituted 1,2-dioxolan-3-ol, 97, successfully underwent base mediated 
silylation (TMSCl), alkylation (MeOTf), and esterification (Ac2O) in good yield.  
Attempts to use less active electrophiles such as MeI and MeOTs were unsuccessful.  
This reaction was only reported for pentasubstituted 1,2-dioxolan-3-ols.  
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Allylation of 3-alkoxy-1,2-dioxolanes 
 The allylation of either hydroperoxyacetals104-106 or silyl peroxyketals107 that 
result in the formation of 1,2-dioxolanes has been reported and will not be discussed in 
depth. 
 In 1999, Dussault reported the allylation of 3-alkoxy-1,2-dioxolanes to form 1,2-
dioxolanes.  The reaction of 98 with allyltrimethylsilane and SnCl4 proceeded in good 
yield to afford 1,2-dioxolanes 99.  The authors suggested that the reaction involved 
ionization to a peroxide-stabilized carbenium anion.  The best yield was obtained when 
SnCl4 was used as opposed to TiCl4 as the Lewis acid.  A variety of silyl enol ethers were 
also successfully applied as nucleophiles under similar the reaction conditions (Not 
shown). 
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Section 3 
 
This section describes the synthesis of first generation 3-alkoxy-1,2-dioxolanes and 
evaluation of their antimalarial activity. 
A portion of this work has been previously published.108 
Section 3.1: Early work 
Section 3.2: Synthesis of 3-alkoxy-1,2p-dioxolanes 
Section 3.3 Antimalarial results 
Section 3.1 
Early work on 3-alkoxy-1,2-dioxolanes 
 Previous work in the Dussault lab by Dr. Liu led to a new method for the 
synthesis of 3-alkoxy-1,2-dioxolanes.82  Six of these 3-alkoxy-1,2-dioxolanes, 100-105, 
were later tested against P. falciparum and showed promising in vitro activity (Table 
2.1).109-111  Inhibition was determined by measuring the uptake and incorporation of 
[3H]hypoxanthine by the parasite compared to the control.  Initial analysis of quantitative 
structure activity relationship (QSAR) data suggested the following: R should not be an 
aliphatic hydrocarbon (compare 100 and 105); and, that the molecule as a whole not be 
too polar (compare 103 vs. 104).  Two of the initial compounds with the best activity, 
101 and 102, share the common structural feature of an aromatic ring in the alkoxy side 
chain. 
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Compound R1 R IC50 (nM) 
100 Me Heptyl >1000 
101 Me Bn 472 
102 Me 2-phenylethyl 415 
103 Me 2-methoxyethyl >1000 
104 Bu 2-methoxyethyl 392 
105 Bu propyl >1000 
Table 2.1 Initial Screen of 3-alkoxy-1,2-dioxolanes 
 
Section 3.2 
Synthesis of additional “first generation” 3-alkoxy-1,2-dioxolanes 
 These early results encouraged further exploration of the QSAR of 3-alkoxy-1,2-
dioxolanes to gain more insight into which features affect activity.  At this stage, I mainly 
focused on varying only the substitution on the alkoxy sidechain.  The synthesis of 107 
utilized addition of basic H2O2 to mesityl oxide, 106.77  The low yield was tolerated as 
mesityl oxide is both cheap and commercially available.  The synthesis of 110 began with 
commercially available enone 108 which underwent a nucleophilic addition and oxidative 
rearrangement to afford enone 109 in moderate yield.  However, conjugate addition of 
basic H2O2 to this more hydrophobic enone led primarily to the epoxide and gave the 
desired 1,2-dioxolan-3-ol, 110, in low yield.   
O O
Bu OH1. n-BuLi (56%)
2. PDC (69%)
O
Bu
O
30% H2O2
7%
109
107
110
O
O O
OH
108
30% H2O2
24%
106
 
Since a route to ketone 109 was established, I decided to investigate Mukaiyama 
cobalt-mediated peroxidation for the insertion of the peroxide bond.112  It was envisioned 
that the crude product of oxygenation, 111, would cyclize in the presence of acid to form 
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the desired 1,2-dioxolan-3-ol, 110.   However, upon performing the oxygenation under 
standard conditions, analysis of the reaction by TLC found that only starting ketone 109 
and 1,2-dioxolan-3-ol 110 were present in appreciable amounts.  A faint spot that might 
have been 111 was present, but all attempts to isolate this spot were unsuccessful.  The 
attractiveness of this route is the formation of 110 in a one-pot fashion.  In addition, 
unreacted 109 can be recovered and resubmitted to the reaction conditions.   
 
The Co-mediated oxygenation, while an improvement over the conjugate addition 
of H2O2, does have a couple of drawbacks.  When the recovered ketone is resubmitted to 
the reaction conditions, the reaction does not always initiate.   This issue can be 
circumvented by utilizing Isayama’s protocol of adding a catalytic amount of t-
BuOOH.113  In addition, purification of 1,2-dioxolan-3-ol (110) is hampered by the co-
elution of a species whose exact identity was never determined but was assumed to be a 
CoIII species based upon the green color.  One solution to this problem is the use of a 
larger ratio of silica gel to compound.  Another solution is to transform 110 into the 
trimethylsilyl ether 112, which is easily purified. 
 With the synthetic route to the precursors established, it became necessary to 
decide which alkoxy sidechains would be employed.  The best results in the initial screen 
were observed for substituents which contained an aromatic ring (Table 2.1).  To 
determine if the beneficial effect of the aromatic ring was related to steric bulk, we 
became interested in the potential of an adamantane ring.  In addition to allowing the 
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investigation of steric bulk, the adamantane ring allows investigation of isomeric modes 
of connectivity (1 vs. 2-adamantyl) to the alkoxide sidechain.  
 2-Adamantanemethanol (115) and 2-adamantaneethanol (116) were not 
commercially available and needed to be synthesized.  Two different approaches were 
employed.  The synthesis of 115 began with Wittig olefination of 2-adamantanone to 
afford alkene 114 which, without purification, was subjected to hydroboration/oxidation 
to provide 2-adamantanemethanol, 115.  A Horner-Wadsworth-Emmons olefination of 2-
adamantanone afforded ester 116 which upon reduction with Dibal-H provided allylic 
alcohol 117.  Hydrogenation of 117 was accomplished over a Pd/C catalyst, but under 
these conditions the deoxygenated product was also isolated.  This problem can be 
circumvented by hydrogenation over Pt/C.  Regardless of which catalyst is used, 2-
adamantaneethanol, 118 is isolated in moderate yield. 
 
Acid catalyzed etherification of the 1,2-dioxolan-3-ols with a variety of alcohols 
proceeded in low yield and required long reaction times.  It was thought that the 
corresponding OTMS ether 112 might be a more effective electrophile that would react to 
generate the same carbocation as the 1,2-dioxolan-3-ol but would not liberate water.  This 
approach worked better than expected, providing improved yields of 3-alkoxy-1,2-
dioxolane, 119, after much shorter reaction times as compared with the free alcohol.  The 
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superiority of the trimethylsiloxydioxolanes as electrophiles for transetherification was 
also observed for other backbones as can be seen in Table 2.2.  
 
Compound X R t (h) Yield (%) 
119 H Bn >12 60 
119 TMS “ 0.3 60 
120 TMS Cyclohexanemethyl 2 86 
121 H CH2CH2Ph >12 30 
121 TMS “ 1 80 
122 TMS Cyclohexaneethyl 2 82 
123 TMS CH2CH2CH2Ph 3 92 
124 H 1-adamantanemethyl 48 26 
124 TMS “ 1 62 
125 H 2-adamantanemethyl 72 34 
125 TMS “ 1 57 
126 H 1-adamantaneethanol 72 43 
126 TMS “ 1 72 
127 H 2-adamantaneethanol 12 23 
127 TMS “ 1 60 
128 H Butyl 48 56 
Table 2.2 C5-Bu/C5’-Me series 
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With the 5,5’-butyl/methyl series complete, I undertook the synthesis of the 5-
methyl/methyl series.  The same strategy as described above was employed for this series 
as well.  As expected, utilization of the trimethylsiloxydioxolane led to improved yields 
and shorter reaction times compared with the use of 1,2-dioxolan-3-ol.  
 
Compound X R t (h) Yield (%) 
129 H Bn 3 66 
129 TMS “ <0.1 74 
130 TMS Cyclohexanemethyl 2 84 
131 H CH2CH2Ph 5 73 
132 TMS Cyclohexaneethyl 2 71 
133 H CH2CH2CH2Ph 2 71 
134 H 1-adamantanemethyl 12 33 
134 TMS “ 3 65 
135 H 2-adamantanemethyl 48 75 
135 TMS “ 2 62 
136 H 1-adamantaneethyl 12 16 
136 TMS “ 1 76 
137 H 2-adamantanethyl 12 59 
138 H Butyl 3 56 
138 TMS Butyl 1 51 
Table 2.3 C5 /C5’ Me series 
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Section 3.3 
Antimalarial results and discussion 
The results of in vitro antimalarial screening for 3-alkoxy-1,2-dioxolanes 119-138 are 
shown in Table 2.4.109-111 
 
Compound R R1 IC50 nM 
119 Bu Bn 140 
120 Bu Cyclohexanemethyl 69 
121 Bu CH2CH2Ph 76 
122 Bu Cyclohexaneethyl 91 
123 Bu CH2CH2CH2Ph 27 
124 Bu 1-adamantanemethyl 136 
125 Bu 2-adamantanemethyl 118 
126 Bu 1-adamantaneethyl 155 
127 Bu 2-adamantaneethyl 169 
128 Bu Butyl 1400 
129 Me Bn 472 
130 Me Cyclohexanemethyl 83 
131 Me CH2CH2Ph 415 
132 Me Cyclohexaneethyl 132 
133 Me CH2CH2CH2Ph 46 
134 Me 1-adamantanemethyl 289 
135 Me 2-adamantanemethyl 257 
136 Me 1-adamantaneethyl 252 
137 Me 2-adamantaneethyl 218 
138 Me Butyl >10000 
Table 2.4 Antimalarial results 
 I was excited to see several of the molecules with IC50 values <100 nM.  When 
analyzing the QSAR data the most obvious trend is the importance of the substitution at 
C5: dioxolanes with R = Bu are significantly more active than those with R = Me.  Only 
the trends within the R = Bu series will be discussed in detail; the same trends also hold 
in R = Me series.  The most active compounds 123 and 133 were synthesized at a later 
date.  They are included in this table as they are structurally most closely related to the 
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“first generation” shown here.  Of the originally synthesized compounds, 131 was the 
most active and demonstrates that the length of the alkoxy sidechain is important, for 
example 119 vs. 121.  The use of a cyclohexane ring in the sidechain instead of the 
aromatic ring leads to a slight decrease in activity, as can be seen for 120 and 122.  When 
a bulkier adamantyl group is present in the alkoxy side chain (124-127) there is a 
decrease in activity, regardless of connectivity.  Taken together, these results suggest that 
the most active compound will have a bulky group at C5 and an alkoxy sidechain that is 
phenylethyl. 
These results show that the 3-alkoxy-1,2-dioxolanes are a promising scaffold for 
potential antimalarials and support further exploration of this framework is needed.  
Given that there was limited rational design to the molecules that were initially 
synthesized, it is reasonable to believe that even higher activities are attainable.  These 
early results give the impression that higher activities can be obtained by placing a 
bulkier group or aromatic ring here or there, but subsequent work will reveal that 
identification of optimal attributes within this system is more complicated.  
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Section 4 
Second generation alkoxydioxolanes: design and synthesis 
 
Portions of the work described in this section have been previously published.108 
 
This chapter has been organized in the following sections: 
Section 4.1: Rationale 
Section 4.2: Incorporation of spirocycle at C5/C5’ 
Section 4.3: Effect of ring size at C5/C5’ 
Section 4.4: Investigation of the nature of the radical leaving group at C3 
Section 4.5: Spirocyclic alkoxydioxolanes 
Section 4.6: Future directions 
Section 4.7: Experimentals 
Section 4.1 
 Rationale for new series 
 With the knowledge that even simple 3-alkoxy-1,2-dioxolanes possessed  
significant antimalarial activity, I set about optimizing the structures to maximize 
activity.  I approached this optimization from three different angles.  The first was 
incorporating cyclic restraint in the form of a spirocyclohexane at the C5 position 
forming a family of spirocycles exemplified by 139.  The second approach is related to 
our hypothesis, which was that the postulated activity of 3-alkoxy-1,2-dioxolanes is 
related to a carbon centered radical generated at the C3 position.  We therefore predicted 
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that changing the proposed radical leaving group to a better leaving group should lead to 
increased activity (140).   
O O
OR
O O
R
O
Ph
139 140  
 The third approach was to synthesize a molecule that more closely resembled 
Vennerstrom’s ozonides enabling a direct comparison.63  As described in the 
introduction, Vennerstrom reported that 1,2-dioxolanes such as 142 had essentially zero 
antimalarial activity even though analogous ozonides (141) were very potent.  We 
hypothesized that this difference reflected a lower rate of β-fragmentation of the 
intermediate alkoxy radical compared with the α-alkoxy alkoxy radical derived from the 
ozonides.  We hypothesized that the faster rate of fragmentation would be restored in 3-
alkoxy-1,2-dioxolanes such as 143.  Like the ozonides, the alkoxydioxolanes place an 
oxygen on the peroxide-bearing carbon. Support for this approach comes from 
McCullough’s work demonstrating that 1,2,4-trioxanes undergo rapid β -scission forming 
a carbon centered radical.22 
 
Section 4.2  
Incorporation of a spirocycle at C5/5’ 
 I began with the synthesis of the spirocyclic series represented by 139.  I 
envisioned a Mukaiyama cobalt peroxidation of an unsaturated ketone as the key step to 
insert the peroxide.  A Prins114 reaction of 144 with acetaldehyde furnished the 
homoallylic alcohol which underwent Swern oxidation to afford ketone 145.  However, 
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peroxidation of ketone 145 under Mukaiyama conditions proceeded in moderate yield 
with starting material being recovered (~30%).112   
 
 Isayama reported that the use of catalytic t-BuOOH led to decreased reaction 
times and increased yields in the Mukaiyama cobalt-mediated peroxidation.113  
Serendipitously, I discovered that the use of 100 mol % of t-BuOOH as an additive leads 
to both rapid initiation and increased yield of 146.  This protocol, while more efficient in 
terms of reactivity, still requires optimization as 1,2-dioxolan-3-ol 146 is not produced as 
the sole product. A TLC of the reaction appears to show some uncyclized intermediate 
(hydroperoxy ketone), but all attempts to force the cyclization with the use of TsOH led 
to decomposition. The more significant problem with this approach is the formation of an 
alkene impurity that is not present in reactions conducted in the absence of t-BuOOH or 
in the presence of catalytic amounts of t-BuOOH.  The impurity can be removed by 
ozonolysis, creating a tradeoff of increased yield versus an additional purification step. 
 
 The transetherification of 147 was undertaken with a variety of primary alcohols.  
Both aromatic and non-aromatic containing alkoxy sidechains were introduced in this 
manner.  In all cases the transetherification proceeded in good yield to afford compounds 
148-155.  It was subsequently discovered that 3-alkoxy-1,2-dioxolanes derived from 2-
phenylethanol (148) was contaminated with less than 5% of the acetal formed from 2-
phenylethanol and bis-2-phenylethylacetal of 2-phenylacetaldehyde.   Although I could 
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detect very little of the aldehyde as an impurity in the 2-phenylethanol used as a reagent, 
the problem was solved by using a fresh supply of reagent.  
 
Compound R t (h) 
Yield 
(%) 
IC50 (nM) 
NF54 
148 2-phenylethyl 2 86 9 
149 Bn 1 57       19 
150 3-phenylpropyl 2 88 19 
151 4-phenylbutyl 3 72 17 
152 2-cyclohexylethyl 2 81 41 
153 Cyclohexylmethyl 2 84 30 
154 1-adamantylethyl 24 70 29 
155 1-adamantylmethyl 2 89 35 
Table 2.5 spirocycle at C5/5’  
 The screening of this set of molecules provided some important QSAR data that 
helped guide subsequent synthesis.  All of the different ethers 148-155 demonstrate good 
or better activity then the “first generation” ether (Section 3), suggesting the most 
important design element is the C5/C5’ spirocycle group.  The most active molecule in 
this series, 148, contains a phenylethyl side chain. The two carbon spacer between the 
oxygen and the arene was optimal, but the chain could either be shortened or lengthened, 
149-151, with only slight decrease in activity.  As was found in the earlier series, there 
was a loss of activity when the non-aromatic analogs were employed (148 vs. 152, 149 
vs. 153), though again this decrease was minor.  Finally, incorporation of adamantane as 
a bulky non-aromatic group in the alkoxy sidechain is effective, but led to a lower IC50 
than the aromatic analog.   
Since the best activity in 3-alkoxy-1,2-dioxolanes was observed in substrates 
containing an aromatic ring in the ether sidechain,  Dr. Vennerstrom suggested that I 
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complete a Topliss scheme.  The Topliss scheme, developed by John Topliss provides a 
pathway for modifying the substitution around an aromatic ring to most rapidly identify 
the derivatives with the best activity.115,116  Due to the time delay between synthesis and 
biological testing, I did not follow the Topliss scheme literally.  Instead, I synthesized 
several “Topliss” generations of 3-alkoxy-1,2-dioxolanes which were submitted for 
biological testing.  The alkene impurity formed as a byproduct in the t-BuOOH mediated 
synthesis of 147 complicated the purification of this series.  Initially, I hoped it would be 
possible to adequately purify the compounds by HPLC, but this was not the case.  It 
became necessary to ozonize 3-alkoxy-1,2-dioxolanes 156-163 in a separate step prior to 
chromatography. The majority of the compounds were not affected, but electron rich 
substrates such as 157 and 165 underwent significant decomposition.   
 
Compound X t  (h) 
Yield 
(%) 
IC50 (nM) 
NF54 
IC50 (nM) 
K1 
148 H - - 9 ND 
156 4-Cl 3 61 18 13 
157 4-OMe 24 39 15 14 
158 4-Me 2 65 18 15 
159 3,4-Cl 3 22 18 20 
160 3-Cl 3 37 19 17 
161 4-F 3 71 15 14 
162 4-tBu 3 65 23 19 
163 4-OH 4 62 11 11 
164 2-Cl 3 57 18 16 
165 4-Br 3 47 29 30 
Table 2.6 Topliss results 
 Compounds 156-165 were tested in vitro against both chloroquine-sensitive 
(NF54) and chloroquine-resistant (K1) strains of P. falciparum and all exhibited excellent 
activity.109-111  Moreover, in almost all cases 156-165 exhibit as good if not better activity 
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against chloroquine-resistant malaria as against chloroquine-sensitive malaria.  Analyses 
of the results from a Topliss perspective show they do not follow the expected activity 
trends.  Since p-chlorophenol derivative 156 was less active than unsubstituted arene 148, 
it was expected that p-methoxyphenol derivative 157 would be more active, however, this 
is not the case.  These results suggest that the sterics or electronics of the substituents of 
the aromatic ring are not a major factor in activity.  The fact that the substitution of the 
aromatic ring does not significantly affect activity suggests the ring may provide a 
synthetic handle to synthesize a more diverse set of compounds.   
Section 4.3  
Effect of ring size at C5/C5’ 
 O’Neill reported that the antimalarial activity of 1,2,4,5-tetraoxanes could be 
modified by altering the attached ring in the following sequence: cyclohexane < 
cyclodecane < adamantyl.25  This report prompted me to briefly explore the effect ring 
size at the C5 position in 3-alkoxy-1,2-dioxolanes to see if it follows the trend reported 
by O’Neill.   I prepared the C5,5’ spirocyclopentane (5-membered) and the 
spirocyclodecyl (12-membered) rings following a similar strategy to that used for the 
synthesis of 148.  The synthesis began with alkenes 166/167, which readily underwent 
Prins114 addition and Swern oxidation to afford ketones 168/169.  As expected, the 
cobalt-mediated peroxidation followed by silylation afforded the trimethylsiloxy 
alkoxydioxolanes 170/171.  Finally, transetherification with 2-phenylethanol under acidic 
conditions afforded the desired 3-alkoxy-1,2-dioxolanes 172/173.  Both of the final 
compounds were accompanied by an alkene impurity, which could be removed by 
ozonation followed by HPLC purification. 
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(CH2)n
O
(CH2)n
Co(acac)2
Et3SiH, O2
ClCH2CH2Cl
O O
(CH2)n
OTMS
166 n = 1
167 n = 8
168 64% two steps
169 70% two steps
170 55% two steps
171 71% two steps
172 n = 1 62%
173 n = 8 24%
HOCH2CH2Ph
PTSA
1. Acetaldehyde
Me2AlCl
2. Swern
O O
(CH2)n
OCH2CH2Ph
 
 In vitro testing against P. falciparum revealed a decrease in activity as the ring 
size either increased or decreased.109-111  This does not follow the trend extrapolated from 
O’Neill’s work.  Though 172/173 are less active then 148, they possess good activity and 
show how robust the system is to changes away from the 3-alkoxy-1,2-dioxolane core.  
If, for example, activity of 148 was related to binding the spirocyclohexyl into a cleft or 
pocket, it would be expected that 173 would have virtually no activity as the larger 
molecule would not be able to fit in the same pocket as 148.  These results appear to 
indicate that the size of the ring at C5 is important but not critical to activity.  
 
Section 4.4 
Improved leaving group 
Based upon the hypothesis that the antimalarial activity is related to ejection of a 
carbon radical from the intermediate α-alkoxyl radical, I wanted to investigate alterations 
of the putative leaving group.  To test this hypothesis I prepared compounds 174-176.  I 
postulated that activity would increase with the ability of the leaving group to stabilize a 
developing radical, and should follow the trend 174>175>176.   The synthesis of 176 
(phenylethyl leaving group) as a negative control was undertaken for two reasons.  The 
 
 
65 
first is that it should behave in a similar manner to methyl in terms of radical stabilization 
while possessing steric bulk more similar to benzyl, enabling a more direct measure of 
the effect the leaving group has on activity.  Synthesis of both the C5 Me/Me and 
spirocyclohexyl series was undertaken as it was not known if substitution at that position 
would have an effect on activity.  
 
 The synthesis of 181 and 182 began with the Prins114 reaction of the appropriate 
aldehyde to afford homoallylic alcohols 177 and 178.  The alcohols underwent Swern 
oxidation to afford ketones 179 and 180.  Subsequent Mukaiyama cobalt-mediated 
peroxidation with the t-BuOOH modification was followed by silylation to afford 
siloxydioxolanes 181 and 182.   
 
 The synthesis of 187 began with the addition of Grignard 184 to aldehyde 183 to 
provide alcohol 185.  Oxidation of the alcohol with PDC afforded ketone 186.  Cobalt-
mediated peroxidation under Isayama conditions113 provided 1,2-dioxolan-3-ol 187.   The 
yield for this reaction is low, in line with my previous experiences for enones.  This low 
yield, in conjunction with the low yields of the previous steps, made this route not viable.  
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I had observed that cobalt-mediated peroxidation of deconjugated systems often 
proceed in higher yields.  I therefore was interested in preparing β-γ-unsaturated ketone 
258.  I decided to utilize a Prins reaction of 183 with isobutylene to afford 188.  
However, the Swern oxidation of 188 was accompanied by isomerization of the alkene 
leading to isomers 189 and 186. 
 
 Use of a Weinreb amide would allow the formation of the ketone without having 
to perform any oxidation.  Formation of the Weinreb amides, 190 and 191, from the 
corresponding acids was accomplished in excellent yield.  Addition of 
methylallylmagnesium chloride proceeded in good yield to afford 189 and 192.  
However, if excess 2N HCl was used during workup, isomerization of the alkene does 
become a problem.  The synthesis of dioxolanes 187 and 193 was completed by cobalt-
mediated peroxidation and silylation. 
  
 The final molecules in this class that I wished to synthesize would incorporate a 
cyclohexane at C3.  The addition of Grignard 184 to aldehyde 194 afforded alcohol 195 
in moderate yield.  The oxidation of 195 proceeded to complete conversion only with 
PDC; the use of MnO2 or Swern oxidation either led to incomplete oxidation or a mixture 
of products.  Unfortunately, the cobalt-mediated peroxidation proceeded in very low 
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yield to give 1,2-dioxolan-3-ol 197. This route was deemed impractical due to the series 
of low yielding steps and the difficulty in obtaining the cyclohexylidene analog of 184. 
 
 This setback encouraged me to employ a DePuy ring expansion to install the 
peroxide moiety.74  The attractiveness of the DePuy expansion in this system was the 
ease of setup and the mildness of the conditions.  The synthesis began with commercially 
available dicyclohexyl ketone 198 which was converted to the silyl enol ether.  Simmons-
Smith reaction formed cyclopropane 199.  The workup of the Simmons-Smith reaction 
led to formation of 10% of the deprotected product 200.  If I was to perform this 
synthesis again, I would perform an acidic workup and isolate only cyclopropanol 200.  
Deprotection of 199 was accomplished with TBAF to afford cyclopropanol 200 in 
excellent yield.  Finally, DePuy oxidative ring expansion proceeded in good yield to 
afford desired 1,2-dioxolan-3-ol 201.  In the course of scaling the reaction up, I found this 
process to be less efficient at larger scale.  In addition, the use of distilled benzene was 
found to be vital as the use of benzene from the bottle did not work even with the 
addition of triethylborane.   
 
 I attempted to extend this methodology to the 3-adamantyl analog of 206, but this 
endeavor turned out to be more challenging than anticipated.  Initially, a route that 
utilized the Mukaiyama cobalt-mediated peroxidation was planned on the ketone derived 
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from 204.  However, the synthesis of the precursor allylic alcohol (204) proved more 
difficult then anticipated.  The synthesis of 202 was uneventful.  However, preparation of 
203 by oxidation of the corresponding alcohol was plagued by formation of the formate 
as a major byproduct.  At this point it was decided that it was more important to know if 
the planned cobalt peroxidation would work, so the synthesis continued with impure 203.  
Reaction of the alkenyl lithium of 202, generated in situ, and aldehyde 203 afforded 204.   
The oxidation of 204 could not be accomplished with a variety of oxidants including 
Swern, PCC, MnO2, or Dess-Martin.  Undeterred by this set back, I converted alcohol 
204 to acetate 205.  Unfortunately, the acetate also failed to undergo Mukaiyama cobalt-
mediated peroxidation.   
 
 With most of the desired 1,2-dioxolan-3-ol precursors in hand, I performed a 
series of acid catalyzed transetherifications yielding 3-alkoxy-1,2-dioxolanes 207-213.  
The resulting 3-alkoxy-1,2-dioxolanes were tested in vitro against P. falciparum 
(NF54).109-111  As predicted from the previous generations, the molecules containing a 
spirocyclohexyl at C5 led to increased activity over those with C5/5’ dimethyl.  
According to the leaving group hypothesis, benzyl 210 should be the most active 
molecule of the series 210-213; instead it was the least active.  In contrast, 213 which was 
predicted to be middle of the road, was very active.  The negative controls 211 and 212 
were also very active.  Closer examination of the screening data reveals that none of the 
modifications were able to increase activity above the level of 148, which features a C3 
Me as the putative leaving group.  Sterically, 148 and 211 are almost identical and have 
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virtually the same activity.  The inhibition data on 212 suggests that having too much 
steric bulk leads to decreased activity.  The only constant in these results is that the 
activity is not greatly improved by having a better radical leaving group at C5, as 
evidenced by the lower activity of 207 and 210.   
 
Compound R R1 X 
t 
(h) 
Yield 
(%) 
IC50 (nM) 
NF54 
  207A Me Bn Me 72 73 968 
208 Me CH2Bn Me >12 99 23 
209 Me CH2Bn CH2Bn 5 61 30 
210 (CH2)5 Bn Me >12 93 335 
211 (CH2)5 CH2Bn Me 5 66 8.6 
212 (CH2)5 CH2Bn CH2Bn 6 66 21 
  213 A (CH2)5 C6H10 Me >12 90 9.2 
148 (CH2)5 Me CH2Bn 2 86 9 
Table 2.7 AFree 1,2-dioxolan-3-ol was employed 
Section 4.5  
Spirocyclic 3-alkoxy-1,2-dioxolanes 
The final target in this series was 143, which would be a close structural mimic 
for one of Vennerstrom’s ozonides and would therefore allow comparison of the 3-
alkoxy-1,2-dioxolanes and the ozonides.  Retrosynthetically, I envisioned 143 being 
formed via an acid catalyzed ring closure of 214, with the key step in this synthesis being 
a Mukaiyama cobalt-mediated peroxidation of alkenyl hemiacetal 215.  It was hoped that 
214 could be quickly assembled via addition of alkenyl lithium 217 to lactone 216.  A 
test reaction showed that n-BuLi could be added successfully to 216.  However, when 
this reaction was repeated with alkenyl lithium 217 the desired lactol 216 was either not 
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formed or formed in very low yield as part of a mixture.  
 
 Ultimately, I decided upon a route that would establish the 1,2-dioxolane via 
electrophilic cyclization.  Hydroxyalkenone 220 would be treated with acidic hydrogen 
peroxide to form hydroperoxyacetal 219.  Cyclization with Hg (II) would provide 
organomercurial 218, which upon demercuration would afford the target 3-alkoxy-1,2-
dioxolane 143. 
 
 The synthesis of the cyclization precursor 219 began from commercially available 
5-hexen-1-ol, 221.  The alcohol was protected as the OTBS ether and the alkene was 
subjected to ozonolysis, affording aldehyde 222.  Prins reaction of 222 with 
methylenecyclohexane, followed by a Swern oxidation of the resulting alcohol afforded 
ketone 224.  Treatment of 224 with TBAF resulted in deprotection to the free alcohol.  
Some isomerization of the alkene occurred during the desilylation.  This was of no 
concern as a treatment of the mixture under acidic conditions with urea hydrogen 
peroxide afforded solely 219. 117 
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 Unsaturated hydroperoxide 219 underwent electrophilic cyclization with 
Hg(OAc)2 to afford organomercurial 218, as a mixture of isomers.  Demercuration with 
NaBH4 led to a mixture of epoxide 225 and 3-alkoxy-1,2-dioxolane 143.  The epoxide 
arises through a SHi reaction of the intermediate radical.  Demercuration with HsnBu3, a 
method reported by Bloodworth, was unsuccessful on this system.118  
 
 I therefore pursued the corresponding peroxyiodination assuming that 
dehalogenation of an iodide would be more easily accomplished.  Peroxyiodination of 
219 furnished dioxolane 231 in moderate yield.  Initially, reduction of the iodide was 
performed with a dilute solution of HsnBu3 in benzene, but the SHi product dominated.  
Increasing the concentration of Bu3SnH resulted in the desired peroxide 143 becoming 
the major product.  The use of neat Bu3SnH leads to almost complete suppression of 225 
formation.  Separation of 225 and 143 could only be accomplished by HPLC, so the 
crude mixture was treated with a hydride reagent to selectively reduce 225 to the more 
polar alcohol.  Dibal-H did not lead to complete consumption of ester 225, but LiAlH4 
was employed successfully.  Since an alkyl tin was used in the final stages of this 
synthesis, there was concern that residual tin might be present in 143.  ICPMS revealed 
that tin was present, but only in ppb concentration. 
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 When 143 was tested against P. falciparum in vitro the reported activity was 16 
nM.109-111  This result is in line with the other 3-alkoxy-1,2-dioxolanes that have tested, 
but is a significant improvement compared with the corresponding Vennerstrom ozonide 
141.119  An explanation for this difference in activity is not known, but suggests the need 
for further exploration of these dispiro systems.  
 
Section 4.6  
Future directions 
 The following discussions suggest potentially profitable future research directions 
related to the results described within this section.  
For the cyclohexyl 3-alkoxy-1,2-dioxolanes (sec. 2.1), future work needs to focus 
on the incorporation of amine containing sidechains.  Throughout this work the presence 
of an aromatic ring has led to increased activity and the Topliss work has shown the 
robustness of this system.  By robust I mean that the 3-alkoxy-1,2-dioxolanes do not 
appear to lose significant efficacy despite changes made around the 1,2-dioxolane core.  
It would have been expected that as changes were made to the aromatic ring there would 
have been an increase or decrease in activity, but, instead it remained fairly constant.  The 
next step in the development of this class of compounds would be the incorporation of an 
amine into the alkoxy sidechain to facilitate solubility and drug delivery.  
 I do not believe that further investigations into a better radical leaving group are 
warranted (Sec 4.4).  The nature of the leaving group appears to have no effect on activity 
and thus the one that is simplest to incorporate synthetically should be employed.  This 
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anomaly can be further explored if the mechanism of action is ever studied.  It would be 
interesting to determine if the better radical leaving groups are less active because the 
radicals are insufficiently reactive with the yet unknown target.  Or does the radical 
binding require a sterically small radical like a methyl or phenylethyl?  Based upon the 
most widely accepted MOA the major radical formed from artemisinin is in essence an 
ethyl radical (see section 1) 226 needs to be synthesized.  Out of all the compounds 
synthesized, I believe that this molecule has the highest potential for further success as it 
is a direct analog of the ozonide series, some of the most active synthetic peroxide 
antimalarials.  The higher activity of 143 to 141 suggests that 226 should have even 
higher activity.   Likewise 227 would provide the other Vennerstrom mimic and should 
be synthesized as well.  
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Section 5 
“Third generation” 3-alkoxy-1,2-dioxolanes” 
This section describes investigations of 3-alkoxy-1,2-dioxolanes bearing 
additional functionalization beyond that contained in the frameworks explored in Section 
2.  All but one of the compounds in this section features the C5/5’ dimethyl substitution.  
While the spirocyclohexyl analogs are always more active than the dimethyl analogs, the 
same trends hold in the two lines. Therefore, since the dimethyl is both quicker and 
cheaper to synthesize it was used as the initial screen to find potential hits.   
This section contains: 
Section 5.1: Esters 
Section 5.2: Alcohols  
Section 5.3: Derivatized alcohols 
Section 5.4: Other Functional groups 
Section 5.5: Animal studies 
Section 5.6: Comments on stability 
Section 5.7: Future directions 
Section 5.1  
Esters 
Rationale 
 The synthesis of 3-alkoxy-1,2-dioxolanes containing esters in the alkoxy 
sidechain was driven by the desire to create more polar 3-alkoxy-1,2-dioxolanes and to 
add a synthetic handle for further functionalization.  For example, saponification of the 
ester would provide an acid that could be used to install a more biologically relevant 
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amide.  Up to this point, all of the 3-alkoxy-1,2-dioxolanes have been hydrophobic with 
Log P values 1.5 to 6.73, as computed by ChemDraw.  Though the majority of previously 
synthesized 3-alkoxy-1,2-dioxolanes fall within Lipinski’s guidelines for Log P,120 most 
are at the higher end of the Log P limit.  Therefore, I wanted to synthesize a small library 
of compounds with Log P values ranging from 1.47 to 4.26.   
Synthesis 
 The key step in the synthesis of the esters would utilize the Ca(OCl)2-mediated 
decomposition of hydroperoxyacetals, a reaction that was recently reported in our lab.121  
Peroxide 107-OTMS underwent acid-catalyzed transetherification with 3-buten-1-ol to 
afford 3-alkoxy-1,2-dioxolane 228.  Ozonolysis of the alkene in the presence of methanol 
afforded the hydroperoxyacetal, which was subsequently treated with Ca(OCl)2 in the 
same reaction flask to provide ester 229 in moderate yield.     
 
Saponification of ester 229 was attempted with K2CO3, but no reaction was 
observed.  The addition of KOH pellets and heating of the reaction led to consumption of 
the starting ester.  By TLC the reaction appeared to be complete and the crude acid 230 
was subjected to column chromatography.  However, by NMR the resulting acid was 
impure.  An acid/base extraction provided a product that appeared by TLC to be pure, but 
remained impure by NMR, suggesting that the impurity was also an acidic species.   
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 Failure of the saponification led to the exploration of other routes to acid 303.  
The oxidative cleavage of alkenes to the corresponding acid is well established and I 
decided to explore this route.  The use of NaIO4 and KmnO4 or OsO4 and oxone122 led to 
complete conversion of the starting material, but the acid could not be purified.  The use 
of Jones reagent to oxidize the alcohol was not employed as there were concerns that the 
acidic conditions might lead to the hydrolysis of the 3-alkoxy-1,2-dioxolane to produce 
the 1,2-dioxolan-3-ol.  In hindsight, the formation of the benzyl ester followed by 
hydrogenation should lead to the desired acid and should have been explored. 
 With a route established for the synthesis of the esters, I set about preparing two 
additional targets.  The synthesis began with transetherification of 107-OTMS using 5-
hexen-1-ol or 10-undecen-1-ol to afford 3-alkoxy-1,2-dioxolane 231 and 232 
respectively.  Formation of the hydroperoxyacetal and subsequent treatment with 
Ca(OCl)2 provided the desired esters 233 and 234. 
  
The synthesis of a 3-alkoxy-1,2-dioxolane that contained both an ester and 
aromatic ring was also undertaken.  Transetherification of 107-OTMS with alcohol 235 
to afford 3-alkoxy-1,2-dioxolane 236 was accomplished using Re2O7.  The use of Re2O7 
as a catalyst for this reaction will be discussed in chapter 4. 
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Antimalarial results and analysis 
 The ester-substituted 3-alkoxy-1,2-dioxolanes were tested for antimalarial 
activity, as described previously (section 1.3).109-111  What is most striking about this 
class of substrates is that all of the activities are higher for the K1 (chloroquine resistant) 
strain of P. falciparum compared with the chloroquine sensitive NF54 strain.  Out of this 
series, ester 236 is the most active possibly due to the presence of an aromatic ring in the 
alkoxy sidechain.  The other esters all exhibited similar in their activity against NF54 
(chloroquine sensitive).  I would have expected a greater change in activity as either the 
Log P or the length of the alkoxy sidechain changed.  In future generations of this class, it 
would be interesting to alter the ester group to determine what effect this has on activity.  
For example, would the benzyl or phenylethyl ester lead to higher activity or would it 
lead to a drop off in activity? 
O O
O (CH2)6 OMe
O
O O
O O
MeO O
O
O OMe
O
229 233
234
O O
O
O
OMe
236
 
Compound Log P IC50 (nM) NF54 
IC50 (nM) 
K1 
229 1.47 159 93 
233 2.17 130 60 
234 4.26 174 141 
236 3.2 56 34 
Table 2.8 Esters in alkoxy side chain 
 
 
 
 
78 
Section 5.2 
 Alcohols 
Rationale 
 The synthesis of 3-alkoxy-1,2-dioxolanes featuring a free alcohol in the C3-
alkoxide was undertaken.  The alcohols would provide polarity, a functional handle for 
subsequent modification, and an opportunity to test the stability of 3-alkoxy-1,2-
dioxolanes under a variety of reaction conditions.  The synthesis of sidechain diols was 
also undertaken because of a 2007 report from Agre demonstrating the importance of the 
glycerol channel to malaria infection in the mouse model.123  If the glycerol channel was 
knocked out, then malaria resistance was imparted onto the mice.  De Kimpe124 and 
Flitsch125 reported small molecules that they claim were able to block the glycerol 
channel.  With this knowledge, it was thought that 3-alkoxy-1,2-dioxolanes possessing a 
diol sidechain could either block the glycerol channel or else hijack this channel for 
transport of the 3-alkoxy-1,2-dioxolanes. 
 
Synthesis 
 The synthesis of diols 239 and 240 was straightforward and began with the 
synthesis of 3-alkoxy-1,2-dioxolanes 237 and 238.  These were then subjected to 
dihydroxylation with OsO4 to afford diols 239 and 240 in good yield.  After diol 240 had 
already been submitted for in vitro screening it was found to be contaminated with a 
small amount of alkene impurity that appeared to have formed during the synthesis of 
146.   
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 The synthesis of alcohol 243 began with the transetherification of 107-OTMS 
with alcohol 241 to afford 3-alkoxy-1,2-dioxolane 242.  Diol monoether 241 was used 
instead of 1,3-propanediol because of a desire to avoid dimer formation.  The dimer side 
reaction could also have been suppressed by the use of a gross excess of 1,3-propanediol, 
but this would have complicated purification.  TBAF deprotection of 242 afforded the 
desired 3-alkoxy-1,2-dioxolane 243 in good yield.  The pentanediol derivative 244 was 
obtained as a byproduct of the attempted synthesis of the dimer, was also isolated and 
tested. 
 
 
Antimalarial results and analysis 
 The analysis of the in vitro screening data shows diols 239 and 240 to exhibit low 
to moderate activity against P. falciparum.109-111  Though 240 does possess moderate 
activity it is not clear if the activity results from blocking the glycerol channel or through 
the hypothesized formation of a carbon radical upon Fe (II)-mediated scission of the 3-
alkoxy-1,2-dioxolane.  One way to determine which of the pathways is operative would 
be to prepare an analog lacking the peroxide group.   
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The activity of the alcohols suggests there is not a direct correlation between Log 
P and activity.  Compound 243 has low activity, but the slightly less polar 244 possesses 
remarkable activity.  Up to this point the hypothesis has been that there was a correlation 
between high activity and a bulky group in the alkoxy sidechain.  However, 3-alkoxy-1,2-
dioxolane 244 does not possess a bulky sidechain, yet has an activity rivaling that of the 
most active compounds described in section 4.  If a Log P argument is applied there is 
also no direct correlation as 148, phenylethyl sidechain, has a Log P of 4.55.    
 
Compound Log P IC50 (nM) NF54 
IC50 (nM) 
K1 
239 0.6 1318 ND 
240 1.49 63 ND 
243 1.24 278 180 
244 3 20 13 
148 4.55 9 ND 
Table 2.9 Alcohols and Diols 
Section 5.3  
Derivatized alcohol 
Rationale 
 When analyzing the data from the first generation 3-alkoxy-1,2-dioxolanes 
(Section 1.3) I became interested in the activity, of substrates featuring a methoxyethyl 
sidechain.  As the Log P of the compound increased the activity also increased, for 
example 103 vs. 104.  Previous results have demonstrated that having an aromatic ring in 
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the alkoxy sidechain increases activity.  Therefore, I thought that combining these two 
factors in compound 245 would provide a compound that was destined to have good 
activity.   
 
 
Synthesis and antimalarial results 
 The synthesis of 245 was accomplished through an acid mediated 
transetherification of 107-OTMS with alcohol 246.  As predicted, 3-alkoxy-1,2-
dioxolane 245 exhibited very good activity against P. falciparum (NF54) in vitro, 41 
nM.109-111  This represents a promising lead that should be followed up with a 
cyclohexane analog to investigate the role of the aromatic ring. 
 
Section 5.4  
Other functional groups 
Rationale 
 The synthesis of several compounds with polar alkoxy sidechains was undertaken 
to test the limits of what functionality could be tolerated in this position.  The choice of 
substrates did not reflect any systematic search, but rather was intended to rapidly test the 
boundaries of the influences of polar functional groups on the activity of 3-alkoxy-1,2-
dioxolanes. 
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Synthesis and antimalarial results 
 The synthesis of 246 began with previously synthesized 3-alkoxy-1,2-dioxolane 
231.  Reaction with mCPBA afforded epoxide 246.  Nitrile 247 was prepared by acid-
catalyzed transetherification of peroxide 107-OTMS.  Neither epoxide 246 nor nitrile 
247 possessed notable antimalarial activity.   
  
 
IC50 values are in vitro against P. falciparum (NF54) 
 
Section 5.5  
Animal studies 
 Having indentified several 3-alkoxy-1,2-dioxolanes that possessed very good in 
vitro activity, I was interested in pursuing in vivo studies against P. berghei.  The 
molecules chosen as candidates possess good in vitro activity and have a polar functional 
group.  However, no therapeutic effect was observed; all of the mice needed to be 
euthanized on day three.  It is unclear as to why the 3-alkoxy-1,2-dioxolanes had no 
therapeutic effect in vivo and further investigation needs to be undertaken.110 
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 3-alkoxy-1,2-dioxolane 
Parasitized 
RBC over 
100 
% control
244 
 
15.94 92.59 
163 
 
17.23 100.06 
233 
 
19.71 114.46 
103 
 
16.06 93.28 
245 
 
18.50 107.41 
NA Control 17.22 NA 
Table 2.10 In vivo testing against P. berghei.  Method of administration was 
subcutaneous injection and values are an average over three days. 
 
Section 5.6  
Stability of 3-alkoxy-1,2-dioxolanes 
 Throughout this work a variety of 3-alkoxy-1,2-dioxolanes have been subjected to 
conditions that would lead to decomposition of many peroxides.  The tetrasubstituted 3-
alkoxy-3,5,5-trialkyl-1,2-dioxolanes proved stable to reducing agents (LiAlH4, Dibal-H, 
and PPh3), base (TBAF, KOH), oxidants (mCPBA, O3), and heat (60oC for 3 days).  
Decomposition of 3-alkoxy-1,2-dioxolanes was only accomplished with FeBr2.  This 
stability provides an excellent platform on which to explore SAR. 
Section 5.7  
Future work 
 My research has shown that 3-alkoxy-1,2-dioxolanes possess a remarkable 
robustness in terms of maintaining antimalarial activity across a range of structures, as 
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long as the 3-alkoxy-1,2-dioxolane core is kept intact.  Changes to the substitution at 
either C3 or C5 do lead to changes in activity but as a whole, do not lead a dramatic 
change in activity.  However, in vivo studies found little activity for these relatively 
hydrophobic 3-alkoxy-1,2-dioxolanes.  This makes the most obvious future direction to 
synthesize molecules that are more drug-like and determine if that increases their in vivo 
efficacy.  One of the ways, I envision this can be done is by changing the substitution at 
C5.  The optimal alkoxy sidechain for C3 is the phenylethyl and the best substitution thus 
far at C3 has been a spirocyclohexyl.  I propose changing the cyclohexane by making a 
compound similar to 248.  In this system the 4-position of the cyclohexane can undergo 
further derivatization to give the molecule more drug-like properties.  
 
 A more ambitious goal is to determine the mechanism of action (MOA) of 3-
alkoxy-1,2-dioxolanes.  Currently, the MOA of peroxide antimalarials is of debate and 
most synthetic peroxide antimalarials have been developed based upon the hypothesis of 
the generation of a carbon centered free radical upon reductive cleavage of the peroxide 
bond.  The exact MOA of 3-alkoxy-1,2-dioxolanes has not been determined as they are a 
new class of peroxide antimalarials.  Determination of the MOA might allow more 
rationale design of a small molecule. 
 I do not have a comprehensive plan to determine the MOA of 3-alkoxy-1,2-
dioxolanes, but do have several experiments that would be beneficial in that pursuit.  A 
degradation study was done with FeBr2, but was never done in the presence of heme to 
determine if the radical formed from the Fe (II)-mediated peroxide decomposition is able 
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to alkylate the heme.  If alkylation of heme was noted, the alkylated product can be tested 
in a manner similar to that reported by Meshnick47 to determine if the alkylated 
compound is the source of activity.  This experiment is beneficial because if a lack of 
alkylation would indicate that 3-alkoxy-1,2-dioxolanes utilize a novel MOA from the 
other reported synthetic peroxides. 
 The synthesis of the non-peroxide analog of a 3-alkoxy-1,2-dioxolane should be 
undertaken to determine if antimalarial activity is from the decomposition of the peroxide 
bond.  The possibility that 3-alkoxy-1,2-dioxolanes block a channel has not been 
excluded and the synthesis of a non-peroxide analog would quickly show if this was a 
component of activity. 
 Though outside of my field of expertise, utilization of either radio labeled or 
flourophore tagged 3-alkoxy-1,2-dioxolanes can be used to determine if there is uptake of 
the 3-alkoxy-1,2-dioxolane into the infected cell.  I believe that the peroxide is being 
uptaken by the cell, but without experimental evidence it is impossible to rule out some 
surface binding effect. 
 Since all of these experiments have been conducted with either artemisinin or a 
synthetic peroxide, they will in their own right not prove the answer, but will instead 
provide a roadmap.  Determination of the MOA of 3-alkoxy-1,2-dioxolanes would 
require significant collaboration across several disciplines.  In the end, the MOA of this 
class of compounds may never be discovered, but even attempts would provide much 
needed information to guide future synthesis. 
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Section 6 
Experimentals 
Abbreviations: THF (tetrahydrofuran); DMF (N,N-dimethylformamide); TsOH (p-
toluenesulfonic acid, monohydrate); EA/hex (ethyl acetate/hexane); DMSO 
(dimethylsulfoxide); RBF (round-bottom flask); rt (room temperature); TLC (thin-layer 
chromatography),  
General Experimental Conditions:  All reagents were used as received from commercial 
vendors, with the exception of CH2Cl2, which was distilled from calcium hydride, and 
THF, which was distilled from sodium/benzophenone.  All reactions were conducted 
under an atmosphere of N2 except where noted.  Thin layer chromatography (TLC) was 
performed on 0.25 mm hard-layer silica G plates; developed plates were visualized with a 
hand-held UV lamp or by staining: 1% ceric sulfate and 10% ammonium molybdate in 
10% H2SO4 (general stain, after charring); 1% N,N’-dimethyl-p-phenylenediamine 
solution in 1:20:100 acetic acid/water/methanol (specific for peroxides);126 1% aq. 
KMnO4 (for unsaturated compounds); 3% vanillin in 3% H2SO4 in ethanol (general stain 
after charring).  “Standard drying and purification” refers to drying of organic extracts 
over MgSO4, removal of solvent under vacuum, and purification by flash 
chromatography using the indicated eluting solvent. 1H /13C NMR spectra were recorded 
in CDCl3 unless otherwise indicated; peaks are reported as: chemical shift (multiplicity, J 
couplings in Hz, number of protons).  Infrared spectra were recorded as neat films (ZnSe, 
ATR mode) with selected absorbances reported in wavenumbers (cm-1). Melting points 
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were collected using a melting point apparatus and all values are uncorrected unless 
otherwise noted. 
 
3,5,5-Trimethyl-1,2-dioxolan-3-ol (107): 
Mesityl oxide (5.2924 g, 53.9 mmol) was stirred with aq. KOH (1.0 mL, 7.1 mmol, 7.1 
M) in a RBF for 5 min at -5 ºC, after which aq. H2O2 (11 mL, ~97 mmol, 30%) was 
added. The resulting solution was stirred at 0 ºC for 3 h and then allowed to warm to rt 
and held at that temperature for 1 h. The reaction mixture was then extracted with Et2O 
(30 mL) and the organic layer washed with brine (2 x 30 mL). The combined organic 
layers were dried with MgSO4 and chromatographed twice with 30% ether/hexanes to 
afford 107 as a colorless oil (1.5647 g, 24%). Rf (30% ether/hexanes): 0.22.  1H NMR 
(300 MHz): 3.15 (s, 1H), 2.51 (d, J = 12.8, 1H), 2.42 (d, J = 12.8, 1H), 1.55 (s, 3H), 1.40 
(s, 3H), 1.37 (s, 3H). 13C (75 MHz): 106.3, 84.2, 58.7, 27.4, 25.0, 23.5.  IR:  3292, 2899, 
2847.  HRMS (ESI): calc for C6H12O3Na: 155.0684; found: 155.0686 (1.3 ppm). 
 
3-Trimethylsilyloxy-3,5,5-trimethyl-1,2-dioxolane (107-OTMS): 
A solution of 107 (142.1 mg, 1.07 mmol) in CH2Cl2 (7.5 mL) in a flame-dried RBF was 
treated sequentially with imidazole (257.7 mg, 2.8 mmol) and chlorotrimethylsilane  (0.3 
mL, 2 mmol).  After 10 min, the reaction was filtered and the filtrate concentrated in 
vacuo.  The residue was purified by flash chromatography with 5% EA/hex to afford 
107-OTMS, as a colorless oil (129 mg, 57%). Rf (5% EA/hex):  0.68.  1H NMR (400 
MHz):  2.56 (d, J = 12.4, 1H), 2.40 (d, J = 12.4, 1H), 1.52 (s, 3H), 1.36 (s, 3H), 1.34 (s, 
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3H), 0.18 (s, 9H).  13C (100 MHz):  107.4, 83.7, 61.3, 27.4, 25.3, 24.8, 1.5. HRMS (ESI):  
calc for C9H20NaO3Si: 227.1079; found: 227.1052 (11.0 ppm).  
 
(3E,3Z)-4-methyl-3-octen-2-one (109):   
To a -78 °C solution of 4-penten-2-one (9.7962 g, 117 mmol) in ether (238 mL) in 
a flame-dried RBF was added n-BuLi (119 mL, 298 mmol, 2.5 M in hexanes).  The 
reaction was stirred for 30 min at -78ºC and at rt for 14 hr.  The reaction was quenched 
with H2O (60 mL) and filtered through a pad of Celite. The combined Et2O extracts (3 x 
100 mL) were subjected to standard drying and purification with 15% EA/hex and a 
subsequent column with 10% EA/hex to afford E-4-methyl-3-octen-2-ol as a yellow oil 
(6.5554 g, 56%). Rf (15% EA/hex): 0.57.  1H NMR (400 MHz):  5.68-5.48 (2H), 1.7 (dd, 
J = 6, 1.1, 3H), 1.5 (m, 2H), 1.38 (s, 1H), 1.36-1.21 (7H), 0.91 (overlapping triplets, J = 
7, 3H). 13C (100 MHz): 138.4, 122.7, 73.0, 42.8, 28.0, 26.4, 23.3, 17.9, 14.3.  IR:  3381, 
2958, 2932, 2861. HRMS (CI ):  calc for C9H19O: 143.1436; found: 143.1435  (0.6 ppm). 
To a 0 °C solution of pyridinium dichromate (3.047 g, 8 mmol) in DMF (12.6 
mL) was added E-4-methyl-2-octen-4-ol (871.0 mg, 6.1 mmol) as a solution in DMF (1 
mL).  The reaction was stirred for 4 h at 0 ºC and rt for 3 hr, and then diluted with H2O 
(100 mL). The combined Et2O extracts (3 x 30 mL) were washed with brine (30 mL) and 
subjected to standard drying and purification with 15% EA/hex to afford 109 as a 
colorless oil and as an E/Z mixture (68:22) (352.9 mg, 41%). Rf (10% EA/hex):  0.42.  1H 
NMR: 6.05 (m, 1H), 2.55 (m, 0.5H), 2.25-2.06 (5.5H), 1.87 (d, J = 1.3, 1H), 1.50-1.21 
(4H), 0.91 (t, J = 7.4, 3H). 13C NMR (75 MHz):  199.0, 159.7, 159.1, 124.0, 123.4, 41.0, 
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33.4, 31.8, 30.3, 29.7, 25.4, 22.9, 22.4, 19.3, 14.0, 13.9. IR:  2957, 2931, 2862, 1687, 
1614.  HRMS (CI): calc for C9H16ONa: 163.1099; found: 163.1094 (3.1 ppm).  
 
(3,5-cis)(3,5-trans)-5-Butyl-3,5-dimethyl-1,2-dioxolan-3-ol (110): 
H2O2 method:  To a RBF containing 109 (1.2125, 8.5 mmol) in THF (8.5 mL) was added 
aq. KOH (0.15 mL, 1.1 mmol, 7.1 M).  The solution was cooled to 0 ºC, after which aq. 
H2O2 (1 mL, ~5 mmol, 30%) was added. The resulting solution was allowed to warm to 
rt and was stirred for 2 days. The reaction mixture was then diluted with H2O (10 mL) 
and extracted with Et2O (2 x 20 mL) and the combined organic layers washed with brine 
(2 x 30 mL) and subjected to standard drying and purification with 20% EA/hex to afford 
a 1:1 cis/trans mixture of 110 as a colorless oil (105.5 mg, 7%). Rf (10% EA/hex):  0.25. 
1H NMR (100 MHz):  3.45 (s, 1H), 2.53 (d, J = 12.9, 0.5H), 2.45 (d, J = 12.8, 0.5H), 2.41 
(d, J = 12.8, 0.5H), 2.31 (d, J = 12.9, 0.5H), 1.73-1.44 (5H), 1.42-1.16 (7H), 0.90 
(apparent triplet, J = 6.5, 3H). 13C (100 MHz):  106.1, 105.9, 86.7, 86.3, 57.6, 57.3, 39.7, 
37.9, 27.2, 26.6, 25.1, 23.5, 23.3, 23.2, 23.1, 22.4, 14.1, 14.0. IR:  3448, 2957, 2935, 
2870. HRMS (ESI):  calc for 197.1154; found: 197.1149 (2.5 ppm).   
Cobalt method:  To a RBF containing cobalt (II) acetylacetone (490 mg, 1.9 mmol) in 
1,2-dichloroethane (170 mL) was added sequentially 4-methyl-3-octen-2-one (2.7228g, 
19 mmol) in 1,2-dichloroethane (20 mL) and triethylsilane (6.1 mL, 38 mmol).  The 
mixture was placed under an O2 balloon and stirred overnight.  The reaction was diluted 
with sat. aq. NH4Cl (50 mL) and extracted with CH2Cl2 (2 x 50 mL).  The combined 
organic layers were subjected to standard drying and purification with 10% EA/hex to 
afford a 1:1 cis/trans mixture of 110 as a colorless oil (395.7 mg, 36% BRSM) 
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(3,5-cis)(3,5-trans)-3-Trimethylsilyloxy-5-butyl-3,5-dimethyl-1,2-dioxolane (112): 
A solution of 110 (129.9 mg, 0.92 mmol) in CH2Cl2 (9.2 mL) in a flame-dried RBF was 
treated sequentially with imidazole (195mg, 2.7 mmol) and chlorotrimethylsilane (302 
mg, 2.8 mmol).  After 2 h, the reaction was quenched with sat. NH4Cl (10 mL) and 
extracted with CH2Cl2 (10 mL).  The organic layer was was subjected to standard drying 
and purification with 5% EA/hex to afford a 1:1 cis/trans mixture of 112 as a colorless oil 
(129 mg, 57%). Rf (5% EA/hex): 0.69.  1H NMR (300 MHz):  2.58 (d, J = 12.5, 0.5H), 
2.50 (d, J = 12.4, 0.5H), 2.40 (d, J = 12.4, 0.5H), 2.30 (d, J = 12.5, 0.5H), 1.76-1.6 (2.5H), 
1.6-1.48 (3.5H), 1.44-1.2 (7H), 0.91 (overlapping triplets, J = 6.8, 3H), 0.20 (overlapping 
singlets, 9H).  13C (75 MHz):  107.4, 107.3, 86.4, 86.0, 60.4, 60.0, 40.2, 37.9, 27.3, 26.8, 
25.6, 25.5, 25.2, 23.4, 23.3, 22.6, 14.2, 14.2, 1.7.  HRMS (ESI):  cal for C12H26O3SiNa: 
269.1549; found: 269.1547 (0.7 ppm). 
 
2-adamantanemethanol (115): 
In a flame-dried three neck RBF a solution of methyltriphenylphosphine bromide 
(16.84 g, 47 mmol) in THF (32 mL) was cooled to 0ºC.  A solution of n- BuLi (26.4 mL, 
66 mmol, 2.5M in hexanes) was added and the solution was brought to rt and stirred for 1 
hr.  A solution of 2-adamantanone (5.2883g, 35.5 mmol) in THF (35 mL) was added 
dropwise from an addition funnel.  The reaction was heated at reflux for 7 hrs, and then 
cooled to 0ºC.  The reaction was quenched with H2O (100 mL), and extracted with Et2O 
(2 x 100 mL).  The combined organic layers were dried with MgSO4, and filtered through 
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a silica plug.  The 2-methyleneadamantane obtained was used without further 
purification. 
The 2-methyleneadamantane (nominally 4.3g, 29 mmol) was dissolved in THF 
(58mL) in a flame-dried RBF and the solution cooled to 0ºC.  A solution of BH3-THF 
(20.6 mL, 20.6 mmol, 1M in THF) was added drop wise.  The reaction was stirred for 30 
min, after which H2O (3 mL, 167 mmol) was added.  The reaction was heated to 45ºC 
and treated sequentially with aq. NaOH (3 M, 15 mL, 46 mmol), and H2O2 (8.2 mL, 65 
mmol, 30% in H2O).  After 1 hr, the reaction was diluted with H2O (50 mL) and extracted 
with Et2O (2 x 50 mL).  The combined organic layers were subjected to standard drying 
and purification with 10% EA acetate/hex): 0.29. Melting point: 90-91ºC.  1H NMR (400 
MHz): 3.74 (d, J = 7.06, 2H), 1.04-1.72 (13H), 1.56 (d, J = 11.92, 2H), 1.26 (s, 1H).  13C 
NMR (100 MHz): 65.1, 47.1, 38.9, 38.2, 31.9, 29.2, 28.4, 28.0.  IR: 3247, 2900, 2848.  
HRMS (CI): calc for C11H18O: 166.1358; found: 166.1361. 
 
Adamantan-2-ylidene-acetic acid ethyl ester (116): 
In a flame-dried RBF sodium hydride (1.3g, 32 mmol) in THF (45 mL) was 
slurried.  Triethyl phosphonoacetate (8.1g, 36 mmol) was added drop wise, and the 
resulting solution was stirred for 1 hr.  A solution of 2-adamantanone (4.1g, 27 mmol) in 
THF (20 mL) was added and the reaction stirred overnight.  The reaction was quenched 
with sat. NH4Cl (80 mL) and extracted with Et2O (3 x 80 mL).  The combined organic 
layers were subjected to standard drying and purification with 10% EA/hex to afford 116 
as a colorless oil (4.7267 g, 79%).  Rf (10% EA/hex): 0.6.  1H NMR (400 MHz): 5.6 (s, 
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1H), 4.15 (q, J = 7, 2H), 4.08 (s, 1H), 2.45 (s, 1H), 2.06-1.93 (6H), 1.92-1.80 (6H), 1.29 
(t, J = 7, 3H). 13C (100 MHz): 172.3, 167.1, 108.6, 59.4, 41.4, 40.1, 39.1, 36.8, 32.9, 27.9, 
14.3. IR: 2902, 2850, 1709, 1644. HRMS (FAB): calc for C14H20O2Li: 227.1623; found: 
227.1627. 
 
2-Adamantylideneethanol (117): 
A solution of enoate 116 (1.0083 g, 4.5 mmol) in THF (15 mL) was added to a 
flame-dried RBF and cooled to -40ºC.  DIBAL-H (1.5 M in toluene, 6.7mL, 10 mmol) 
was added and the reaction stirred at -40ºC for 2 hrs.  The reaction was warmed to rt and 
quenched with a solution of sat. aq. Rochelles salt (20 mL).  The resulting mixture was 
treated sequentially with glycol (1 mL) and ethyl acetate (10 mL).  After 2 hrs, the 
mixture was extracted with Et2O (25 mL).  The combined organic layers were subjected 
to standard drying and purification with 30% EA/hex to afford 117 as a colorless oil 
(748.6 mg, 92%). Rf (30% EA/hex): 0.57. 1H NMR (400 MHz): 5.35 (t, J = 7.1, 1H), 4.15 
(d, J = 7.1, 2H), 2.90 (s, 1H), 2.40 (s, 1H), 2.08-1.68 (12H), 1.18 (s, 1H).  13C (100 MHz): 
152.8, 115.4, 58.2, 40.4, 39.7, 39.1, 37.1, 32.4, 28.4. IR: 3207, 2897, 2846. HRMS 
(FAB): calc for C12H18OLi: 185.1518; found: 185.1514. 
OH
 
2-Adamantaneethanol (118): 
A RBF was charged with 10% Pd/C (2.46 g, 0.23 mmol) and evacuated under 
vacuum.  The flask was placed under an atmosphere of H2 (balloon) and a solution of 117 
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(2.0311 g, 11.4 mmol) in EA (110 mL) was added and the reaction was allowed to stir 
overnight.  The flask was purged with N2 and the supernatant filtered through celite.  The 
filtrate was concentrated in vacuo and the residue was purified by flash chromatography 
with 30% EA/hex to afford 118 as a white solid (1.18 g, 57%).  Rf (10% EA/hex): 0.21.  
Melting point: 60-62ºC.  1H NMR (400 MHz): 3.69 (t, J = 6.9, 2H), 1.92-1.66 (14H), 1.55 
(m, 3H), 1.22 (s, 1H).  13C NMR (100 MHz): 61.7, 40.7, 39.1, 38.4, 35.9, 32.0, 31.7, 
28.2, 28.0.  IR: 3292, 2899, 2847.  HRMS (FAB): calc for C12H20OLi: 187.1674; found: 
187.1668. 
Method A: From the corresponding 1,2-dioxolan-3-ol 
Method B: From the corresponding 3-trimethylsiloxy-1,2-dioxolane 
 
 
(3,5-cis)(3,5-trans)-3-(1-Phenyl)methoxy-5-butyl-3,5-dimethyl-1,2-dioxolane (119):  
Method A: 
To a vial containing 110 (197.6 mg, 1.1 mmol) was added sequentially benzyl alcohol 
(15.5, 143 mmol) and TsOH (37.2 mg, 0.2 mmol) and the reaction was stirred overnight.  
The reaction was quenched with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted 
with CH2Cl2 (2 x 10 mL).  The combined organic layers were subjected to standard 
drying and purification with 10% EA/hex to afford 119 as a yellow oil (180.7 mg, 60%).  
 Method B:  
To a vial containing 112 (126.7 mg, 0.52 mmol) in CH2Cl2 (5 mL) was added 
sequentially benzyl alcohol (175 mg, 1.62 mmol) and TsOH (9.2 mg, 0.05mmol).  After 
20 min, the reaction was treated with sat. NaHCO3 (5 mL) and H2O (10 mL) and 
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extracted with CH2Cl2 (20 mL). The combined organic layers were subjected to standard 
drying and purification with 10% EA/hex to afford 119 as a yellow oil (83.4 mg, 60%). 
Rf (10% EA/hex):0.45.  1H NMR (400 MHz): 7.48-7.24 (5H), 4.78 (d, J = 11.2, 1H), 4.52 
(d, J = 11.2, 1H), 2.71 (d, J = 12.5, 0.5H), 2.62 (d, J = 12.5, 0.5H), 2.45 (d, J = 12.5, 
0.5H), 2.35 (d, J = 12.5, 0.5H), 1.83-1.55 (5H), 1.52-1.28 (7H), 0.95 (overlapping triplets, 
J = 6.9, 3H). 13C (100 MHz): 138.8, 128.3, 128.2, 127.8, 127.7, 127.3, 108.4, 108.3, 86.4, 
86.0, 64.0, 63.9, 57.8, 57.4, 40.1, 37.6, 27.2, 26.6, 25.5, 23.2, 22.3, 20.2, 19.6, 14.1, 14.0.  
HRMS (CI): calc for C16H24O3: 264.1725; found: 264.1727. 
 
(3,5-cis)(3,5-trans)-3-Butyl-5-(cyclohexylmethoxy)-3,5-dimethyl-1,2-dioxolane (120) 
Method B: 
To a vial containing 112 (196.5 mg, 0.80 mmol) in CH2Cl2 (8 mL) was added 
sequentially cyclohexanemethanol (0.5 mL, 4.05 mmol) and TsOH (15 mg, 0.08 mmol).  
After 2 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and 
extracted with CH2Cl2 (10 mL). The combined organic layers were subjected to standard 
drying and purification with 10% ethyl acetate/hexanes to afford 120 as a yellow oil 
(185.8 mg, 86%). Rf  (10% /hex): 0.61.  1H NMR (600 MHz): 3.40 (m, 1H), 3.21 (m, 1H), 
2.56 (d, J = 12.5, 0.5H), 2.46 (d, J = 12.5, 0.5H), 2.33 (d, J = 12.5, 0.5H), 2.22 (d, J = 
12.5, 0.5H), 1.83-1.49 (8H), 1.45 (d, J = 12.5, 3H), 1.40-1.11 (10H), 1.0-0.86 (5H).  13C 
(150 MHz):108.1, 108.0, 86.3, 85.9, 67.43, 67.41, 58.0, 57.5, 40.3, 38.33, 38.31, 37.8, 
30.3, 30.28, 30.25, 27.3, 26.9, 26.8, 26.1, 26.0, 25.7, 23.4, 23.3, 22.5, 20.1, 19.6, 14.2, 
14.1.   HRMS (ESI): calc for C16H30O3Na: 293.2093; found: 293.2088 (2 ppm). 
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(3,5-cis)(3,5-trans)-3-Butyl-3,5-dimethyl-5-(2-phenyl)ethoxy-1,2-dioxolane (121):  
Method A: 
To a vial containing 110 (62 mg, 0.35 mmol) was added sequentially 2-phenylethanol 
(5.4186g, 44 mmol) and TsOH (7.2 mg, 0.04 mmol) and the solution stirred overnight.  
The reaction was quenched with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted 
with CH2Cl2 (2 x 10 mL). The combined organic layers were subjected to standard drying 
and purification with 5% EA/hex to afford 121 as a yellow oil (32.6 mg, 30%).  
Method B: 
To a vial containing 112 (74.0 mg, 0.3 mmol) in CH2Cl2 (5 mL) was added sequentially 
2-phenylethanol (102 mg, 0.84 mmol) and TsOH (6.7 mg, 0.04mmol).  After 1 hr, the 
reaction was quenched with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and extracted 
with CH2Cl2 (10 mL). The combined organic layers were subjected to standard drying 
and purification with 5% EA/hex to afford 121 as a yellow oil (66.6 mg, 80%). Rf  (10% 
EA/hex):0.5.  1H NMR (400 MHz): 7.4-7.2 (5H), 3.88 (m, 1H), 3.66 (m, 1H), 2.9 (m, 
2H), 2.58 (d, J = 12.5, 0.5H), 2.50 (d, J = 12.5, 0.5H), 2.37 (d, J = 12.5, 0.5H), 2.25 (d, J 
= 12.5, 0.5H), 1.78-1.5 (2H), 1.47 (d, J = 9, 3H), 1.44-1.24 (7H), 0.93 (overlapping 
triplets, J = 6.9, 3H). 13C (100 MHz): 139.2, 129.0, 128.2, 126.1, 108.1, 108.0, 85.9, 62.6, 
62.5, 57.8, 57.3, 40.1, 37.6, 36.7, 27.2, 26.6, 25.4, 23.2, 22.2, 20.0, 19.5, 14.1, 14.0. 
HRMS (FAB): calc for C17H26O3Li: 285.2042; found: 285.2053. 
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(3,5-cis)(3,5-trans)-3-Butyl-5-(2-cyclohexylethoxy)-3,5-dimethyl-1,2-dioxolane (122) 
Method B: 
To a vial containing 112 (133.5 mg, 0.54 mmol) in CH2Cl2 (6 mL) was added 
sequentially 2-cyclohexylethanol (0.38 mL, 2.7 mmol) and TsOH (10 mg, 0.05 mmol).  
After 2 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and 
extracted with CH2Cl2 (10 mL). The combined organic layers were subjected to standard 
drying and purification with 10% EA/hex to afford 122 as a yellow oil (126.1 mg, 82%). 
Rf  (10% EA/hex): 0.55.  1H NMR (600 MHz): 3.64 (m, 1H), 3.44 (m, 1H), 2.55 (d, J = 
12.6, 0.5H), 2.47 (d, J = 12.6, 0.5H), 2.33 (d, J = 12.6, 0.5H), 2.22 (d, J = 12.6, 0.5H), 
1.80-1.10 (23H), 0.96-0.84 (5H). 13C (150 MHz):108.1, 108.0, 86.3, 86.0, 59.62, 59.60, 
57.9, 57.5, 40.3, 37.8, 37.6, 34.8, 34.7, 33.74, 33.71, 33.24, 33.21, 27.3, 26.9, 26.8, 26.6, 
26.5, 25.7, 23.4, 23.3, 22.5, 20.1, 19.6, 14.2, 14.1. HRMS (ESI): calc for C17H32O3Na: 
307.2249; found: 307.2243 (2 ppm). 
 
(3,5-cis)(3,5-trans)-3-butyl-3,5-dimethyl-5-(3-phenylpropoxy)-1,2-dioxolane (123) 
Method B: 
To a vial containing 112 (211.3 mg, 0.86 mmol) in CH2Cl2 (8 mL) was added 
sequentially 3-phenyl-1-propanol (0.55 mL, 4.1 mmol) and TsOH (15 mg, 0.08 mmol).  
After 3 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and 
extracted with CH2Cl2 (10 mL). The combined organic layers were subjected to standard 
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drying and purification with 10% EA/hex to afford 123 as a yellow oil (211.3 mg, 92%). 
Rf  (10% EA/hex): 0.41.  1H NMR (600 MHz): 7.29 (5H), 3.63 (m, 1H), 3.44 (m, 1H), 
2.71 (m, 2H), 2.58 (d, J = 12.5, 0.5H), 2.48 (d, J = 12.5, 0.5H), 2.35 (d, J = 12.5, 0.5H), 
2.23 (d, J = 12.5, 0.5H), 1.88 m, 2H, 1.72-1.48 (2H), 1.44 (d, J = 13.2, 3H), 1.40-1.23 
(7H), 0.88 (m, 3H). 13C (150 MHz): 142.5, 128.73, 128.71, 128.4, 125.8, 108.2, 108.1, 
86.4, 86.0, 61.0, 60.9, 58.0, 57.5, 40.3, 37.8, 32.6, 32.6, 32.0, 31.9, 27.3, 26.8, 25.6, 23.4, 
23.3, 22.5, 20.2, 19.6, 14.2, 14.1. HRMS (ESI): calc for C18H28O3Na: 315.1936; found: 
315.1936 (<1 ppm). 
 
(3,5-cis)(3,5-trans)-3-(1-(1-Adamantyl)methoxy)-5-butyl-3,5-dimethyl-1,2-dioxolane 
(124):  
Method A: 
To a vial containing 110 (161.9 mg, 0.93 mmol) in CH2Cl2 (10 mL) was added 
sequentially 1-adamantanemethanol (754.1 mg, 4.54 mmol) and TsOH (42.2 mg, 0.22 
mmol).   After 48 hrs, the reaction was treated with sat. aq NaHCO3 (5 mL) and H2O (5 
mL) and extracted with CH2Cl2 (2 x 10mL). The combined organic layers were subjected 
to standard drying and purification with 2.5% EA/hex to afford 124 as a yellow oil (78.4 
mg, 26%).  
Method B: 
To a vial containing 112 (74.5 mg, 0.3 mmol) in CH2Cl2 (5 mL) was added sequentially 
1-adamantanemethanol (176.9 mg, 1.1 mmol) and TsOH (5 mg, 0.03mmol).  After 1 hr, 
the reaction was quenched with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and extracted 
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with CH2Cl2 (10 mL). The combined organic layers were subjected to standard drying 
and purification with 5% EA/hex to afford 124 as a yellow oil (60.4 mg, 62%). Rf (5% 
EA/hex): 0.31.  1H NMR (400 MHz): 3.19 (d, J = 3.7, 0.5H), 3.17 (d, J = 3.7, 0.5H), 2.96 
(dd, J = 0.7, 8.8, 1H), 2.58 (d, J = 12.4, 0.5H), 2.48 (d, J = 12.4, 0.5H), 2.34 (d, J = 12.2, 
0.5H), 2.22 (d, J = 12.2, 0.5H), 2.04-1.93 (3H), 1.76-1.48 (14H), 1.44 (d, J = 8.2, 3H), 
1.41-1.24 (7H), 0.92 (t, J = 7.1, 3H). 13C (100 MHz): 107.8, 107.7, 85.9, 85.6, 72.0, 71.9, 
57.8, 57.1, 40.3, 39.7, 37.7, 37.3, 33.3, 33.2, 28.3, 27.1, 26.6, 26.0, 23.2, 23.1, 22.5, 19.6, 
19.1, 14.1, 14.0. HRMS (FAB): calc for C20H35O3: 323.2586; found: 323.2594. 
 
((3,5-cis)(3,5-trans)-3-(1-(2-Adamantyl)methoxy)-5-butyl-3,5-dimethyl-1,2-dioxolane 
(125):  
Method A: 
To a vial containing 110 (198.3 mg, 1.14 mmol) in CH2Cl2 (11 mL) was added 
sequentially 2-adamantanemethanol (755.2 mg, 4.5 mmol) and TsOH (22.4 mg, 0.12 
mmol).  After 72 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and 5 mL 
H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were 
subjected to standard drying and purification with 5% EA/hex to afford 125 as a yellow 
oil (145.8 mg, 34%).  
Method B: 
To a vial containing 112 (72.9 mg, 0.30 mmol) in CH2Cl2 (5 mL) was added sequentially 
2-adamantanemethanol (176.9 mg, 1.1 mmol) and TsOH (5 mg, 0.03mmol).  After 1 hr, 
the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and extracted 
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with CH2Cl2 (10 mL). The combined organic layers were subjected to standard drying 
and purification with 5% EA/hex to afford 125 as a yellow oil (54.9 mg, 57%). Rf (5% 
EA/hex): 0.41.  1H NMR (300 MHz): 3.72 (m, 1H), 3.45 (ddd, J = 2.1, 6.6, 9.2, 1H), 2.56 
(d, J = 12.5, 0.5H), 2.46 (d, J = 12.4, 0.5H), 2.33, 2.33 (d, J = 12.4, 0.5H), 2.27 (d, J = 
12.4, 0.5H), 2.05-1.67 (13H), 1.67-1.49 (4H), 1.46 (d, J = 6.3, 3H), 1.42-1.20 (7H), 0.91 
(overlapping triplet, J = 7.1, 3H).  13C (75 MHz): 107.9, 107.8, 86.0, 85.7, 63.6, 57.7, 
57.2, 44.2, 44.1, 40.2, 39.0, 38.9, 38.8, 38.3, 37.6, 32.1, 31.8, 29.7, 29.2, 28.5, 28.0, 27.0, 
26.6, 25.6, 23.2, 23.1, 22.3, 19.9, 19.4, 14.0, 13.96.  HRMS (FAB): calc for C20H35O3: 
323.2586; found: 323.2675. 
O O
C4H9 O
 
(3,5-cis)(3,5-trans)-3-(2-(1-Adamantyl)ethoxy)-5-butyl-3,5-dimethyl-1,2-dioxolane 
(126): 
Method A: 
To a vial containing 110 (54.4 mg, 0.30 mmol) in CH2Cl2 (5 mL) was added sequentially 
1-adamantaneethanol (223.2 mg, 1.24 mmol) and TsOH (15.3 mg, 0.08 mmol).  After 3 
days, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and 
extracted with CH2Cl2 (2 x 20 mL). The combined organic layers were subjected to 
standard drying and purification with 5% EA/hex to afford 126 as a yellow oil (191 mg, 
43%).  
Method B: 
To a vial containing 112 (76.5 mg, 0.31 mmol) in CH2Cl2 (3 mL) was added sequentially 
1-adamantaneethanol (153 mg, 0.85 mmol) and TsOH (10.1 mg, 0.05mmol).  After 1 hr, 
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the reaction was treated with sat. aq. NaHCO3 (3 mL) and H2O (5 mL) and extracted with 
CH2Cl2 (2 x 5 mL). The combined organic layers were subjected to standard drying and 
purification with 5% EA/hex to afford 126 as a yellow oil (75.5 mg, 72%). Rf (10% 
EA/hex):0.7.  1H NMR (300 MHz): 3.67 (m, 1H), 3.46 (m, 1H), 2.54 (d, J = 12.4, 0.5H), 
2.46 (d, J = 12.4, 0.5H), 2.34 (d, J = 12.4, 0.5H), 2.23 (d, J = 12.4, 0.5H), 2-1.87 (3H), 
1.78-1.58 (7H), 1.58-1.5 (5H), 1.47 (d, J = 6.4, 3H), 1.43-1.2 (9H), 0.92 (overlapping 
triplets, J = 7.1, 3H). 13C (75 MHz): 108.1, 108, 86.2, 85.8, 57.9, 57.59, 57.55, 57.5, 44, 
43.9, 42.7, 40, 37.6, 37.2, 31.8, 28.7, 27.2, 26.6, 25.3, 23.2, 23.1, 22.2, 20.1, 19.6, 14, 
13.9.  HRMS (FAB): calc for C21H36LiO3: 343.2824; found: 343.2839. 
 
(3,5-cis)(3,5-trans)-3-(2-(2-Adamantyl)ethoxy)-5-butyl-3,5-dimethyl-1,2-dioxolane 
(127):  
Method A: 
To a vial containing 110 (220.3 mg, 1.27 mmol) in CH2Cl2 (5 mL) was added 
sequentially 2-adamantaneethanol (614.3 mg, 3.4 mmol) and TsOH (30.6 mg, 0.16 
mmol).  After 12 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (5 
mL) and extracted with CH2Cl2 (2 x 20mL). The combined organic layers were subjected 
to standard drying and purification with 5% EA/hex to afford 127 as a yellow oil (99.1 
mg, 23%).  
Method B: 
To a vial containing 112 (52.2 mg, 0.21 mmol) in CH2Cl2 (5 mL) was added sequentially 
2-adamantaneethanol (128.3 mg, 0.71 mmol) and TsOH (7.1 mg, 0.04mmol).  After 1 hr, 
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the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted with 
CH2Cl2 (2 x 5 mL). The combined organic layers were subjected to standard drying and 
purification with 5% EA/hex to afford 127 as a yellow oil (42.6 mg, 60%). Rf (10% 
EA/hex): 0.37.  1H NMR (400 MHz): 3.62 (m, 1H), 3.44 (m, 1H), 2.54 (d, J = 12.6, 0.5), 
2.45 (d, J = 12.4, 0.5H), 2.34 (d, J = 12.6, 0.5H), 2.22 (d, J = 12.6, 0.5H), 1.97-1.57 
(16H), 1.57-1.43 (5H), 1.41-1.22 (7H), 0.91 (overlapping triplets, J = 6.8, 3H). 13C (100 
MHz): 108.1, 108.0, 86.3, 86.0, 60.4, 60.3, 57.9, 57.5, 41.1, 41.0, 40.3, 39.4, 39.3, 38.6, 
37.8, 33.1, 33.0, 32.4, 32.0, 31.8, 31.5, 28.5, 28.3, 27.3, 26.8, 25.6, 23.4, 23.3, 22.4, 20.1, 
19.6, 14.3, 14.2.   HRMS (FAB): calc for C21H36LiO3: 343.2824; found: 343.2830. 
 
(3,5-cis)(3,5-trans)-3-Butoxy-5-butyl-3,5-dimethyl-1,2-dioxolane (128): 
Method A: 
To a vial containing 110 (71 mg, 0.41 mmol) was added sequentially 1-butanol (3.25g, 44 
mmol) and TsOH (7.1 mg, 0.04 mmol).  After 2 days, the reaction was quenched with sat. 
aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 20 mL). The 
combined organic layers were subjected to standard drying and purification with 5% 
EA/hex to afford 128 as a yellow oil (162 mg, 56%).  Rf (5% EA/hex): 0.41.  1H NMR 
(400 MHz): 3.62 (m, 1H), 3.44 (m, 1H), 2.57 (d, J = 12.6, 0.5H), 2.47 (d, J = 12.4, 0.5H), 
2.35 (d, J = 12.4, 0.5H), 2.24 (d, J = 12.6, 0.5H), 1.76-1.53 (4H), 1.47 (d, J = 8.6, 3H), 
1.44-1.24 (9H), 0.93 (m, 3H). 13C (100 MHz): 108.0, 107.8, 86.1, 85.8, 61.3, 57.8, 57.3, 
40.1, 37.6, 32.13, 32.11, 27.1, 26.6, 25.4, 23.2, 23.1, 22.2, 20.0, 19.5, 19.4, 19.3, 14.1, 
14.0, 13.9, 13.8. HRMS (EI): calc for C13H26O3: 230.1882; found: 230.1883. 
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3-(1-Phenylmethoxy)-3,5,5-trimethyl-1,2-dioxolane (129): 
Method A: 
To a vial containing 107 (203.7 mg, 1.5 mmol) was added sequentially benzyl alcohol 
(19.376 g, 108 mmol) and TsOH (28.53 mg, 0.15 mmol).  After 3 hrs, the reaction was 
treated with sat. aq. NaHCO3 (20 mL) and extracted with Et2O (30 mL).  The combined 
organic layers were washed with brine (30 mL) and subjected to standard drying and 
purification with 10% EA/hex to afford 129 as a yellow oil (226.4 mg, 66%).  
Method B: 
To a vial containing 107-OTMS (110.7 mg, 0.54 mmol) in CH2Cl2 (5 mL) was added 
sequentially benzyl alcohol (158 mg, 1.46 mmol) and TsOH (10 mg, 0.05mmol).  After 5 
min, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted 
with CH2Cl2 (2 x 10 mL).  The combined organic layers were subjected to standard 
drying and purification with 10% EA/hex to afford 129 as a yellow oil (89.2 mg, 74%). 
Rf (10% EA/hex): 0.62. 1H NMR (500 MHz): 7.36 (m, 5H), 4.78 (d, J = 11.3, 1H), 4.54 
(d, J = 11.3, 1H), 2.69 (d, J = 12.6, 1H), 2.42 (d, J = 12.6, 1H), 1.60 (s, 3H), 1.44 (s, 6H). 
13C (125 MHz): 138.8, 12.3, 127.7, 127.4, 108.7, 83.9, 64.1, 58.8, 27.7, 24.7, 20.1. 
LRMS (ESI): calc for C13H18O3Na: 245.1; found: 245.1.  HRMS (EI M-CH3): calc for 
C12H15O3: 207.1021; found: 207.1012 (4.4 ppm).  
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3-(Cyclohexylmethoxy)-3,5,5-trimethyl-1,2-dioxolane (130) 
Method B: 
To a vial containing 107-OTMS (202.8 mg, 0.99 mmol) in CH2Cl2 (10 mL) was added 
sequentially cyclohexanemethanol (0.60 mL, 4.9 mmol) and TsOH (19 mg, 0.1mmol).  
After 2 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and 5 mL H2O (5 mL) 
and extracted with CH2Cl2 (2 x 10 mL).  The combined organic layers were subjected to 
standard drying and purification with 10% EA/hex to afford 130 as a yellow oil (180 mg, 
79%). Rf (10% EA/hex): 0.52. 1H NMR (400 MHz): 3.39 (m, 1H), 3.22 (m, 1H), 2.53 (d, 
J = 12.4, 1H), 2.31 (d, J = 12.4, 1H), 1.84-1.59 (5H), 1.58-1.47 (1H), 1.44 (s, 3H), 1.36 
(s, 3H), 1.35 (s, 3H), 1.31-1.08 (3H), 1.0-0.86 (2H). 13C (100 MHz): 108.3, 83.7, 76.9, 
67.5, 58.8, 38.3, 30.3, 30.2, 27.8, 26.8, 26.1, 26.0, 24.8, 20.0. HRMS (ESI): calc for 
C13H24O3Na: 251.1623; found: 251.1622 (1 ppm). 
O O O Ph  
3-(2-phenylethoxy)-3,5,5-Trimethyl-1,2-dioxolane (131): 
Method A: 
To a vial containing 107 (190.9 mg, 1.44 mmol) was added sequentially 1-phenylethanol 
(22 mL, 183 mmol) and TsOH (26.3 mg, 0.14 mmol).  After 5 hrs, the reaction was 
treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted with Et2O (25 mL).  
The combined organic layers were washed with brine (25 mL) and subjected to standard 
drying and purification with 5% EA/hex to afford 131 as a yellow oil (234 mg, 73%). Rf 
(5% EA/hex): 0.46. 1H NMR (500 MHz): 7.17 (m, 5H), 3.89 (m, 1H), 3.67 (m, 1H), 2.92 
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(m, 2H), 2.55 (d, J = 12.4, 1H), 2.34 (d, J = 12.4, 1H), 1.47 (s, 3H), 1.39 (d, J = 6.2, 6H). 
13C (125 MHz): 139.2, 129.0, 128.3, 126.1, 108.4, 83.8, 62.7, 58.7, 36.7, 27.6, 24.6, 19.9. 
HRMS (ESI): calc for C14H21O3: 237.1491; found: 237.1499 (0.8 ppm) 
O O O
 
3-(2-Cyclohexylethoxy)-3,5,5-trimethyl-1,2-dioxolane (132) 
Method B: 
To a vial containing 107-OTMS (202.1 mg, 0.99 mmol) in CH2Cl2 (10 mL) was added 
sequentially 2-cyclohexylethanol (0.69 mL, 4.9 mmol) and TsOH (19 mg, 0.1mmol).  
After 2 hrs, the reaction was treated sequentially with sat. aq. NaHCO3 (5 mL) and H2O 
(5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined organic layers were 
subjected to standard drying and purification with 10% EA/hex to afford 132 as a yellow 
oil (180 mg, 79%). Rf (10% EA/hex): 0.48. 1H NMR (400 MHz): 3.64 (m, 1H), 3.45 (m, 
1H), 2.53 (d, J = 12.4, 1H), 2.32 (d, J = 12.4, 1H), 1.81-1.59 (5H), 1.54-1.33 (12H), 1.30-
1.08 (3H), 0.98-0.82 (2H).  13C (100 MHz): 108.4, 83.8, 59.8, 58.9, 34.7, 33.7, 33.2, 27.8, 
26.8, 26.6, 26.5, 24.8, 20.1. HRMS (ESI): calc for C14H26O3Na: 265.1779; found: 
265.1176 (1 ppm). 
 
3-(3-phenylpropoxy)-3,5,5-Trimethyl-1,2-dioxolane (133) 
Method A: 
To a vial containing 107 (203.5 mg, 1.54 mmol) in CH2Cl2 (15 mL) was added 
sequentially 3-phenyl-1-propanol (1 mL, 7.5 mmol) and TsOH (27 mg, 0.14 mmol).  
After 2 hrs, the reaction was treated sequentially with sat. aq. NaHCO3 (5 mL) and H2O 
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(5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined organic layers were 
subjected to standard drying and purification with 10% EA/hex to afford 133 as a yellow 
oil (272.2 mg, 71%). Rf (10% EA/hex): 0.5. 1H NMR (400 MHz): 7.34-7.17 (5H), 3.67 
(m, 1H), 3.51 (m, 1H), 2.82-2.70 (2H), 2.59 (d, J = 12.5, 1H), 2.38 (d, J = 12.5, 1H), 2.0-
1.89 (2H), 1.20 9s, 3H), 1.42 (s, 3H), 1.41 (s, 3H). 13C (100 MHz): 142.4, 128.7, 128.4, 
125.8, 108.4, 83.8, 61.0, 58.9, 32.5, 31.9, 27.8, 24.8, 20.1. HRMS (ESI): calc for 
C15H22O3Na: 273.14687; found: 273.1468 (<1 ppm). 
 
3-(1-(1-Adamantyl)methoxy)-3,5,5-trimethyl-1,2-dioxolane (134): 
Method A: 
To a vial containing 107 (236.8 mg, 1.8 mmol) in dichloromethane (15 mL) was added 
sequentially 1-adamantanemethanol (1.1228 g, 6.8 mmol) and TsOH (32 mg, 0.17 
mmol).  After 12 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and extracted 
with Et2O (2 x 30 mL).  The combined organic layers were washed with brine (30 mL) 
and subjected to standard drying and purification with 5% EA/hex to afford 134 as a 
yellow oil (164 mg, 33%).  
Method B: 
To a vial containing 107-OTMS (81.2 mg, 0.4 mmol) in CH2Cl2 (5 mL) was added 
sequentially 1-adamantanemethanol (171 mg, 1.02 mmol) and TsOH (6.46 mg, 
0.034mmol).  After 3 hrs, the reaction was treated sequentially with sat. aq. NaHCO3 (5 
mL) and H2O (10 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic 
layers were subjected to standard drying and purification with 5% EA/hex to afford 134 
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as a yellow oil (77.6 mg, 65%). Rf(5% EA/hex): 0.38.  1H NMR (400 MHz): 3.19 (d, J = 
8.9, 1H), 2.99 (d, J = 8.9, 1H), 2.55 (d, J = 12.3, 1H), 2.56 (d, J = 12.3, 1H), 2.01-1.94 
(3H), 1.78-1.63 (6H), 1.63-1.52 (7H), 1.45 (s, 3H), 1.38 (d, J = 5.6, 6H).  13C (100 MHz): 
108.1, 83.4, 72.0, 58.7, 39.7, 37.3, 33.3, 28.3, 27.7, 24.9, 19.6.  HRMS (FAB): calc for 
C17H28O3Li: 280.2030; found: 280.2038. 
 
3-(1-(2-adamantyl)methoxy)-3,5,5-trimethyl-1,2-dioxolane (135): 
Method A: 
To a vial containing 107 (213 mg, 1.61 mmol) in CH2Cl2 (15 mL) was added sequentially 
2-adamantanemethanol (1.2134 g, 7.3 mmol) and TsOH (20 mg, 0.11 mmol).  After 2 
days, the reaction was treated with sat. NaHCO3 (5 mL) and H2O (5 mL) and extracted 
with CH2Cl2 (2 x 10mL). The combined organic layers were subjected to standard drying 
and purification with 10% EA/hex to afford 135 as a yellow oil (340.7 mg, 75%).  
Method B: 
To a vial containing 107-OTMS (81.2 mg, 0.40 mmol) in CH2Cl2 (5 mL) was added 
sequentially 1-adamantanemethanol (171 mg, 1.03 mmol) and TsOH (6.4 mg, 
0.03mmol).  After 2 hrs, the reaction was treated with sat. NaHCO3 (5 mL) and H2O (10 
mL) and extracted with CH2Cl2 (2 x 10mL). The combined organic layers were subjected 
to standard drying and purification with 5% EA/hex to afford 135 as a yellow oil (60.4 
mg, 62%). Rf(10% EA/hex): 0.7.  1H NMR (500 MHz): 3.7 (apparent triplet, J = 8.4, 1H), 
3.46 (m, 1H), 2.51 (d, J = 12.4, 1H), 2.3 (d, J = 12.4, 1H), 2.08-1.64 (13H), 1.54 (d, J = 
12.6, 2H), 1.45 (s, 3H), 1.34 (m, 6H). 13C (100  MHz): 108.1, 83.4, 63.7, 58.6, 44.1, 39.0, 
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38.8, 38.3, 32.1, 31.7, 29.6, 29.2, 28.4, 28.0, 27.6, 24.6, 19.8.  HRMS (FAB): calc for 
C17H29O3: 281.2117; found: 281.2206. 
 
3-(2-(1-Adamantyl)ethoxy)- 3,5,5-trimethyl-1,2-dioxolane (136): 
Method A: 
To a vial containing 107 (262.2 mg, 1.99 mmol) in CH2Cl2 (15 mL) was added 
sequentially 1-adamantaneethanol (837.2 mg, 4.7 mmol) and TsOH (31 mg, 0.16 mmol).  
After 12 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and extracted with 
Et2O (2 x 30 mL).  The combined organic layers were and washed with brine (30 mL) 
and subjected to standard drying and purification with 10% EA/hex to afford 136 as a 
yellow oil (93 mg, 16%).  
Method B: 
To a vial containing 107-OTMS (76.2 mg, 0.37 mmol) in CH2Cl2 (5 mL) was added 
sequentially 1-adamantaneethanol (184.6 mg, 1.02 mmol) and TsOH (5.4 mg, 
0.03mmol).  After 1 hr, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O 
(10 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined organic layers were 
subjected to standard drying and purification with 5% EA/hex to afford 136 as a yellow 
oil (83.1 mg, 76%). Rf (5% EA/hex): 0.38.  1H NMR (400 MHz): 3.60 (OT, J = 9.0, 1H), 
3.51 (overlapping triplets, J = 9.0, 1H), 2.54 (d, J = 12.4, 1H), 2.34 (d, J = 12.4, 1H), 2-
1.91 (3H), 1.75-1.63 (6H), 1.58-1.52 (6H), 1.49 (s, 3H), 1.46-1.30 (8H).  13C (100 MHz): 
108.3, 83.7, 58.8, 57.7, 44.0, 42.7, 37.1, 31.8, 28.7, 27.5, 24.6, 20.1.  HRMS (EI): calc for 
C18H30O3: 294.2195; found: 294.2196. 
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3-(2-(2-Adamantyl)ethoxy)- 3,5,5-trimethyl-1,2-dioxolane (137): 
Method A: 
To a vial containing 107 (123.6 mg, 0.96 mmol) in CH2Cl2 (10 mL) was added 
sequentially 2-adamantaneethanol (540 mg, 3.0 mmol) and TsOH (20.8 mg, 0.11 mmol).  
After 12 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and extracted Et2O 
(30 mL).  The combined organic layers were and washed with brine (30 mL) and 
subjected to standard drying and purification with 5% EA/hex to afford 137 as a yellow 
oil (161.9 mg, 59%). Rf (5% EA/hex): 0.37.  1H (400 MHz): 3.63 (m, 1H), 3.45 (m, 1H), 
2.51 (d, J = 12.4, 1H), 2.3 (d, J = 12.4, 1H), 1.93-1.60 (15H), 1.53-1.43 (5H), 1.36 (d, J = 
3.1, 6H). 13C (100 MHz): 108.2, 83.5, 60.3, 58.7, 41.0, 39.2, 39.1, 38.4, 32.8, 32.2, 31.8, 
31.6, 31.4, 28.3, 28.0, 27.6, 24.6, 19.8.  HRMS (FAB): calc for C18H31O3: 295.2273; 
found: 295.2270. 
 
3-Butoxy-3,5,5-trimethyl-1,2-dioxolane (138): 
Method A: 
To a vial containing 107 (201.4 mg, 1.53 mmol) was added sequentially 1-butanol 
(13.2764 g, 179.1 mmol) and TsOH (46.6 mg, 0.25 mmol).  After 3 hrs, the reaction was 
treated with sat. aq. NaHCO3 (5 mL) and extracted with Et2O (2 x 30 mL).  The 
combined organic layers were washed with brine (2 x 30 mL) and subjected to standard 
drying and purification with 2.5% EA/hex to afford 138 as a yellow oil (162 mg, 56%).  
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Method B: 
To a solution of 107-OTMS (70.4 mg, 0.34 mmol) in CH2Cl2 (5 mL) in a vial was added 
sequentially 1-butanol (75 mg, 1.02 mmol) and TsOH (6.3 mg, 0.03 mmol).  After 1 h, 
the reaction was quenched with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted 
with CH2Cl2 (10 mL).  The combined organic layers were subjected to standard drying 
and purification with 5% EA/hex to afford 138 as a yellow oil (33 mg, 51%). Rf (5% 
EA/hex):  0.23.  1H NMR (300 MHz):  3.6 (overlapping triplets, J = 6.5, 1H), 3.45 
(overlapping triplets, J = 6.3, 1H), 2.54 (d, J = 12.4, 1H), 2.84 (d, J = 12.4, 1H), 1.56 (m, 
2H), 1.48 (s, 3H), 1.70-1.34 (8H), 0.94 (t, J = 7.3, 3H). 13C (75 MHz):  108.4, 83.8, 61.6, 
58.8, 32.3, 27.8, 24.8, 20.1, 19.5, 14.0.  HRMS (CI):  calc for C10H21O3: 189.1491; found: 
189.1498 (3.9 ppm). 
 
1-(Cyclohex-1-en-1-yl)propan-2-one (145): 
 
To a 0 °C solution of methylene cyclohexane (5 g, 100 mmol) and acetaldehyde (3.8 mL, 
68 mmol) in CH2Cl2 (174 mL) in a flame-dried RBF was added Me2AlCl (68 mL, 68 
mmol, nominally 1M in hexanes).  The reaction was allowed to stir at 0 °C for 2 hr and 
then brought to rt. After two more hours of stirring, the reaction was treated with sat. aq. 
Na2HPO4 (20 mL) and aq. 2N HCl (10 mL) and extracted with CH2Cl2 (2 x 50 mL).  The 
combined organic layers were subjected to standard drying and purification with 20 % 
EA/hex to afford 1-cyclohexenyl-2-propanol as a yellow oil (6.619g, 90%). Rf (20% 
EA/hex):  0.30.  1H NMR:  5.54 (s, 1H), 3.87 (m, 1H), 2.14-1.83 (4H), 1.76 (d, J = 2.2, 
1H), 1.70-1.50 (6H), 1.19 (d, J = 6.3, 3H).  13C:  135.0, 125.1, 65.0, 48.5, 28.5, 25.4, 23.0, 
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22.9, 22.5.  HRMS (ESI):  calc for C9H16NaO: 163.1099; found: 163.1098 (0.6 ppm).  
The NMR spectra matched those previously reported.114 
To a -78 °C solution of oxalyl chloride (0.96 mL, 12 mmol) in CH2Cl2 (72 mL) in 
a flame-dried RBF containing was added DMSO (1.3 mL, 19 mmol) in CH2Cl2 (20 mL) 
drop wise via an addition funnel and allowed to stir for 20 min.  1-cyclohexenyl-2-
propanol (1.35 g, 9.6 mmol) in CH2Cl2 (20 mL) was added drop wise via an addition 
funnel and the reaction allowed to stir at -78oC for 1 hr.  Et3N (7 mL, 48 mmol) was next 
added and the reaction stirred at -78oC for 30 min and rt for 1 hr.  The reaction was then 
treated with H2O (30 mL) and extracted with CH2Cl2 (2 x 30 mL).  The combined 
organic layers were subjected to standard drying and purification with 5% EA/hex to 
afford 145 as a yellow oil (1.0833g, 81%).  Rf (10% EA/hex):  0.27.  1H NMR (300 
MHz):  5.61-5.53 (1H), 3.00 (s, 2H), 2.09-2.00 (2H), 1.96-1.87 (2H), 1.70-1.51 (4H).  13C 
(75 MHz):  208.1, 131.9, 126.5, 53.6, 29.2, 28.8, 25.6, 22.9, 22.2.  IR:  2925, 2836, 1710, 
1437, 1354. HRMS (CI): calc for C9H15O: 139.1123; found: 139.1123 (0.1 ppm). 
O O
OH
 
3-Methyl-1,2-dioxaspiro[4.5]decan-3-ol (146): 
In a RBF containing cobalt (II) acetylacetonate (77.4 mg, 0.30 mmol) in 1,2-
dichloroethane (29 mL) was added 145 (404.2 mg, 2.93 mmol) and triethylsilane (0.96 
mL, 5.8 mmol) and the solution placed under an atmosphere of O2 (balloon).  The 
reaction was stirred overnight and treated with sat. aq. NH4Cl (10 mL) and extracted with 
CH2Cl2 (2 x 20 mL).  The combined organic layers were subjected to standard drying and 
purification with 40% Et2O/pent to afford 146 as a colorless oil (262.9 mg, 52 %).  Rf 
(30% EA/hex):  0.30. 1H NMR (600 MHz):  3.32 (s, 1H), 2.4 (d, J = 12.8, 1H), 2.36 (d, J 
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= 12.8, 1H), 1.80-1.53 (6H), 1.52 (s, 3H), 1.44-1.31 (4H).  13C (150 MHz):  105.7, 86.0, 
57.1, 36.0, 34.9, 25.2, 24.2, 23.4, 23.2.  IR:  3452, 2933, 2858, 1447, 1256.  HRMS 
(ESI): calc for C9H16NaO3: 195.0997; found: 195.0990 (3.5 ppm). 
 
3-Methyl-3-trimethylsiloxy-1,2-dioxaspiro[4.5]decane (147): 
To a flame-dried RBF containing 146 (960.7 mg, 5.6 mmol) in CH2Cl2 (56 mL) was 
added imidazole (1.1 g, 17 mmol) and chlorotrimethylsilane (1.1 mL, 8.4 mmol) and the 
reaction was stirred at rt for 1 hr.  The reaction was treated with H2O (20 mL) and 
extracted with CH2Cl2 (2 x 50 mL).  The combined organic layers were subjected to 
standard drying and purification with 5 % EA/hex to afford 147 as a yellow oil (1.2255 g, 
90%). Rf (5% EA/hex):  0.48.  1H NMR (600 MHz): (2.46 (d, J = 12.3, 1H), 2.34 (d, J = 
12.3, 1H), 1.80-1.53 (6H), 1.51 (s, 3H), 1.44-1.43 (4H), 0.19 (9H).  13C (75 MHz):  107.0, 
85.7, 59.8, 36.5, 35.0, 25.5, 25.4, 24.4, 23.4, 1.7.  HRMS (ESI):  calc for C12H24NaO3Si: 
267.1392; found: 267.1398 (2.2 ppm). 
 
3-Methyl-3-(1-phenylethoxy)-1,2-dioxaspiro[4.5]decane (148): 
To a vial containing a solution of 147 (102.6 mg, 0.42 mmol) in CH2Cl2 (8 mL) was 
added sequentially 2-phenylethanol (250 mg, 2.0 mmol) and TsOH (8.0 mg, 0.04 mmol) 
and the solution stirred for 2 hr.  The reaction was then treated with sat. aq. NaHCO3 (8 
mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were 
subjected to standard drying and purification with 5% EA/hex to afford 148 as a yellow 
oil (99.3 mg, 86%). Rf (5% EA/hex): 0.43.  1H NMR (300 MHz): 7.36-7.12 (5H), 3.92 
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(dt, J = 9.2, 7.2, 1H), 3.69 (dt, J = 9.2, 7.2), 3.04 (2H), 2.49 (d, J = 12.5, 1H), 2.31 (d, J = 
12.5, 1H), 1.90-1.30 (13H).  13C (75 MHz): 139.3, 129.1, 128.3, 126.2, 107.9, 85.6, 62.7, 
57.3, 36.8, 36.4, 34.6, 25.3, 24.3, 23.3, 20.0.  HRMS (ESI): calc for C17H24NaO3: 
299.1623; found: 299.1615 (2.6 ppm). 
 
3-Methyl-3-(1-phenylmethoxy)-1,2-dioxaspiro[4.5]decane (149): 
To a vial containing a solution of 147 (202.9mg, 0.83 mmol) in CH2Cl2 (8 mL) was 
added sequentially benzyl alcohol (0.42 mL, 4.1 mmol) and TsOH (16 mg, 0.08 mmol) 
and the solution stirred for 1 hr.  After which the reaction was treated with sat. aq. 
NaHCO3 (8 mL) and extracted with CH2Cl2 (2 x 10 mL). The combined organic layers 
were concentrated in vacuo, and the residue was purified via column chromatography.  
The semi purified product was dissolved in CH2Cl2 and treated with O3 (O3/O2).  The 
residue obtained upon concentration was purified by column chromatography with 10% 
EA/hex to afford 149 (123.6 mg, 57%).  Rf (5% EA/hex): 0.54.  1H NMR (300 MHz): 
7.48-7.25 (5H), 4.77 (d, J = 11.4, 1H), 4.51 (d, J = 11.4, 1H), 2.59 (d, J = 12.5, 1H), 2.37 
(d, J = 12.5, 1H), 1.91-1.54 (9H), 1.50-1.33 (4H).  13C (75 MHz): 139.0, 128.5, 127.9, 
127.5, 108.2, 85.8, 64.1, 57.3, 36.6, 34.7, 25.4, 24.4, 23.4, 20.2. HRMS (ESI): calc for 
C16H22O3Na: 285.1467; found: 285.1466 (0.4 ppm). 
 
3-Methyl-3-(1-phenylpropoxy)-1,2-dioxaspiro[4.5]decane (150): 
To a vial containing a solution of 147 (201.2 mg, 0.82 mmol) in CH2Cl2 (8 mL) was 
added sequentially 3-phenyl-1-propanol (0.55 mL, 4.1 mmol) and TsOH (11.5 mg, 0.06 
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mmol) and the solution stirred for 2 hrs.  The reaction was treated with sat. aq. NaHCO3 
(5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined organic 
layers were subjected to standard drying and purification 10% EA/hex to afford 150 as a 
yellow oil (209.7 mg, 88%).  Rf (10% EA/hex): 0.48.  1H NMR (400 MHz): 7.33-7.17 
(5H), 3.67 (m, 1H), 3.48 (m, 1H), 2.75 (m, 2H), 2.50 (d, J = 12.5, 1H), 2.33 (d, J = 12.5, 
1H), 1.99-1.55 (8H), 1.51-1.35 (7H). 13C (100 MHz): 142.5, 128.7, 128.4, 125.8, 107.9, 
85.6, 61.0, 57.3, 36.5, 34.7, 32.6, 31.9, 25.4, 24.4, 23.4, 20.0. HRMS (ESI): calc for 
C18H26O3Na: 313.1780; found: 313.1770 (3 ppm). 
 
3-Methyl-3-(1-phenylbutoxy)-1,2-dioxaspiro[4.5]decane (151): 
To a vial containing 147 (202.3 mg, 0.83 mmol) in CH2Cl2 (8 mL) was added 
sequentially 4-phenyl-1-butanol (0.63 mL, 4.1 mmol) and TsOH (16 mg, 0.08 mmol) and 
the solution stirred for 3 hrs.  After which the reaction was treated with sat. aq. NaHCO3 
(5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined organic 
layers were subjected to standard drying and purification with column chromatography, 
ozonolysis, column chromatography and HPLC with 10% EA/hex to afford 151 as a 
yellow oil (188.9 mg, 72%).  Rf (10% EA/hex): 0.59.  1H NMR (600 MHz): 7.28-7.14 
(5H), 3.62 (m, 1H), 3.45 (m, 1H), 2.64 (m, 2H), 2.42 (d, J = 12.4, 1H), 2.27 (d, J = 12.4, 
1H), 1.81-1.50 (10 H), 1.46-1.32 (7H). 13C (150 MHz): 142.9, 128.6, 128.4, 125.8, 107.8, 
85.6, 61.5, 57.3, 36.5, 35.8, 34.7, 29.8, 28.2, 25.4, 24.4, 23.4, 20.1.  HRMS (ESI): calc 
for C19H28O3Na: 327.1936; found: 327.1926.  
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3-(2-Cyclohexylethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (152): 
To a vial containing a solution of 147 (198.9 mg, 0.82 mmol) in CH2Cl2 (8 mL) was 
added sequentially 2-cyclohexaneethanol (0.57 mL, 4.1 mmol) and TsOH (16 mg, 0.08 
mmol) and the solution stirred for 2 hrs.  The reaction was treated with sat. aq. NaHCO3 
(5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined organic 
layers were subjected to standard drying and purification with 10% EA/hex to afford 152 
as a yellow oil (185.8 mg, 81%).  Rf (10% EA/hex): 0.56.  1H NMR (400 MHz): 3.39 (dd, 
J = 9.0, 6.8, 1H), 3.21 (dd, J = 9.0, 6.8, 1H), 2.43 (d, J = 12.4, 1H), 2.26 (d, J = 12.4, 1H), 
1.84-0.82 (26H).. 13C (100 MHz): 107.8, 85.5, 59.6, 57.3, 37.6, 36.6, 34.72, 34.70, 33.72, 
33.2, 26.8, 26.6, 26.5, 25.4, 24.4, 23.4, 20.0. HRMS (ESI): calc for C17H30O3Na: 
305.2093; found 305.2091 (1 ppm). 
 
3-(2-Cyclohexylmethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (153): 
To a vial containing a solution of 147 (195.9 mg, 0.80 mmol) in CH2Cl2 (8 mL) was 
added sequentially 2-cyclohexanemethanol (0.5 mL, 4 mmol) and TsOH (16 mg, 0.08 
mmol) and the solution stirred for 2 hrs.  The reaction was treated with sat. aq. NaHCO3 
(5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined organic 
layers were subjected to standard drying and purification with 10% EA/hex to afford 153 
as a yellow oil (181.5 mg, 84%).  Rf (10% EA/hex): 0.6.  1H NMR (600 MHz): 3.7 (m, 
1H), 3.47 (m, 1H), 2.44 (d, J = 12.5, 1H), 2.27 (d, J = 12.5, 1H), 1.84-0.81 (24H). 13C 
(100 MHz): 107.8, 85.6, 67.5, 57.3, 38.3, 36.6, 34.7, 30.3, 30.2, 26.9, 26.1, 26.0, 25.4, 
 
 
115 
24.4, 23.4, 20.0.  HRMS (ESI): calc for C16H28O3Na: 291.1936; found 291.1922 (4.8 
ppm). 
 
3-(1-(1-Adamantyl)ethoxy))-3-methyl-1,2-dioxaspiro[4.5]decane (154): 
To a vial containing a solution of 147 (202.1 mg, 0.83 mmol) in CH2Cl2 (8 mL) was 
added sequentially 1-adamantaneethanol (735.8 mg, 4.1 mmol) and TsOH (16 mg, 0.08 
mmol) and the solution stirred for 24 hrs.  The reaction was treated with sat. aq. NaHCO3 
(20 mL) and extracted with CH2Cl2 (3 x 10 mL).  The combined organic layers were 
subjected to standard drying and the residue was purified via column chromatography.  
The semi purified product was dissolved in CH2Cl2 and treated with O3 (O3/O2).  The 
residue obtained upon concentration was purified by column chromatography and HPLC 
with 5% EA/hex to afford 154 as a yellow oil (185.8 mg, 81%).  Rf (5% EA/hex): 0.4.  1H 
NMR (600 MHz): 3.67 (m, 1H), 3.49 (m, 1H), 2.42 (d, J = 12.5, 1H), 2.29 (d, J = 12.5, 
1H), 1.63 (s, 3H), 1.84-1.28 (27H). 13C (150 MHz): 107.9, 85.6, 57.8, 57.4, 44.2, 42.9, 
37.3, 36.5, 34.7, 32.0, 28.9, 25.4, 24.4, 23.4, 20.2. HRMS (ESI): calc for C21H34O3Na: 
357.2406; found: 357.2399 (2.0 ppm). 
 
 
3-(1-(1-Adamantyl)methoxy))-3-methyl-1,2-dioxaspiro[4.5]decane (155): 
To a vial containing a solution of 147 (101.5mg, 0.42 mmol) in CH2Cl2 was added 
sequentially 1-adamantanemethanol (350.8 mg, 2.11 mmol) and TsOH (11.3 mg, 0.06 
mmol) and the solution stirred for 2 hrs.  The reaction was treated with sat. aq. NaHCO3 
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(8 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined organic layers were 
subjected to standard drying and purification with 5% EA/hex to afford 155 as a white 
solid (116.7 mg, 89%).  Rf (5% EA/hex): 0.21.  MP = 36-38 oC.   1H NMR (300 MHz): 
3.17 (d, J = 8.9, 1H), 2.95 (d, J = 8.9, 1H), 2.44 (d, J = 12.4, 1H), 2.24 (d, J = 12.4, 1H), 
2.0-1.90 (3H), 1.80-1.45 (17H), 1.45-1.30 (6H). 13C (75 MHz): 107.6, 85.4, 72.1, 57.3, 
39.8, 37.5, 36.7, 34.8, 33.4, 28.5, 25.4, 24.4, 23.4, 19.7.  HRMS (ESI): calc for 
C20H32NaO3: 343.2249; found: 343.2255 (2 ppm). 
 
3-(4-Chlorophenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (156): 
To a vial containing a solution of 147 (197.7 mg, 0.81 mmol) in CH2Cl2 (10 mL) was 
added sequentially 4-chlorophenethyl alcohol (0.51 mL, 4.1 mmol) and TsOH (16 mg, 
0.08 mmol) and the solution stirred for 3 hrs.  The reaction was treated with sat. aq. 
NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined 
organic layers were subjected to standard drying and purification and was purified via 
column chromatography.  The semi purified product was dissolved in CH2Cl2 and treated 
with O3 (O3/O2).  The residue obtained upon concentration was purified by column 
chromatography and HPLC with 10% EA/hex to afford 156 as a yellow oil (152.6 mg, 
61%).  Rf (10% EA/hex): 0.56.  1H NMR (400 MHz): 7.30-7.18 (4H), 3.87 (dt, J = 9.3, 
7.0, 1H), 3.63 (dt, J = 9.3, 7.0, 2.94-2.82 (2H), 2.43 (d, J = 12.5, 1H), 2.28 (d, J = 12.5, 
1H), 1.89-1.31 (13H).  13C (100 MHz): 138.0, 132.0, 130.5, 128.5, 107.9, 85.7, 62.3, 
36.5, 36.0, 34.7, 25.4, 24.3, 23.4, 19.9.  HRMS (ESI): calc for C17H23O3NaCl: 333.1233; 
found: 333.1218 (4.5 ppm). 
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3-(4-Methoxyphenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (157): 
To a vial containing a solution of 147 (201.7 mg, 0.83 mmol) in CH2Cl2 (8 mL) was 
added sequentially 4-methoxyphenethyl alcohol (663.5 mg, 4.4 mmol) and TsOH (16 mg, 
0.08 mmol) and the solution stirred for 24 hrs.  The reaction was treated with sat. aq. 
NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined 
organic layers were subjected to standard drying and purification and was purified via 
column chromatography.  The semi purified product was dissolved in CH2Cl2 and treated 
with O3 (O3/O2).  The residue obtained upon concentration was purified by column 
chromatography and HPLC with 10% EA/hex to afford 157 as a yellow oil (98.2 mg, 
39%).  Rf (10% EA/hex): 0.47.  1H NMR (600 MHz): 7.18 (d, J = 8.7, 2H), 6.84 (d, J = 
8.7, 2H), 3.84 (m, 1H), 3.79 (s, 3H), 3.61(m, 1H), 2.84 (m, 2H), 2.44 (d, J = 12.6, 1H), 
2.28 (d, J = 12.6, 1H), 1.81-1.51 (6H), 1.45-1.33 (7H). 13C (150 MHz): 158.2, 131.4, 
130.0, 113.8, 107.9, 85.7, 63.0, 57.3, 55.4, 36.5, 35.9, 34.6, 25.4, 24.4, 23.4, 20.1.  
HRMS (ESI): calc for C18H26O4Na: 329.1729; found 329.1721 (2.4 ppm). 
 
3-Methyl-3-(4-methylphenethoxy)-1,2-dioxaspiro[4.5]decane (158): 
To a vial containing a solution of 147 (197 mg, 0.81 mmol) in CH2Cl2 (8 mL) was added 
sequentially 4-methylphenethyl alcohol (0.57 mL, 4.1 mmol) and TsOH (16 mg, 0.08 
mmol) and the solution stirred for 2 hrs.  The reaction was treated with sat. aq. NaHCO3 
(5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined organic 
layers were subjected to standard drying and purification and was purified via column 
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chromatography.  The semi purified product was dissolved in CH2Cl2 and treated with O3 
(O3/O2).  The residue obtained upon concentration was purified by column 
chromatography with 5% EA/hex to afford 158 (155.7 mg, 65%).  Rf (10% EA/hex): 
0.43.  1H NMR (600 MHz): 7.19-7.05 (4H), 3.85 (m, 1H), 3.62 (m, 1H), 2.87 (m, 2H). 
2.45 (d, J = 12.4, 1H), 2.35-2.25 (4H), 1.84-1.49 (6H), 1.48-1.29 (7H). 13C (150 MHz): 
136.2, 135.7, 129.1, 129.0, 107.9, 85.7, 63.0, 57.3, 36.5, 36.4, 34.6, 25.4, 24.4, 23.4, 21.2, 
20.1.  HRMS (ESI): calc for C18H26O3Na: 313.1780; found: 313.1766 (4.47 ppm). 
 
3-(3,4-Dichlorophenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (159): 
To a vial containing a solution of 147 (203 mg, 0.83 mmol) in CH2Cl2 (8 mL) was added 
sequentially 3,4-dichlorophenethyl alcohol (0.59 mL, 4.1 mmol) and TsOH (17.1 mg, 
0.08 mmol) and the solution stirred for 3 hrs.  The reaction was treated with sat. aq. 
NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined 
organic layers were subjected to standard drying and purification and was purified via 
column chromatography.  The semi purified product was dissolved in CH2Cl2 and treated 
with O3 (O3/O2).  The residue obtained upon concentration was purified by column 
chromatography and HPLC (x2) with 5% EA/hex to afford 159 (63.7 mg, 22%).  Rf (10% 
EA/hex): 0.3.  1H NMR (600 MHz): 7.39 (d, J = 1.9, 1H), 7.34 (d, J = 8.3, 1H), 7.10 (dd, 
J = 8.3, 1.8, 1H), 3.86 (m, 1H), 3.62 (m, 1H), 2.84 (t, J = 6.8, 2H), 2.4 (d, J = 12.5, 1H), 
2.27 (d, J = 12.5, 1H), 1.80-1.50 (6H), 1.40-1.32 (7H).  13C (150 MHz): 140.0, 132.2, 
131.2, 130.2, 130.1, 128.7, 107.9, 85.7, 61.8, 57.4, 36.5, 35.7, 34.7, 25.3, 24.3, 23.3, 19.8.   
HRMS (ESI): calc for C17H22O3NaCl2: 367.0344; found: 367.0843 (3.0 ppm). 
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3-(3-Chlorophenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (160): 
To a vial containing a solution of 147 (249.1 mg, 1.02 mmol) in CH2Cl2 (10 mL) was 
added sequentially 3-chlorophenethyl alcohol (0.66 mL, 5 mmol) and TsOH (19 mg, 0.1 
mmol) and the solution stirred for 3 hrs.  The reaction was treated with sat. aq. NaHCO3 
(5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined organic 
layers were subjected to standard drying and purification via column chromatography.  
The semi purified product was dissolved in CH2Cl2 and treated with O3 (O3/O2).  The 
residue obtained upon concentration was purified by column chromatography and HPLC 
with 5% EA/hex and HPLC with 2.5% EA/hex to afford 160 (117.2 mg, 37%).  Rf (10% 
EA/hex): 0.56.  1H NMR (600 MHz): 7.30-7.09 (5H), 3.86 (m, 1H), 3.63 (m, 1H), 2.87 
(m, 2H), 2.42 (d, J = 12.5, 1H), 2.27 (d, J = 12.5, 1H), 1.81-1.50 (6H), 1.45-1.30 (7H).  
13C (150 MHz): 141.6, 134.1, 129.6, 129.4, 127.4, 126.4, 107.9, 85.7, 62.2, 57.4, 36.5, 
36.4, 34.6, 25.4, 24.4, 23.4, 19.9.   HRMS (ESI): calc for C17H23O3NaCl: 333.1233; 
found: 333.1223 (3.0 ppm). 
 
3-(4-Fluorophenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (161): 
To a vial containing a solution of 147 (200 mg, 0.82 mmol) in CH2Cl2 (8 mL) was added 
sequentially 4-fluorophenethyl alcohol (0.51 mL, 4.1 mmol) and TsOH (16 mg, 0.08 
mmol) and the solution stirred for 3 hrs.  The reaction was treated with sat. aq. NaHCO3 
(5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined organic 
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layers were subjected to standard drying and purification via column chromatography.  
The semi purified product was dissolved in CH2Cl2 and treated with O3 (O3/O2).  The 
residue obtained upon concentration was purified by column chromatography and HPLC 
with 10% EA/hex to afford 161 (144.5 mg, 71%).  Rf (10% EA/hex): 0.55.  1H NMR 
(600 MHz): 7.24-7.19 (2H), 7.0-6.94 (2H), 3.85 (m, 1H), 3.61 (m, 1H), 2.42 (d, J = 12.5, 
1H), 2.28 (d, J = 12.5, 1H), 1.82-1.51 (6H), 1.47-1.33 (7H).  13C (150 MHz): 162.5, 
160.9, 135.1, 135.1, 130.6, 130.5, 115.2, 115.0, 107.9, 85.7, 62.6, 57.4, 57.3, 36.5, 35.9, 
24.7, 25.4, 24.4, 23.4, 20.0.  19F (376 MHz): -117.52, -117.53, -117.54, -117.56, -117.57, 
-117.58, -117.6.  HRMS (ESI): calc for C17H23O3NaF: 317.1529; found: 317.1521 (2.5 
ppm). 
 
3-(4-(tert-Butyl)phenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (162): 
To a vial containing a solution of 147 (204.2 mg, 0.84 mmol) in CH2Cl2 (8 mL) was 
added sequentially 4-t-butylphenethyl alcohol (0.75 mL, 4.1 mmol) and TsOH (16 mg, 
0.08 mmol) and the solution stirred for 3 hrs.  The reaction was treated with sat. aq. 
NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined 
organic layers were subjected to standard drying and purification via column 
chromatography.  The semi purified product was dissolved in CH2Cl2 and treated with O3 
(O3/O2).  The residue obtained upon concentration was purified by column 
chromatography with 5% EA/hex to afford 162 (176.3 mg, 65%).  Rf (10% EA/hex): 
0.35.  1H NMR (300 MHz): 7.36-7.3 (2H), 7.24-7.17 (2H), 3.87 (m, 1H), 3.65 (m, 1H), 
3.65 (m, 1H), 2.80 (m, 2H), 2.46 (d, J = 12.5, 1H), 2.30 (d, J = 12.5, 1H), 1.86-1.51 (6H), 
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1.50-1.27 (16H).  13C (75 MHz): 149.0, 136.2, 128.8, 125.3, 107.9, 85.7, 62.9, 57.3, 36.5, 
36.5, 36.2, 34.6, 34.5, 31.6, 25.4, 24.4, 23.3, 20.1.  HRMS (ESI):  calc for C21H32O3Na: 
355.2249; found: 355.2253 (1.1 ppm). 
 
3-(4-Hydroxyphenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (163): 
To a flame-dried RBF containing a solution of 147 (1.2513 g, 5.1 mmol) in CH2Cl2 (51 
mL) was added sequentially 2-[4-(tert-butyldimethylsilanyloxy)phenyl]ethanol (3.8872 g, 
15.4 mmol) and TsOH (97 mg, 0.51 mmol) and the solution stirred for 2 hrs.  The 
reaction was treated with sat. aq. NaHCO3 (8 mL) and extracted with CH2Cl2 (2 x 10 
mL).  The combined organic layers were subjected to standard drying and purification 
with 5% EA/hex to afford 3-((tert-butyldimethyl(phenoxy)silane)ethoxy)-3-methyl-1,2-
dioxaspiro[4.5]decane (1.2919 g, 62%).  Rf (10% EA/hex): 0.62.  1H NMR (400 MHz): 
7.12-7.08 (2H), 6.78-6.72 (2H), 3.82 (m, 1H), 3.6 (m, 1H), 2.82 (m, 2H), 2.44 (d, J = 
12.6, 1H), 2.27 (d, J = 12.6, 1H), 1.83-1.50 (6H), 1.46-1.32 (7H), 0.99 (s, 9H), 0.19 (s, 
6H). 13C (100 MHz): 154.1, 133.0, 130.0, 120.0, 108.0, 85.7, 63.0, 57.3, 36.5, 36.0, 34.7, 
25.9, 25.4, 24.4, 23.4, 20.1, 18.4, -4.2.  HRMS (ESI):; calc for C23H38O4NaSi: 429.2437; 
found: 429.2427 (2.3ppm). 
To a flame-dried vial containing a solution of 3-((tert-
butyldimethyl(phenoxy)silane)ethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (1.1509 g, 
2.8 mmol) in THF (15 mL) was added TBAF (3.4 mL, 3.4 mmol, 1M in THF).  After 30 
min the reaction was treated with H2O (30 mL) and extracted with Et2O (3 x 30 mL).  
The combined organic layers were subjected to standard drying and purified twice by 
column chromatography with 30% EA/hex to afford 163 (790.5 mg, 96%). Rf (30% 
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EA/hex): 0.48. 1H NMR (400 MHz): 7.11 (d, J = 8.5, 2H), 6.76 (m, 2H), 4.85 (s, 1H), 
3.82 (m, 1H), 3.60 (m, 1H), 2.82 (m, 2H), 2.45 (d, J = 12.5, 1H), 2.29 (d, J = 12.5, 1H), 
1.82-1.52 (7H), 1.47-1.32 (6H). 13C (100 MHz): 154.1, 131.5, 130.2, 115.3, 108.0, 85.8, 
63.1, 57.3, 36.5, 35.9, 34.6, 25.4, 24.4, 23.4, 20.1. HRMS (ESI): calc for C17H24O3Na: 
315.1572; found: 315.1562 (3.2 ppm). 
 
3-(2-Chlorophenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (164): 
To a vial containing a solution of 147 (200.1 mg, 0.82 mmol) in CH2Cl2 (8 mL) was 
added sequentially 2-chlorophenethyl alcohol (0.54 mL, 4.1 mmol) and TsOH (16 mg, 
0.08 mmol) and the solution stirred for 3 hrs.  The reaction was treated with sat. aq. 
NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined 
organic layers were subjected to standard drying and purification via column 
chromatography.  The semi purified product was dissolved in CH2Cl2 and treated with O3 
(O3/O2).  The residue obtained upon concentration was purified by column 
chromatography and HPLC with 10% EA/hex to afford 164 (146 mg, 57%).  Rf (10% 
EA/hex): 0.50.  1H NMR (600 MHz): 7.37-7.32 (2H), 7.21-7.12 (2H), 3.88 (m, 1H), 3.71 
(m, 1H), 3.03 (m, 2H), 2.43 (d, J = 12.5, 1H), 2.28 (d, J = 12.5, 1H), 1.82-1.52 (6H), 
1.48-1.32 (7H).  13C (150 MHz): 136.8, 134.2, 131.3, 129.3, 127.6, 126.6, 107.9, 85.5, 
60.8, 57.1, 36.3, 34.5, 34.3, 25.2, 24.2, 23.2, 19.9.  HRMS (ESI): calc for C17H23O3NaCl: 
333.1233; found: 333.1231 (0.6 ppm). 
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3-(4-Bromophenethoxy)-3-methyl-1,2-dioxaspiro[4.5]decane (165): 
To a vial containing a solution of 147 (203.5 mg, 0.83 mmol) in CH2Cl2 (8 mL) was 
added sequentially 4-bromophenethyl alcohol (0.57 mL, 4.1 mmol) and TsOH (16 mg, 
0.08 mmol) and the solution stirred for 3 hrs.  The reaction was treated with sat. aq. 
NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined 
organic layers were subjected to standard drying and purification via column 
chromatography.  The semi purified product was dissolved in CH2Cl2 and treated with O3 
(O3/O2).  The residue obtained upon concentration was purified by column 
chromatography and HPLC with 10% EA/hex to afford 165 (140.1 mg, 47%).  Rf (10% 
EA/hex): 0.52.  1H NMR (600 MHz): 7.40 (d, J = 8.3, 2H), 7.14 (d, J = 8.3, 2H), 3.85 (m, 
1H), 3.61 (m, 1H), 2.85 (m, 1H), 2.40 (d, j = 12.5, 1H), 2.32 (d, J = 12.5, 1H), 1.81-1.51 
(6H), 1.44-1.32 (7H).  13C (150 MHz): 138.5, 131.4, 131.0, 120.0, 107.9, 85.7, 62.2, 57.4, 
36.5, 36.1, 34.6, 25.4, 24.3, 23.4, 19.9.  HRMS (ESI): calc for C17H23O3NaBr: 377.0728; 
found: 377.0715 (3.0 ppm). 
 
1-(Cyclopent-1-en-1-yl)propan-2-one (168): 
To a flame-dried RBF containing a 0 °C solution of acetaldehyde (1.7 mL, 29 mmol) and 
methylene cyclopentane (2.3 mL, 22 mmol) in CH2Cl2 (106 mL) was added Me2AlCl (28 
mL, 28 mmol, nominally 1M in hexanes).  The resulting solution was stirred at 0 °C for 2 
hrs and allowed to warm to rt. After stirring an additional 3 hrs, the reaction was treated 
with sat. aq. NaH2PO4 (20 mL) and aq. 2N HCl until clear.  The resulting suspension was 
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extracted with CH2Cl2 (2 x 50 mL).  The combined organic layers were subjected to 
standard drying and purification with 30% EA/hex to afford 1-(cyclopent-1-en-1-
yl)propan-2-ol (2.15 g, 78%). Rf (30% EA/hex):  0.53. 1H NMR (400 MHz): 5.51-5.48 
(1H), 3.97-3.88 (1H), 2.37-2.15 (6H), 1.88 (m, 2H), 1.70 (s, 1H), 1.20 (d, J = 6.1, 3H).  
13C (100 MHz): 141.5, 127.3, 65.7, 41.5, 35.3, 32.7, 23.6, 23.1.   
To a flame-dried RBF containing a -78oC solution of oxalyl chloride (1.5 mL, 18 
mmol) in CH2Cl2 (90 mL) was added a solution of DMSO (2.2 mL, 30 mmol) in CH2Cl2 
(30 mL) via an addition funnel.  The resulting solution was stirred at -78 oC for 30 min, 
after which 1-(cyclopent-1-en-1-yl)propan-2-ol (1.89 g, 15 mmol) in CH2Cl2 (30 mL) 
was added via an addition funnel. The reaction was stirred for 1 hr, after which Et3N (11 
mL, 75 mmol) was added. The reaction was stirred at -78 °C for 30 min and then allowed 
to warm to rt.  After 30 min, the reaction was quenched with H2O (50 mL) and extracted 
with CH2Cl2 (2 x50 mL).  The combined organic layers were subjected to standard drying 
and purification with 20% Et2O/pent to 30% Et2O/pent to afford 168 (1.48 g, 82%).  Rf 
(20% EA/hex): 0.61.  1H NMR (300 MHz): 5.53 (s, 3H), 3.20 (s, 2H), 2.39-2.21 (4H), 
2.15 (s, 3H), 1.96-1.89 (1H). 13C (75 MHz): 207.3, 137.3, 128.9, 46.7, 35.4, 32.8, 29.5, 
23.7.  IR: 2925, 2836, 1710.  HRMS (CI): calc for C8H13O: 125.0966; found: 125.0967 
(0.5 ppm). 
O
 
1-(Cyclododec-1-en-1-yl)propan-2-one (169): 
To a flame-dried RBF containing a 0 °C solution of acetaldehyde (0.47 mL, 8.4 mmol) 
and 1-methylidenecyclododecane (1.1642g, 6.5 mmol) in CH2Cl2 (33 mL) was added 
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Me2AlCl (8.4 mL, 8.4 mmol, nominally 1M in hexanes).  The resulting solution was 
stirred at 0 °C for 2 hrs and allowed to warm to rt. After stirring an additional 3hrs, the 
reaction was treated with sat. aq. NaH2PO4 (20 mL) and aq. 2N HCl until clear.  The 
resulting suspension was extracted with CH2Cl2 (3 x 20 mL).  The combined organic 
layers were subjected to standard drying and purification with 20% EA/hex to afford 1-
(cyclododec-1-en-1-yl)propan-2-ol (1.15 g, 79%). Rf (20% EA/hex):  0.44. 1H NMR (300 
MHz): 5.57-5.46 (1H), 3.88 (m, 1H), 2.44-1.88 (6H), 1.71 (s, 1H), 1.65-1.11 (18H).  13C 
(75 MHz): 134.7, 131.8, 66.3, 38.8, 36.0, 27.7, 26.7, 26.6, 26.0, 25.5, 25.0, 24.7, 24.66, 
24.63, 24.0, 23.1.  HRMS (ESI): calc for C15H28ONa: 247.2038; found: 247.2037 (0.4 
ppm). 
To a flame-dried RBF containing a -78oC solution of oxalyl chloride (0.45 mL, 
5.4 mmol) in CH2Cl2 (30 mL) was added a solution of DMSO (0.64 mL, 9 mmol) in 
CH2Cl2 (10 mL) via an addition funnel.  The resulting solution was stirred at -78 oC for 
30 min, after which 1-(cyclododec-1-en-1-yl)propan-2-ol (930 mg, 4.2 mmol) in CH2Cl2 
(10 mL) was added via an addition funnel. The reaction was stirred for 1 hr, after which 
Et3N (3.1 mL, 23 mmol) was added. The reaction was stirred at -78 °C for 30 min and 
then allowed to warm to rt.  After 30 min, the reaction was quenched with H2O (50 mL) 
and extracted with CH2Cl2 (2 x 20 mL).  The combined organic layers were subjected to 
standard drying and purification with 5% EA/hex to afford 169 (789.7 mg, 86%).  Rf (5% 
EA/hex): 0.48.  1H NMR (600 MHz):  5.56 (t, J = 7.7, 1H), 3.15 (s, 2H), 2.18-2.02 (7H), 
1.56-1.13 (16H). 13C (75 MHz):  207.2, 132.1, 131.1, 44.8, 36.5, 29.3, 28.1, 27.0, 26.4, 
26.1, 25.4, 25.0, 24.5, 24.2, 24.1.  IR: 2924, 2855, 1708 HRMS (ESI): calc for 
C15H26ONa: 245.1881; found: 245.1873 (3.3 ppm). 
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3-Methyl-3-trimethylsiloxy-1,2-dioxaspiro[4.4]-nonane (170): 
To a RBF containing a solution of cobalt (II) acetylacetonate (247 mg, 0.96 mmol) in 1,2-
dichloroethane (96 mL) was added sequentially 168 (1.1936 g, 9.6 mmol), triethylsilane 
(3.1 mL, 19.2 mmol), and t-BuOOH (1.75 mL, 9.6 mmol, 5.5M in decane). The resulting 
solution was stirred under an atmosphere of O2 (balloon).  After 24 hrs the reaction was 
diluted with NH4Cl (20 mL) and extracted with CH2Cl2 (3 x 30mL).  The combined 
organic layers were subjected to standard drying and purification with 30% EA/hex to 
afford 3-methyl-1,2-dioxaspiro[4.4]nonan-3-ol (979.4 mg, 65%).  1H NMR (300 MHz): 
3.01 (s, 1H), 2.69 (d, J = 13.0, 1H), 2.57 (d, J = 13.0, 1H), 2.26 (1H), 1.94-1.37 (10H).  
13C (75 MHz): 105.9, 94.6, 56.7, 38.7, 34.9, 24.5, 24.4, 23.4.  HRMS (ESI): calc for 
C8H14O3Na: 181.0841; found: 181.0839 (1.1 ppm).  
To a flame-dried RBF containing a solution of 3-methyl-1,2-dioxaspiro[4.4]nonan-3-ol 
(853.6 mg, 5.4 mmol) in CH2Cl2 (23 mL) was added sequentially imidazole (1.1 g, 16 
mmol) and chlorotrimethylsilane (1.0 mL, 8.1 mmol) and the reaction was allowed to stir 
for 1 hr.  The reaction was treated with H2O (20 mL) and extracted with CH2Cl2 (2 x 20 
mL).  The combined organic layers were subjected to standard drying and purification 
with column chromatography with 5% EA/hex to afford 170 (1.0401 g, 89%). Rf (5% 
EA/hex):  0.38. 1H NMR (400 MHz): 2.73 (d, J = 12.6, 1H), 2.54 (d, J = 12.6, 1H), 2.22-
2.13 (1H), 1.92-1.85 (2H), 1.77-1.39 98H), 0.20 (s, 9H).  13C (100 MHz): 107.3, 94.5, 
59.3, 38.5, 34.7, 25.8, 24.6, 24.3, 1.7.  HRMS (ESI): calc for C1H22O3Na: 253.1236; 
found: 253.1240 (1.6 ppm). 
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3-Methyl-3-trimethylsiloxy-1,2-dioxaspiro[4.4]-hexadecane (171): 
To a RBF containing a solution of cobalt (II) acetylacetonate (85 mg, 0.32 mmol) in 1,2-
dichloroethane (32 mL) was added sequentially 169 (720.7 mg, 3.2 mmol), triethylsilane 
(1.1 mL, 6.4 mmol), and t-BuOOH (0.6 mL, 3.2 mmol, 5.5M in decane). The resulting 
solution was stirred under an atmosphere of O2.  After 24 hrs the reaction was diluted 
with NH4Cl (20 mL) and extracted with CH2Cl2 (3 x 30mL).  The combined organic 
layers were subjected to standard drying and purification with 30% EA/hex to afford 3-
methyl-1,2-dioxaspiro[4.11]hexadecan-3-ol (645.1 mg, 78%).  1H NMR (400 MHz): 3.00 
(s, 1H), 2.47 (d, J = 12.9, 1H), 2.37 (d, J = 12.9, 1H), 1.86-1.74 (2H), 1.62-1.27 (24H).  
13C (100 MHz): 105.8, 100.2, 89.4, 57.2, 32.1, 31.6, 26.6, 26.4, 26.1, 23.5, 22.7, 22.6, 
22.4, 22.2, 20.7, 19.7.  HRMS (ESI): calc for C15H28O3Na: 279.1936; found: 279.1927 
(3.2 ppm). 
To a flame-dried RBF containing a solution of 3-Methyl-1,2-
dioxaspiro[4.11]hexadecan-3-ol (587.3 mg, 2.3 mmol) in CH2Cl2 (23 mL) was treated 
sequentially with imidazole (0.80 g, 12 mmol) and chlorotrimethylsilane (0.9 mL, 7 
mmol) and was allowed to stir for 1 hr.  After which the reaction was treated with H2O 
(20 mL) and extracted with CH2Cl2 (2 x 20 mL).  The combined organic layers were 
subjected to standard drying and purification with column chromatography twice with 
5% EA/hex to afford 171 (688.3 mg, 91%). Rf (10% EA/hex):  0.57. 1H NMR (400 
MHz): 2.50 (d, J = 12.4, 1H), 2.31 (d, J = 12.4, 1H), 1.88-138 (1H), 1.63-1.22 (24H), 
0.18 (s, 9H).  13C (100 MHz): 107.1, 89.1, 59.9, 32.4, 31.3, 26.7, 26.4, 26.1, 25.6, 22.7, 
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22.6, 22.4, 22.2, 20.8, 19.7, 1.7. HRMS (ESI): calc for C18H36O3NaSi: 351.2331; found: 
351.2328 (0.85 ppm). 
 
3-Methyl-3-phenethoxy-1,2-dioxaspiro[4.4]nonane (172):  
To a vial containing a solution of 170 (202 mg, 1.5 mmol) in CH2Cl2 (9 mL) was added 
sequentially 2-phenethanol (0.73 mL, 4.4 mmol) and TsOH (17 mg, 0.09 mmol) and the 
solution stirred for 3 hrs.  The reaction was then treated with sat. aq. NaHCO3 (5 mL) and 
H2O (5 mL) and extracted with CH2Cl2 (3 x 10 mL).  The combined organic layers were 
subjected to standard drying and purification via column chromatography.  The semi 
purified product was dissolved in CH2Cl2 and treated with O3 (O3/O2).  The residue 
obtained upon concentration was purified by column chromatography (5% EA/hex) and 
HPLC (x3 with 5% EA/hex) to afford 172 (141.8 mg, 62%).  Rf (5% EA/hex): 0.40.  1H 
NMR (400 MHz): 7.36-7.18 (5H), 3.87 (m, 1H), 3.70 (m, 1H), 2.93 (m, 2H), 2.74 9d, J = 
12.4, 1H), 2.48 (d, J = 12.4, 1H), 2.24-2.15 (1h), 1.94-1.43 (10H).  13C (100 MHz): 138.3, 
129.2, 128.4, 126.3, 108.2, 94.4, 63.2, 56.4, 38.7, 36.9, 34.7, 24.6, 24.3, 20.4.  HRMS 
(ESI):  calc for C16H22O3Na: 285.1467; found: 285.1472 (1.8 ppm). 
O O
O
Ph
 
3-Methyl-3-phenethoxy-1,2-dioxaspiro[4.11]hexadecane (173): 
To a vial containing a solution of 171 (501.2 mg, 1.5 mmol) in CH2Cl2 (15 mL) was 
added sequentially 2-phenethanol (0.90 mL, 7.5 mmol) and TsOH (29 mg, 0.15 mmol) 
and the solution stirred overnight.  After which the reaction was treated with sat. aq. 
NaHCO3 (20 mL) and extracted with CH2Cl2 (3 x 20 mL).  The combined organic layers 
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were subjected to standard drying and purification via column chromatography.  The 
semi purified product was dissolved in CH2Cl2 and treated with O3 (O3/O2).  The residue 
obtained upon concentration was purified by column chromatography and HPLC with 
10% EA/hex to afford 173 (132.8 mg, 24%).  Rf (10% EA/hex): 0.46.  1H NMR (600 
MHz): 7.34-7.16 (5H), 3.87 (m, 1H), 3.65 (m, 1H), 2.91 (m, 2H), 2.48 (d, J = 12.5, 1H), 
2.26 (d, J = 12.5, 1H), 1.83-1.70 (2H), 1.59-1.24 (23H).  13C (150 MHz): 139.4, 129.2, 
128.4, 126.3, 108.1, 89.2, 62.8, 57.2, 36.9, 32.5, 31.0, 26.7, 26.4, 26.1, 22.7, 22.6, 22.5, 
22.3, 20.8, 20.1, 19.7.  HRMS (ESI): calc for C23H36O3Na: 383.2562; found: 383.2574 
(3.1 ppm). 
Bn
OH
 
1-(Cyclohex-1-en-1-yl)-3-phenylpropan-2-ol (177): 
To a flame-dried RBF containing a 0 °C solution of phenylacetaldehyde (1.2443 g, 10.3 
mmol) and methylenecyclohexane (1.0873 g, 11.3 mmol) in CH2Cl2 (30 mL)  was added 
Me2AlCl (13 mL, 13 mmol, nominally 1M in hexanes).  The resulting solution was 
stirred at 0 °C for 2 hrs and then allowed to warm to rt. After stirring an additional 1 hr, 
the reaction was treated with sat. aq. NaH2PO4 (10 mL) and aq. 2N HCl (5 mL) and 
extracted with CH2Cl2 (2x30 mL).  The combined organic layers were subjected to 
standard drying and purification with 20% EA/hex to afford 177 as a yellow oil (1.7025 
g, 76%). Rf (20% EA/hex):  0.44. 1H NMR (300 MHz):  7.40-7.20 (5H), 5.58 (s, 1H), 
3.96 (m, 1H), 2.80 (s, 1H), 2.77 (s, 1H), 2.26-1.78 (7H), 1.70-1.52 (4H).  13C (75 MHz):  
139.0, 134.8, 129.6, 128.6, 126.5, 125.2, 70.0, 46.1, 43.7, 28.6, 25.6, 25.5, 23.0, 22.5.  
IR: 3424, 2922, 2855, 2833, 1495.  HRMS (CI): calc for C15H19O: 215.1436; found: 
215.1437 (0.5ppm). 
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1-(Cyclohex-1-en-1-yl)-4-phenylbutan-2-ol (178): 
To a flame-dried RBF containing a 0 °C solution of 3-phenyl-1-propanal (1.4592 g, 10.9 
mmol) and methylenecyclohexane (1.0562 g, 11 mmol) in CH2Cl2 (30 mL)  was added 
Me2AlCl (13 mL, 13 mmol, nominally 1M in hexanes).  The resulting solution was 
stirred at 0 °C for 2 hrs and allowed to warm to rt. After stirring an additional hour, the 
reaction was treated with sat. aq. NaH2PO4 (10 mL) and aq. 2N HCl (5 mL) and extracted 
with CH2Cl2 (2 x 30 mL).  The combined organic layers were subjected to standard 
drying and purification with 20% EA/hex to afford 178 (2.0325 g, 89%). Rf (20% 
EA/hex): 0.48. 1H NMR (400 MHz): 7.34-7.14 (5H), 5.55 (s, 1H), 3.76-3.65 (1H), 2.89-
2.63 (2H), 2.22-1.47 (13H).  13C (100 MHz): 142.3, 134.6, 128.4, 128.3, 125.7, 125.2, 
67.9, 46.6, 38.7, 32.2, 28.4, 25.3, 22.9, 22.3.  HRMS (FAB): calc for C16H22ONa: 
253.1568; found: 253.1566 (0.7 ppm). 
 
1-(Cyclohex-1-en-1-yl)-3-phenylpropan-2-one (179): 
To a flame-dried RBF containing a -78oC solution of oxalyl chloride (0.76 mL, 9 mmol) 
in CH2Cl2 (36 mL) was added a solution of DMSO  (1.1 mL, 15 mmol) in CH2Cl2 (15 
mL)  via an addition funnel.  The resulting solution was stirred at -78 oC for 30 min, after 
which 177 (1.6192g, 7.5 mmol) in CH2Cl2 (15 mL) was added via an addition funnel. 
The reaction was stirred for 1h, after which Et3N (5.3 mL, 37 mmol) was added. The 
reaction was stirred at -78 °C for 30 min and then allowed to warm to rt.  After 30 min, 
the reaction was quenched with H2O (50 mL) and extracted with CH2Cl2 (2 x5 0 mL).  
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The combined organic layers were subjected to standard drying and purification with 5% 
EA/hex to afford 179 as a yellow oil (1.5189 g, 95%).  Rf (20% EA/hex): 0.64.  1H NMR 
(600 MHz):  7.36-7.30 (2H), 7.27 (m, 1H), 7.23-7.19 (2H), 5.55 (s, 1H), 3.72 (s, 2H), 
3.06 (s, 2H), 2.07-2.01 (2H), 1.89-1.83 (2H), 1.63-1.53 (4H). 13C (150 MHz):  207.0, 
134.5, 131.7, 129.7, 128.8, 127.1, 126.8, 51.9, 48.9, 28.7, 25.6, 22.9, 22.2. IR:  2942, 
2856, 2834, 1711, 1495. HRMS (CI):  calc for C15H19O: 215.1436; found: 215.1441 (2.4 
ppm). 
 
1-(Cyclohex-1-en-1-yl)-4-phenylbutan-2-one (180): 
To a flame-dried RBF containing a -78 oC solution of oxalyl chloride (0.84 mL, 10 
mmol) in CH2Cl2 (40 mL) was added a solution of DMSO (1.2 mL,  16.6 mmol) in 
CH2Cl2 (17 mL)  via an addition funnel.  The resulting solution was stirred at -78 oC for 
30 min, after which 178 (1.909 g, 8.3 mmol) in CH2Cl2 (17 mL) was added via an 
addition funnel. The reaction was stirred for 1 hr, after which Et3N (6 mL, 42 mmol) was 
added. The reaction was stirred at -78 °C for 30 min and then allowed to warm to rt.  
After 30 min, the reaction was quenched with H2O (50 mL) and extracted with CH2Cl2 (2 
x 50 mL).  The combined organic layers were subjected to standard drying and 
purification with 5% EA/hex to afford 180 (1.8667 g, 99%).  Rf (10% EA/hex): 0.54.  1H 
NMR (600 MHz):  7.32-7.13 (5H), 5.54 (s, 1H), 3.00 (s, 2H), 2.92-2.88 (2H), 2.81-2.76 
(2H), 2.05-2.00 (2H), 1.91-1.86 (2H), 1.66-1.53 (4H). 13C (150 MHz): 208.7, 141.2, 
131.6, 128.4, 128.3, 126.4, 126.1, 52.8, 43.1, 29.8, 28.6, 25.4, 22.7, 22.0.  IR: 2924, 
2857, 1710.  HRMS (FAB):  calc for C16H21O: 229.1592; found: 229.1589 (1.5 ppm). 
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3-Benzyl-3-trimethylsiloxy-1,2-dioxaspiro[4.5]decane (181): 
To a RBF containing a solution of cobalt (II) acetylacetonate (179 mg, 0.7 mmol) in 1,2-
dichloroethane (70 mL) were added sequentially 179 (1.4915 g, 7 mmol) and 
triethylsilane (2.3 mL, 14 mmol).  The solution was stirred under an atmosphere of O2 
(balloon).  After 2 hrs it was noticed that the reaction had not begun so t-BuOOH (1.3 
mL, 7 mmol, 5.5M in decane) was added and the reaction allowed to stir overnight.  The 
reaction was quenched with NH4Cl (20 mL) and extracted with CH2Cl2 (2 x 20mL).  The 
combined organic layers were subjected to standard drying and purification with 20% 
EA/hex to afford 3-benzyl-1,2-dioxaspiro[4.5]decan-3-ol as a light green solid (1.0111 g, 
58%).  The green color is presumably due to some residual cobalt and the sample 
contains an alkene impurity <5% which could not be separated by column 
chromatography. Rf (20% EA/hex):  0.32.  1H NMR (400 MHz):  7.36-7.25 (5H), 3.14 (d, 
J = 14, 1H), 3.09 (d, J = 14, 1H), 2.88 (bs, 1H), 2.44 (d, J = 12.6, 1H), 2.35 (d, J = 12.6, 
1H), 1.78-1.56 (5H), 1.45 -1.22 (5H).   13C (100 MHz):  135.1, 130.7, 128.6, 127.4, 
106.7, 85.7, 55.2, 43.2, 35.9, 35.0, 25.3, 24.3, 23.3. IR:  3471, 2987, 2926, 1394, 1111. 
HRMS (ESI):  calc for C15H20NaO3: 271.1310; found: 271.1297 (4.7 ppm). 
To a flame-dried RBF containing a solution of 3-benzyl-1,2-dioxaspiro[4.5]decan-3-ol 
(393.6 mg, 1.59 mmol) in CH2Cl2 (16 mL) was treated sequentially with imidazole (129 
mg, 1.9 mmol) and chlorotrimethylsilane (0.25 mL, 1.9 mmol) and was allowed to stir for 
1 hr.  The reaction was treated with H2O (20 mL) and extracted with CH2Cl2 (2 x 20 mL).  
The combined organic layers were subjected to standard drying and purification with 5% 
EA/hex to afford 181 as a white solid (423.8 mg, 84%).  Rf (5% EA/hex):  0.42. MP:  58-
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59 oC.  1H NMR (300 MHz): 7.34-7.20 (5H), 3.01 (s, 2H), 2.45 (d, J = 12.5, 1H), 2.25 (d, 
J = 12.5, 1H), 1.72-1.12 (10H), 0.18 (s, 9H).  13C (75 MHz):  136.5, 130.8, 128.2, 126.9, 
108.7, 85.6, 56.9, 44.7, 35.9, 35.0, 25.3, 24.4, 23.3, 1.8. HRMS (ESI):  calc for 
C18H28NaO3Si: 343.1705; found: 343.1712 (2.0 ppm). 
O O
OTMS
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3-Phenethyl-3-trimethylsiloxy-1,2-dioxaspiro[4.5]decane (182): 
To a RBF containing a solution of cobalt (II) acetylacetonate (205 mg, 0.8 mmol) in 1,2-
dichloroethane (80 mL) were added sequentially 180 (1.821 g, 8 mmol), triethylsilane 
(2.7 mL, 16 mmol) and t-BuOOH (5.5M in decane, 1.45 mL, 8 mmol).  The solution was 
placed under an atmosphere of O2 (balloon) and the reaction allowed to stir overnight.  
The reaction was quenched with NH4Cl (20 mL) and extracted with CH2Cl2 (2 x 50mL).  
The combined organic layers were subjected to standard drying and purification with 
15% EA/hex to afford 3-phenethyl-1,2-dioxaspiro[4.5]decan-3-ol (1.5071 g, 72%) that 
was carried through to the next reaction.   
To a flame-dried RBF containing a solution of 3-phenethyl-1,2-
dioxaspiro[4.5]decan-3-ol (767.5 mg, 2.92 mmol) in CH2Cl2 (30 mL) was treated 
sequentially with imidazole (0.6 g, 9 mmol) and chlorotrimethylsilane (1.1 mL, 9 mmol) 
and was allowed to stir for 30 min.  The reaction was treated with H2O (20 mL) and 
extracted with CH2Cl2 (2 x 20 mL).  The combined organic layers were subjected to 
standard drying and purification with column chromatography twice with 5% EA/hex to 
afford 182 (530.3 mg, 54%). Rf (5% EA/hex):  0.34. 1H NMR (300 MHz): 7.36-7.17 
(5H), 2.77 (m, 1H), 2.38 (s, 2H), 2.17-1.21 912h), 0.22 (s, 9H).  13C (75 MHz): 141.7, 
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128.6, 128.5, 126.2, 108.6, 85.5, 57.9, 40.3, 36.5, 35.0, 21.8, 31.7, 25.4, 24.4, 23.4, 1.8.  
HRMS (ESI):  calc for C19H30O3SiNa 357.1862, found 357.1877 (4 ppm). 
 
4-Methyl-1-phenylpent-3-en-2-ol (185): 
To a flask containing a 0oC solution of 3-phenyl-1-propanal (606.2 mg, 5 mmol) in THF 
(25 mL) was added 2-methyl-1-propenylmagnesium bromide (12 mL, 6 mmol, 0.5 M in 
THF).  The reaction was stirred for 7 hrs and then treated with sat. aq. NH4Cl (30 mL) 
and extracted with Et2O (2 x 30 mL).  The combined organic layers were subjected to 
standard drying and purification with column chromatography with 30% EA/hex to 
afford 185 (609 mg, 69%). Rf (30% EA/hex):  0.45. 1H NMR (600 MHz): 7.39-7.19 (5H), 
5.27-5.23 (1H), 4.60-4.55 (1H), 2.81 (m, 2H), 1.71 (s, 3H), 1.60 (s, 3H), 1.49 (d, J = 3.3, 
1H).   
 
4-Methyl-1-phenylpent-3-en-2-one (186): 
To a flame-dried RBF containing a solution of 185 (557.7 mg, 3.1 mmol) in DMF (15 
mL) was added PDC (1.4 g, 3.8 mmol) and was stirred overnight.  The reaction was 
treated with H2O (20 mL) and extracted with Et2O (2 x 20 mL).  The combined organic 
layers were washed with brine (20 mL) and subjected to standard drying and purification 
with column chromatography with 10% EA/hex to afford 186 (277.8, 50%). Rf (10% 
EA/hex):  0.44. 1H NMR (400 MHz): 7.40-7.20 (5H), 6.13 (s, 1H), 3.71 (s, 2H), 2.17 (s, 
3H), 1.88 (s, 3H).  The NMR spectra matched that previously reported.127 
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N-Methoxy-N-methylbenzeneacetamide (190): 
In a flame-dried RBF containing a solution of phenylacetic acid (2.7 g, 20 mmol) in 
CH2Cl2 (50 mL) was added 1,1’-carbonyldiimidazole (4.3 g, 26.5 mmol) portion wise 
and stirred for 1 hr.  N,O-Dimethylhydroxylamine hydrochloride (3.8 g, 40 mmol) was 
added and stirred overnight.  The reaction flask was treated with H2O (50 mL) and 
extracted with CH2Cl2 (2 x 20 mL).  The combined organic layers were subjected to 
standard drying and purification with 50% EA/hex to afford 190 as a colorless oil (3.4345 
g, 97%).  Rf (50% EA/hex):  0.36. 1H NMR (400 MHz):  7.36-7.21 (5H), 3.78 (s,2H), 
3.61 (s, 3H), 3.2 (s, 3H).  13C (75 MHz):  172.5, 135.1, 129.4, 128.6, 126.9, 61.4, 39.5, 
32.3. HRMS (CI):  calc for C10H14NO2: 180.1025; found: 180.1019 (3.1 ppm).  
 
 
N-Methoxy-N-methyl-3-phenylpropanamide (191): 
In a flame-dried RBF containing a solution of 3-phenylpropanoic acid (3.03 g, 20 mmol) 
in CH2Cl2 (54 mL) was added 1,1’-carbonyldiimidazole (3.8g, 24 mmol) in small 
portions.  The reaction was stirred for 1 hr and N,O-Dimethylhydroxylamine 
hydrochloride (3.8g, 40 mmol) was added and stirred overnight.  The reaction flask was 
treated with H2O (50 mL) and extracted with CH2Cl2 (2 x 20 mL).  The combined 
organic layers were subjected to standard drying and purification with 50% EA/hex to 
afford 191 (3.7778 g, 97%).  Rf (50% EA/hex):  0.50. 1H NMR (400 MHz): 7.37-7.18 
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(5H), 3.62 (s, 3H), 3.20 (s, 3H), 3.01-2.95 (2H), 2.82-2.71 (2H).  The NMR spectra 
matched those previously reported.128 
O
Bn  
4-Methyl-1-phenyl-4-penten-2-one (189): 
A solution of 190 (1.0056 g, 5.6 mmol) in THF (56 mL) in a flame-dried RBF was cooled 
to 0 oC and 2-methylallylmagnesium chloride (13.5 mL, 6.8 mmol, 0.5M in 2-
methylTHF) was added.  The reaction was stirred at 0 oC for 30 min and rt for 1 hr.  The 
reaction was quenched with H2O (20 mL) and aq. 2N HCl (2 mL) and extracted with 
ether (2 x 20mL).  The combined organic layers were subjected to standard drying and 
purification with 10% EA/hex to afford 189 as a yellow oil (797.1 mg, 82%).  Rf (10% 
EA/hex):  0.48.  1H NMR:  7.37-7.17 (5H), 4.97 (m, 1H), 4.82 (m, 1H), 3.74 (s, 2H), 3.16 
(s, 2H), 1.73 (s, 3H). 13C:  206.2, 139.2, 134.3, 129.7, 128.9, 127.2, 115.4, 51.4, 49.2, 
22.8. IR:  1709, 890, 657. HRMS (CI):  calc for C12H15O: 175.1123; found: 175.1115 
(4.5 ppm). 
 
5-Methyl-1-phenylhex-5-en-3-one (192): 
A solution of 191 (970.4g, 5 mmol) in THF (25 mL) in a flame-dried RBF was cooled to 
0 oC and 2-methylallylmagnesium chloride (12 mL, 6 mmol, 0.5 M in 2-methylTHF) was 
added and stirred at 0 oC for 30 min and rt for 1 hr.  The reaction was quenched with H2O 
(20 mL) and aq.  2N HCl (10 mL) and extracted with Et2O (2 x 20mL).  The combined 
organic layers were subjected to standard drying and purification with 10% EA/hex to 
afford 192 (844.2 mg, 89%).  Rf (10% EA/hex):  0.48.  1H NMR (400): 2.33-2.27 (2H), 
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7.29-7.19 (3H), 4.95 (m, 1H), 4.82-4.80 (1H), 3.11 (s, 2H), 2.92 (m, 2H), 2.81 (m, 2H), 
1.79 (s, 3H). 13C (100 MHz):  208.0, 141.2, 139.3, 128.5, 126.3, 115.2, 52.6, 43.5, 29.9, 
22.8.  HRMS (FAB):  calc for C13H17O: 189.1279; found: 189.1274 (2.85 ppm). 
O O
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3-Benzyl-5,5-dimethyl-1,2-dioxolan-3-ol (187): 
To a RBF containing a solution of cobalt (II) acetylacetonate (103 mg, 0.40 mmol) in 1,2-
dichloroethane (40 mL) was added sequentially 189 (697.1 mg, 4 mmol), triethylsilane 
(1.3 mL, 8 mmol), and t-BuOOH (0.73 mL, 4 mmol, 5.5 M in decane). The resulting 
solution was placed under an atmosphere of O2 (balloon).  After 24 hrs the reaction was 
diluted with sat. aq. NH4Cl (20 mL) and extracted with CH2Cl2 (2 x 20mL).  The 
combined organic layers were subjected to standard drying and purification with 30% 
EA/hex to afford 187 as a golden oil (715.3 mg, 86%). Rf (10% EA/hex):  0.43.  1H NMR 
(300 MHz):  7.43-7.22 (5H), 3.12 (m, 2H), 2.98 (s, 1H), 2.47 (m, 2H), 1.39 (s, 3H), 1.20 
(s, 3H).  13C (75 MHz):  135.0, 130.7, 128.6, 127.4, 107.3, 83.9, 56.9, 43.2, 27.2, 25.0. 
IR: 3443, 3031, 2975, 1604, 1367.  HRMS (ESI):  calc for C12H16NaO3: 231.0997; found: 
231.0989 (3.0 ppm). 
 
5,5-Dimethyl-3-phenethyl-3-trimethylsiloxy-1,2-dioxolane (193): 
To a RBF containing a solution of cobalt (II) acetylacetonate (101.3 mg, 0.40 mmol) in 
1,2-dichloroethane (40 mL) was added sequentially 192 (751.3 mg, 4 mmol), 
triethylsilane (1.3 mL, 8 mmol), and t-BuOOH (0.72 mL, 4 mmol, 5.5 M in decane). The 
resulting solution was placed under an atmosphere of O2 (balloon).  After 24 hrs the 
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reaction was diluted with sat. aq. NH4Cl (20 mL) and extracted with CH2Cl2 (2 x 20mL).  
The combined organic layers were subjected to standard drying and purification with 
30% EA/hex to afford 5,5-dimethyl-3-phenethyl-1,2-dioxolan-3-ol (435.4 mg, 49%).  
To a flame-dried RBF containing a solution of 5,5-dimethyl-3-phenethyl-1,2-
dioxolan-3-ol (388.7 mg, 1.75 mmol) in CH2Cl2 (18 mL) was added imidazole (174.4 
mg, 2.6 mmol) and chlorotrimethylsilane (0.33 mL, 2.6 mmol).  The reaction was 
allowed to stir for 1 hr.  The reaction was treated with H2O (20 mL) and extracted with 
CH2Cl2 (2 x 20 mL).  The combined organic layers were subjected to standard drying and 
purification with column chromatography twice with 10% EA/hex to afford 193 (261 mg, 
51%). Rf (10% EA/hex):  0.57. 1H NMR (400 MHz): 7.44-7.07 (5H), 2.82 (m, 1H), 2.71 
(m, 1H), 2.47 (d, J = 12.5, 1H), 2.42 (d, J = 1H), 2.10 (m, 1H), 1.87 (m, 1H), 1.40 (s, 3H), 
1.36 (s, 3H), 0.23 (s, 9H).  13C (100 MHz): 141.7, 128.7, 128.5, 126.2, 109.3, 83.7, 59.7, 
40.3, 31.8, 27.7, 25.0, 17.8.  HRMS (ESI); calc for C16H26O3SiNa: 317.1549; found: 
317.1547 (1 ppm). 
 
1-Cyclohexyl-3-methylbut-2-en-1-ol (195): 
To a flask containing a -78oC solution of cyclohexanecarboxaldehyde (553.6 mg, 4.9 
mmol) in THF (25 mL) was added 2-methyl-1-propenylmagnesium bromide (12 mL, 6 
mmol, 0.5M in THF).  After stirring for 3 hrs the reaction was treated with H2O (100 mL) 
and extracted with Et2O (2 x 20 mL).  The combined organic layers were washed with 
brine (20 mL) and subjected to standard drying and purification with column 
chromatography with 20% EA/hex to afford 195 (608.2 mg, 73%). Rf (20% EA/hex):  
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0.43. 1H NMR (500 MHz): 5.18 (d, J = 9.1, 1H), 4.06 (t, J = 8.2, 1H), 1.97-1.89 (1H), 
1.82-1.61 (10H), 1.40-0.85 (6H).   
 
1-Cyclohexyl-3-methylbut-2-en-1-one (196): 
To a flame-dried RBF containing a solution of 195 (390.1 mg, 2.3 mmol) in DMF (10 
mL) was added PDC (1.09g mg, 2.9 mmol).  After stirring overnight the reaction was 
treated with H2O (50 mL) and extracted with Et2O (2 x 20 mL).  The combined organic 
layers were washed with brine (20 mL) and subjected to standard drying and purification 
with column chromatography with 5% EA/hex to afford 196 (196.5 mg, 51%).  Rf (5% 
EA/hex):  0.53. 1H NMR (400 MHz): 6.04-6.01 (1H), 2.25-2.16 91H), 2.04 (s, 3H), 2.04 
(s, 3H), 1.76-1.51 (6H), 1.78-1.02 (6H).  13C (100 MHz): 203.9, 155.1, 122.9, 51.5, 28.5, 
27.6, 25.9, 25.7, 20.6. 
 
3-Cyclohexyl-5,5-dimethyl-1,2-dioxolan-3-ol (197): 
To a RBF containing a suspension of cobalt (II) acetylacetonate (110.3 mg, 0.43 mmol) 
in 1,2-dichloroethane (41 mL) was added sequentially 196 (688.3 mg, 4.1 mmol) and 
triethylsilane (1.4 mL, 8 mmol). The resulting solution was placed under an atmosphere 
of O2 (balloon).  After 24 hrs the reaction was diluted with sat. aq. NH4Cl (20 mL) and 
extracted with CH2Cl2 (2 x 20mL).  The combined organic layers were subjected to 
standard drying and purification with 20% EA/hex to afford 197 (75.2 mg, 9%). Rf (20% 
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EA/hex):  0.25.  1H NMR (400 MHz): 2.73 (s, 1H), 2.45 (d, J = 12.8, 1H), 2.34 (d, J = 
12.8, 1H), 1.93-1.59 (6H), 1.42 (s, 3H), 1.36 (s, 3H), 1.32-1.05 (5H).  13C (100 MHz): 
109.7, 100.2, 83.4, 55.8, 44.7, 28.3, 27.7, 27.5, 26.3, 26.2, 26.1, 25.4.   
 
1-Cyclohexyl-1-trimethylsiloxyspiro[2.5]octane (199): 
In a flame-dried RBF dicyclohexylketone (5g, 25.7 mmol) was dissolved in THF (100 
mL).  LiHMDS (39 mL, 39 mmol, 1M in THF) was added and the reaction was allowed 
to stir for 30 min before chlorotrimethylsilane (3.9 mL, 31 mmol) was added.  After 30 
min the reaction was treated with H2O (20 mL) and extracted with CH2Cl2 (2 x 50 mL).  
The combined organic layers were subjected to standard drying and purification with 
2.5% EA/hex to afford 1-cyclohexyl-1-trimethylsiloxy-methylenecyclohexane as a 
colorless oil (6.2954g, 92%). Rf (2.5% EA/hex):  0.38.  1H NMR (400 MHz):  2.46 (m, 
1H), 2.17-2.05 (4H), 1.82-1.04 (16H), 0.21 (s, 9H). 13C (75 MHz): 146.4, 116.5, 39.6, 
30.9, 29.5, 28.5, 28.4, 27.6, 27.2, 26.8, 26.4, 1.3.  HRMS (EI): calc for C16H30OSi: 
266.2066; found: 266.2058 (3.0 ppm). 
In a flame-dried RBF, 1-cyclohexyl-1-trimethylsiloxy-methylenecyclohexane (6 
g, 23 mmol) was dissolved in CH2Cl2 (225 mL) and the solution was cooled to 0 oC.  To 
the flask via an addition funnel was added drop wise ZnEt2 (45 mL, 45 mmol, 1M in 
hexanes) followed by addition of CH2I2 (5.4 mL, 67.5 mmol) in one portion and stirred at 
0 oC for 1 hr and rt for 1 hr.  After which the reaction was treated with H2O (100 mL) and 
extracted with CH2Cl2 (4 x 100 mL).  The combined organic layers were subjected to 
standard drying and purification with 2.5% - 10% EA/hex to afford 199 as a white solid 
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(4.8426 g, 77%).  Rf (5% EA/hex):  0.75.  MP: 29-30 oC.  1H NMR (400 MHz): 2.46 (m, 
1H), 2.28-2.03 (4H), 1.81-1.05 (16H), 0.22 (s, 9H).   13C (100 MHz): 69.0, 43.0, 32.2, 
31.3, 30.2, 29.7, 28.5, 27.2, 27.0, 26.8, 26.7, 25.9, 25.6, 23.9, 2.24. HRMS (ESI): calc for 
C17H32NaOSi 303.2120, found 303.2112 (0.1 ppm).  Also isolated from the reaction was 
1-cyclohexylspiro[2.5]octan-1-ol, 270, (481.4 mg, 10%). 
 
1-Cyclohexylspiro[2.5]octan-1-ol (200) 
To a flame-dried RBF containing a solution of 199 (4.0 g, 14 mmol) in THF (70 mL) was 
added TBAF (17.2 mL, 17.2 mmol, 1 M in THF) and stirred for 2 hrs.  The reaction was 
treated with H2O (20 mL) and extracted with Et2O (3 x 50 mL).  The combined organic 
layers were subjected to standard drying and purification to afford 200 as a colorless oil 
(2.9354 g, 99%). Rf (10% EA/hex):  0.47.  1H NMR (400 MHz): 1.88-1.01 (22H), 0.37 
(d, J = 5.3, 1H), 0.18 (d, J = 5.3, 1H).  13C (100 MHz): 66.3, 42.1, 31.8, 30.7, 30.2, 29.1, 
28.8, 27.0, 26.9, 26.7, 26.6, 26.0, 25.7, 24.1.  IR: 3369, 2922, 2848, 1444, 1243.  HRMS 
(FAB): calc for C14H23O2: 223.1698; found: 223.1692 (2.8 ppm). 
O O
OH
 
3-Cyclohexyl-1,2-dioxaspiro[4.5]decan-3-ol (201): 
A vial containing a solution of 200 (493.2 mg, 2.4 mmol) in benzene (10 mL) was placed 
under an atmosphere of O2 (balloon) and stirred for 3 days.  After which the solvent was 
removed in vacuo and was purified via column chromatography with 20% EA/hex to 
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afford 201 as a yellow oil that slowly crystallizes to a white solid (360 mg, 81% BRSM). 
Rf (40% EA/hex):  0.5.  MP:  61-32 oC.  1H NMR (300 MHz): 2.82 (s, 1H), 2.37 (d, J = 
12.8, 1H), 2.23 (d, J = 12.8, 1H), 1.93-1.03 (23H).  13C (75 MHz): 109.0, 85.1, 54.0, 44.6, 
36.3, 35.3, 28.2, 27.5, 26.3, 26.2, 26.1, 25.3, 24.4, 23.3.  IR: 3453, 2930, 2854, 1448, 
1168. HRMS (ESI): calc for C14H24NaO3: 263.1623; found: 263.1636 (4.9 ppm). 
OH
 
1-adamantan-2-yl-2-cyclohexylideneethanol (204): 
To a flame-dried RBF containing a -78oC solution of bromomethylene cyclohexane 
(1.0655 g, 6 mmol) in THF (65 mL) was added t-BuLi (3.9 mL, 6.2 mmol, 1.6 M in 
pentane).  After the solution had stirred for 1 hr 2-adamantanecarboxaldehyde (953 mg, 
5.7 mmol, impure) was added in THF (5 mL) and allowed to warm to rt and stirred for 3 
hrs.  The reaction was treated with sat. aq. NH4Cl (20 mL) and the resulting suspension 
was extracted with Et2O (3 x 20 mL).  The combined organic layers were subjected to 
standard drying and purification with 10% EA/hex to afford 204 (450.3 mg, 30%).  Rf 
(10% EA/hex): 0.29.  1H NMR (400 MHz): 5.05-5.01 (1H), 4.65 (t, J = 9.8, 1H), 2.33-
1.35 (25H).   
 
1-adamantan-2-yl-2-cyclohexylideneethyl acetate (205): 
To a flame-dried RBF containing a solution of 204 (450.3 mg, 1.73 mmol) in pyridine 
(10 mL) was added sequentially Ac2O (353 mg, 3.46 mmol) and DMAP (21 mg, 0.2 
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mmol).  After 3 hrs the reaction was treated with 2N HCl (20 mL) and the resulting 
suspension was extracted with Et2O (3 x 30 mL).  The combined organic layers were 
washed with brine (30 mL) and subjected to standard drying and purification with 5% 
EA/hex to afford 205 (483.1 mg, 92%).  Rf (10% EA/hex): 0.74.  1H NMR (400 MHz): 
5.90 (t, J = 10.3, 1H), 4.93 (d, J = 9.7, 1H), 2.41-1.42 (28H).  13C (100 MHz): 170.4, 
145.8, 120.0, 70.9, 47.9, 39.0, 28.6, 38.1, 37.2, 32.2, 31.9, 29.9, 29.0, 28.7, 28.03, 28.01, 
28.0, 27.6, 26.7, 21.3.  
O O
OMe
Ph
 
3-Benzyl-3-methoxy-5,5-dimethyl-1,2-dioxolane (207): 
In a vial containing a solution of 187 (190 mg, 0.91 mmol) in CH2Cl2 (5 mL) and 
methanol (5 ml) was added TsOH (16 mg, 0.08 mmol) and the solution stirred for 3 days.  
After which the reaction was treated with sat. aq.  NaHCO3 (5 mL) and H2O (5 mL) and 
extracted with CH2Cl2 (2 x 10 mL).  The combined organic layers were subjected to 
standard drying and purification with 10% EA/hex to afford 207 as a yellow oil (147.7 
mg, 73%).  Rf (10% EA/hex): 0.50. 1H NMR (300 MHz): 7.37-7.20 (5H), 3.45 (s, 3H), 
3.07 (2H), 2.42 (d, J = 12.8, 1H), 2.34 (d, J = 12.8, 1H), 1.34 (s, 3H), 1.06 (s, 3H). 13C 
(75 MHz):  136.1, 130.5, 128.5, 127.0, 110.4, 83.8, 55.4, 49.5, 38.1, 27.2, 24.8. HRMS 
(ESI): calc for C13H18NaO3: 245.1154; found: 245.1144 (4 ppm). 
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3-Methoxy-5,5-dimethyl-3-phenethyl-1,2-dioxolane (208): 
In a vial containing a solution of 193 (130.2 mg, 0.44 mmol) in CH2Cl2 (2 mL) and 
methanol (4 ml) was added TsOH (10 mg, 0.05 mmol) and the solution stirred overnight.  
The reaction was treated with sat. aq.  NaHCO3 (5 mL) and H2O (10 mL) and extracted 
with CH2Cl2 (2 x 10 mL).  The combined organic layers were subjected to standard 
drying and purification with 10% EA/hex to afford 208 (103.1 mg, 99%).  Rf (10% 
EA/hex): 0.44.  1H NMR (500 MHz): 7.34-7.30 (2H), 7.25-7.20 (3h), 3.37 (s, 3H), 2.77 
(m, 1H), 2.67 (m, 1H), 2.48 (d, J = 12.6, 1H), 2.39 (d, J = 12.6, 1H), 2.25 (m, 1H), 1.89 
(m, 1H), 1.42 (s, 3H), 1.40 (s, 3H). 13C (125 MHz): 141.2, 128.6, 128.4, 126.3, 110.2, 
83.7, 56.5, 49.2, 33.9, 31.2, 27.8, 24.7. HRMS (ESI): calc for C14H20O3Na: 259.1310; 
found: 259.1307 (1.5 ppm). 
 
3,3-Dimethyl-5-phenethoxy-5-phenethyl-1,2-dioxolane (209): 
In a vial containing a solution of 193 (101.1 mg, 0.34 mmol) in CH2Cl2 (5 mL) was 
sequentially 2-phenylethanol (0.2 mL, 1.7 mmol) and TsOH (6 mg, 0.03 mmol).  After 
the reaction had stirred for 5 hrs, it was treated with sat. aq. NaHCO3 (8 mL) and H2O (8 
mL) and extracted with CH2Cl2 (2 x 10 mL).  The combined organic layers were 
subjected to standard drying and purification with 10% EA/hex to afford 209 (60 mg, 
55%).  Rf (10% EA/hex): 0.57. 1H NMR (400 MHz): .7.38-7.11 (10H), 3.96 (m, 1H), 
3.70 (m, 1H), 2.98 (m, 1H), 2.65 (m, 1H), 2.49 (d, J = 12.5, 1H), 2.36 (d, J = 12.5, 1H), 
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2.22 (m, 1H), 1.90 (m, 1H), 1.42 (s, 3H), 1.41 (s, 3H). 13C (100 MHz): 141.4, 139.5, 
129.2, 128.6, 128.4, 126.3, 126.2, 110.1, 83.7, 62.5, 56.8, 36.8, 34.7, 31.2, 27.9, 24.8.  
HRMS (ESI): calc for C21H26O3Na: 349.1780; found: 349.1785 (0 ppm). 
 
3-Benzyl-3-methoxy-1,2-dioxaspiro[4.5]decane (210): 
To a vial containing a solution of 181 (105.1 mg, 0.33 mmol) in CH2Cl2 (1 mL) was 
added sequentially methanol (3.1 mL) and TsOH (12.6 mg, 0.07 mmol) and the reaction 
was stirred overnight. The reaction was treated with sat. aq. NaHCO3 (8 mL) and H2O (8 
mL) and extracted with CH2Cl2 (2 x 8 mL).  The combined organic layers were subjected 
to standard drying and purification with 10% EA/hex to afford 210 as a yellow oil (89.5 
mg, 93%). Rf (10% EA/hex): 0.38.  1H NMR (500 MHz): 7.40-7.23 (5H), 3.64 (s, 3H), 
3.1 (d, J = 12.5, 1H), 3.04 (d, J = 12.5, 1H), 2.39 (d, J = 12.6, 1H), 2.25 (d, J = 12.6, 1H), 
1.74-1.12 (10H).  13C (125 MHz): 136.1, 130.4, 128.4, 126.9, 109.7, 85.6, 53.4, 49.4, 
38.0, 35.8, 34.6, 25.2, 24.4, 23.2. HRMS (ESI): calc for C16H22NaO3: 285.1467; found: 
285.1463 (2 ppm). 
 
3-Methoxy-3-phenethyl-1,2-dioxaspiro[4.5]decane (211): 
To a vial containing a solution of 182 (205.9 mg, 0.61 mmol) in CH2Cl2 (2 mL) was 
added sequentially methanol (6 mL) and TsOH (10.1 mg, 0.05 mmol) and was stirred for 
5 hrs.  The reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and 
extracted with CH2Cl2 (2 x 30 mL).  The combined organic layers were subjected to 
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standard drying and purification with 10% EA/hex to afford 211 (111.4 mg, 66%). Rf 
(10% EA/hex): 0.37.  1H NMR (300 MHz): 7.35-7.12 (5H), 3.36 (s, 3H), 2.71 (m, 2H), 
2.39 (d, J = 12.7, 1H), 2.33 (d, J = 12.7, 1H), 2.22 (m, 1H), 1.91-1.25 (11H).  13C (75 
MHz): 141.3, 128.7, 128.4, 126.3, 109.6, 85.6, 55.0, 49.2, 36.5, 34.7, 33.9, 31.3, 25.4, 
24.4, 23.3. HRMS (ESI):  calc for C17H24O3Na: 299.1623; found: 299.1629 (2 ppm). 
 
3-Phenethoxy-3-phenethyl-1,2-dioxaspiro[4.5]decane (212): 
To a vial containing a solution of 182 (209.5 mg, 0.6 mmol) in CH2Cl2 (6 mL) was added 
sequentially 2-phenylethanol (0.36 mL, 3 mmol) and TsOH (10.4 mg, 0.06 mmol).  After 
stirring for 6 hrs, the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (8 mL) 
was added and extracted with CH2Cl2 (2 x 30 mL).  The combined organic layers were 
subjected to standard drying and purification with 5% EA/hex to afford 212 (151.4 mg, 
66%).  Less than 5% of uncharacterized impurities were present by 1H NMR and the 
sample was submitted for in vitro testing.  A pure sample can be obtained by subjecting 
212 to ozonolysis and re-purification prior to the etherification, Rf (10% EA/hex): 0.48.  
1H NMR (500 MHz): 7.34-7.10 (10H), 3.92 (m, 1H), 3.64 (m, 1H), 2.92 (m, 1H), 2.61 
(m, 1H), 2.37 (d, J = 12.5, 1H), 2.27 (d, J = 12.5, 1H), 2.21-2.14 (1H), 1.87-1.32 (11H).  
13C (100 MHz): 141.4, 139.5, 129.2, 128.6, 128.4, 126.3, 126.2, 109.5, 85.5, 62.5, 55.2, 
36.7, 34.7, 34.6, 31.3, 25.4, 24.4, 23.4. HRMS (ESI): calc for C24H30O3Na: 389.2093; 
found: 289.2074 (<5 ppm). 
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3-Cyclohexyl-3-methoxy-1,2-dioxaspiro[4.5]decane (213): 
To a vial containing a solution of 201 (360 mg, 1.5 mmol) in CH2Cl2 (5 mL) and 
methanol (10 mL) was added TsOH (29.5 mg, 0.16 mmol) and was stirred overnight.  
The reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (10 mL) and extracted 
with CH2Cl2 (2 x 10 mL).  The combined organic layers were subjected to standard 
drying and purification with 10% EA/hex to afford 213 as a white solid (344.8 mg, 90%).  
Rf (10% EA/hex): 0.57.  MP: 44 oC.  1H NMR (400 MHz): 3.28 (s, 3H), 2.39 (d, J = 12.7, 
1H), 2.16 (d, J = 12.7, 1H), 1.90-0.85 (21H).  13C (100MHz): 111.8, 85.0, 51.5, 48.7, 
38.8, 36.3, 34.9, 28.6, 28.2, 26.5, 26.4, 26.1, 25.4, 24.5, 23.4.  HRMS (ESI): calc for 
C15H26NaO3: 277.1779; found: 277.1774 (1 ppm). 
OTBS
O
 
5-(tert-Butyldimethylsilanyloxy)pentanal (222): 
To a flame-dried RBF containing a solution of 5-hexen-1-ol (1.9878 g, 20 mmol) in THF 
(40 mL) was added sequentially imidazole (3.22 g, 47 mmol) and TBSCl (3.72 g, 25 
mmol) in THF (10 mL) and stirred overnight.  The reaction was treated with H2O (50 
mL) and extracted with Et2O (3 x 50 mL).  The combined organic layers were subjected 
to standard drying and purification with 2.5% EA/hex to afford 6-tert-
butyldimethylsiloxy)hex-1-ene (3.8385 g, 90%).  Rf (2.5% EA/hex):  0.42.  1H NMR 
(400 MHz): 5.02 (ddt, J = 17.0, 10.1, 6.9, 1H). 5.07-4.90 (2H), 3.62 (t, J = 6.4, 2H), 2.07 
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(m, 2H), 1.68-1.37 (4H), 0.90 (s, 9H), 0.06 (s, 6H).  The NMR spectra matched those 
previously reported.129 
To a flame-dried RBF containing a 0oC solution of 6-tert-
butyldimethylsiloxy)hex-1-ene (3.7776 g, 17.6 mmol) in acetone (120 mL) and Sudan 
Red (trace) was passed O3 until disappearance of the red color.  The flask was purged 
with O2 for 2 min.  The contents of the flask were concentrated in vacuo and the residue 
obtained upon concerntation was purified via column chromatography with 10% EA/hex 
to afford 222 (2.859 g, 75%).  Rf (10% EA/hex):  0.41.  1H NMR (400 MHz): 9.78 (t, J = 
1.8, 1H), 3.64 (t, J = 6.2, 2H), 2.47 (dt, J = 1.8, 6.8, 2H), 1.75-1.65 (2H), 1.62-1.51 (2H), 
0.90 (s, 9H), 0.05 (s, 6H).  The NMR spectra matched those previously reported.130 
OTBS
HO
 
6-((tert-Butyldimethylsilyl)oxy)-1-(cyclohex-1-en-1-yl)hexan-2-ol (223): 
To a flame-dried RBF containing a 0oC solution of methylene cyclohexane (2.5 mL, 20 
mmol) and 222 (3.68 g, 17 mmol) was added Me2AlCl (22 mL, 22 mmol, 1 M in 
hexanes) and stirred for 3 hrs.  The reaction was treated with sat. aq. NaH2PO4 (20 mL) 
and 2 N HCl was added until the solution became clear and was extracted with Et2O (3 x 
50 mL).  The combined organic layers were subjected to standard drying and purification 
with 20 % EA/hex to afford 223 (4.2695 g, 81%).  Rf (20% EA/hex):  0.38.  (400 MHz): 
5.55-5.50 (1H), 3.71-3.59 (3H), 2.17-1.30 (17H), 0.090 (s, 9H), 0.05 (s, 6H).  13C (100 
MHz): 135.0, 125.2, 68.7, 63.4, 46.7, 37.0, 33.0, 28.5, 26.2, 25.5, 23.1, 22.5, 22.2, 18.6, -
5.1.  IR: 3399, 2927, 2856. HRMS (FAB): calc for C18H36O2SiLi: 319.2645; found: 
319.2654 (2.9 ppm). 
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6-((tert-Butyldimethylsilyl)oxy)-1-(cyclohex-1-en-1-yl)hexan-2-one (224): 
To a flame-dried RBF containing a -78 °C solution of oxalyl chloride (1.024 g, 8 mmol) 
in CH2Cl2 (30 mL) was added DMSO (0.9 mL, 12.8 mmol) in CH2Cl2 (13 mL) dropwise 
via an addition funnel and allowed to stir for 20 min.  After which 223 (1.35g, 9.6 mmol) 
in CH2Cl2 (13 mL) was added dropwise via an addition funnel and allowed to stir at -78 
oC for 1 hr and Et3N (4.4 mL, 32 mmol) was added and stirred at -78oC for 30 min and rt 
for 1 hr.  The reaction was treated with H2O (30 mL) and extracted with CH2Cl2 (2 x 20 
mL).  The combined organic layers were subjected to standard drying and purification 
with 5% EA/hex to afford 224 a yellow oil (1.8971 g, 93%).  Rf (10% EA/hex):  0.317.  
1H NMR (400 MHz):  5.54 (bs, 1H), 3.61 (t, J = 6.1, 2H), 3.00 (s, 2H), 2.46 (t, J = 7.3, 
2H), 2.07-2.00 (2H), 1.94-1.88 (2H), 1.67-1.46 (8H), 0.89 (s, 9H), 0.05 (s, 6H).  13C (100 
MHz):  209.8131.8, 126.1, 62.9, 52.5, 41.5, 32.2, 28.6, 26.0, 25.4, 22.8, 22.0, 20.3, 18.3, -
5.3.  IR:  2927, 2856, 1713. HRMS (FAB): calc for C18H34O2SiLi: 317.2488; found: 
317.2500 (3.9 ppm). 
 
2-(Cyclohex-1-en-1-ylmethyl)-2-hydroperoxytetrahydro-2H-pyran (219): 
To a flame-dried RBF containing a solution of 224 (3.672 g, 11.8 mmol) in THF (118 
mL) was cooled to 0oC and TBAF (13 mL, 13 mmol, 1 M in THF) was added.  After 4 
hrs the reaction was treated with sat. aq. NH4Cl (50 mL) and extracted with Et2O (2 x 50 
mL).  The combined organic layers were subjected to standard drying and purified twice 
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by column chromatography with 50% EA/hex to afford 2-(cyclohex-1-en-1-
ylmethyl)tetrahydro-2H-pyran-2-ol (2.0815 mg, 90%). 
To a flame-dried RBF containing a solution of 2-(cyclohex-1-en-1-
ylmethyl)tetrahydro-2H-pyran-2-ol (567 mg, 2.9 mmol) in THF (50 mL) was added 
sequentially urea hydrogen peroxide (1.9 g, 20 mmol) and camphor sulfonic acid (2 g, 9 
mmol) and stirred for 24 hrs.  The reaction was diluted with H2O (30 mL) and extracted 
with Et2O (3 x 30 mL).  The combined organic layers were washed with brine (30 mL).  
The combined organic layers were dried with Na2SO4 and the residue obtained upon 
concentration in vacuo was purified by column chromatography with 30 % EA/hex to 
afford 219 (472.3 mg, 78%).  Rf (50 % EA/hex): 0.74.  1H NMR (300 MHz): 7.56 (s, 
1H), 5.51 (bs, 1H), 3.90-3.69 (2H), 2.60 (d, J = 14.0, 1H), 1.72 (d, J = 14.0, 1H), 1.77-
1.47 (10H).  13C (75 MHz): 133.4, 126.1, 104.5, 61.9, 44.8, 29.8, 29.2, 25.6, 24.8, 23.1, 
22.3, 18.7.  IR: 3296, 2925, 2854, 2831.  HRMS (ESI): calc for C12H20O3Na: 235.1310; 
found: 235.1319 (3.8 ppm). 
 
 
8-bromomercurial-1,2,4-trioxaspiro[5.4.5]pentadecane (218): 
To a flame-dried RBF containing a solution of 219 (326 mg, 1.6 mmol) in CH2Cl2 (60 
mL) was added Hg(OAc)2 (542, 1.7) and stirred for 3 days.  The reaction was treated 
with H2O (50 mL) and KBr (200 mg, 1.7 mmol) and strirred for 2 hrs.  The suspension 
was extracted with CH2Cl2 (2 x 10 mL).  The combined organic layers were subjected to 
standard drying and purification with 20% EA/hex to afford 218 (464.3 mg, 60%).  Rf 
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(20% EA/hex): 0.45.  1H NMR (400 MHz): 4.04-3.91 (1H), 3.75-3.65 (1H), 2.73-2.63 
(1H), 2.48 (d, J = 13.2, 1H), 2.39-1.15 (15H).  13C (100 MHz): 106.8, 88.7, 66.1, 62.5, 
57.7, 37.2, 31.2, 30.8, 28.0, 25.0, 24.5, 20.4.  HRMS (ESI); calc for C12H19O3NaHgBr: 
513.0091; found: 513.0089 (0.1 ppm).  
 
Epoxide byproduct (225): 
Isolated via HPLC with 10 % EA/hex from the HSnBu3 reduction of 218.  1H NMR (400 
MHz): 4.14-4.04 (2H): 3.09-3.06 (1H), 2.71 (d, J = 15.4, 1H), 2.36 (d, J = 15.4, 1H), 
1.99-1.17 (12H), 0.92 (t, J = 7.4, 3H). 13C (100 MHz): 170.7, 64.7, 58.7, 57.2, 43.8, 30.8, 
28.4, 24.7, 20.2, 19.3, 19.2, 13.8. 
 
8-iodo-1,2,4-trioxaspiro[5.4.5]pentadecane (231): 
To a flame-dried RBF containing a solution of 219 (221.0 mg, 1 mmol) in CH2Cl2 (30 
mL) was added sequentially I2 (280, 1.1 mmol) and potassium tert-butoxide (128 mg, 1 
mmol).  After 10 min the reaction was treated with sat. aq. Na2S2O3 (20 mL).  The 
resulting suspension was extracted with CH2Cl2 (2 x 20 mL).  The combined organic 
layers were washed with H2O (20 mL) and subjected to standard drying and purification 
with 20% EA/hex to afford 231 (239.5 mg, 68%).  Rf (30% EA/hex): 0.80.  1H NMR 
(500 MHz): 4.636-4.56 (1H), 4.00-3.89 (1H), 3.76-3.65 (1H), 2.82-2.63 (1H), 2.42-2.09 
(3H), 1.96-1.93 (12H).  13C (150 MHz): 106.8, 106.3, 86.2, 62.6, 62.5, 41.0, 34.4, 32.01, 
32.00, 31.8, 30.9, 24.7, 24.6, 23.0, 22.1, 20.4, 20.3.  HRMS (ESI); calc for C12H19O3INa: 
361.0277; found: 361.0263 (3.8 ppm). 
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One-Pot Procedure: 
1,2,4-trioxaspiro[5.4.5]pentadecane (143): 
To a flame-dried RBF containing a solution of 219 (206.6 mg, 1 mmol) in CH2Cl2 (30 
mL) was added sequentially I2 (289.2 mg, 1.1) and potassium tert-butoxide (138.8 mg, 
1.1 mmol).  After 30 min. the reaction was treated with sat. aq. Na2S2O3 (30 mL).  The 
resulting suspension was extracted with CH2Cl2 (2 x 30 mL).  The combined organic 
layers were washed with H2O (20 mL), dried with MgSO4, and filtered through a silica 
plug.   The residue obtained upon concentration in vacuo was dissolved in HSnBu3 (1.8 
mL, 10 mmol) and stirred overnight.  The contents of the reaction were purified directly 
via column chromatography twice with 1 x 10% EA/hex and 1 x 20% EA/hex.  The 
isolated product was dissolved in THF (5 mL) in a vial and LiAlH4 (21.8mg) was added 
and stirred overnight.  H2O (10 mL) was added and the resulting suspension was 
extracted with Et2O (2 x 10 mL) and subjected to standard drying and purification with 
20% EA/hex to afford 143 (85.2 mg, 41%).  1H NMR (400 MHz): 4.01-3.90 (1H), 3.72-
3.62 (1H), 2.30 (d, 12.6, 1H), 2.17 (d, 12.6, 1H), 1.91-1.26 (16H).  13C (100 MHz): 106.3, 
84.9, 62.6, 57.4, 36.2, 34.7, 32.1, 25.3, 24.8, 24.2, 23.2, 20.5.  HRMS (FAB):  calc for 
C12H21O3: 213.1491; found: 213.1490 (0.2 ppm). 
O O
O
 
3-(But-3-en-1-yloxy)-3,5,5-trimethyl-1,2-dioxolane (228): 
To a flame-dried vial containing a solution of 107-OTMS (3.3724g, 16.5 mmol) in 
CH2Cl2 (160 mL) was added sequentially 3-buten-1-ol (4.2 mL, 48 mmol) and TsOH 
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(313 mg, 1.65 mmol).  After 3 hrs the reaction was treated with sat. aq. NaHCO3 (40 mL) 
and the resulting suspension was extracted with CH2Cl2 (2 x 20 mL).  The combined 
organic layers were subjected to standard drying and purification with 10% EA/hex to 
afford 228 (2.2212 g, 74%). Rf (10% EA/hex): 0.48. 1H NMR (300 MHz): 5.86 (ddt, J = 
17.1, 10.3, 6.8, 1H), 5.07 (m, 2H), 3.68 (m, 1H), 3.49 (m, 1H), 2.55 (d, J = 12.5, 1H), 
2.40-2.28 (3H) 1.47 (s, 3H), 1.37 (s, 6H). 13C (75 MHz): 135.7, 116.3, 108.5, 83.9, 61.3, 
58.9, 34.7, 27.8, 24.8, 20.1. HRMS (ESI):  calc for C10H18O3Na: 209.1154; found: 
209.1163 (4 ppm). 
O O
O OMe
O
 
Methyl 3-((3,5,5-trimethyl-1,2-dioxolan-3-yl)oxy)propanoate (229): 
A flame-dried RBF containing a solution of 228 (503.7 mg, 2.7 mg) in MeOH (0.6 mL) 
and CH2Cl2 (20mL) was cooled to -78oC.  A nominally 1% solution of O3/O2 was 
bubbled into the reaction flask solution until the solution was blue in color.  The reaction 
mixture was purged with O2 for 2 min and allowed to warm to rt.  To the flask was added 
sequentially acetonitrile (11 mL) and Ca(OCl)2 (0.76g, 5.4 mmol).  After 20 min the 
reaction was filtered through a pad of silica, concentrated in vacuo, and purified by flash 
chromatography twice with 30% EA/hex to afford 229 as a yellow oil (359.6 mg, 61%). 
Rf (30% EA/hex): 0.5. 1H NMR (300 MHz): 3.84 (m, 2H), 3.70 (s, 3H), 2.61 (m, 2H), 
2.55 (d, J = 12.7, 1H), 2.32 (d, J = 12.7, 1H), 1.48 (s, 3H), 1.36 (s, 6H). 13C (75 MHz): 
108.6, 83.9, 58.7, 57.7, 51.8, 35.5, 27.8, 24.7, 19.9. IR: 2976, 1736. HRMS (ESI):  calc 
for C10H18O5Na: 241.1052; found: 241.1045 (3 ppm). 
 
 
 
154 
3-(Hex-5-en-1-yloxy)-3,5,5-trimethyl-1,2-dioxolane (231) 
To a flame-dried vial containing a solution of 107-OTMS (2.67 g, 13.1 mmol) in CH2Cl2 
(130 mL) was added sequentially 5-hexen-1-ol (4.7 mL, 39.3 mmol) and TsOH (247 mg, 
1.3 mmol).  After 3 hrs the reaction was treated with sat. aq. NaHCO3 (40 mL) and the 
resulting suspension was extracted with CH2Cl2 (3 x 50 mL).  The combined organic 
layers were subjected to standard drying and purification with 10% EA/hex to afford 231 
(2.1497 g, 77%). Rf (10% EA/hex): 0.50. 1H NMR (300 MHz): 5.82 (ddt, J = 16.9, 10.2, 
6.8), 5.0 (m, 2H), 3.61 (m, 1H), 3.45 (m, 1H), 2.54 (d, J = 12.5, 1H), 2.41 (d, J = 12.5, 
1H), 2.15-2.02 (2H), 1.70-1.44 (7H), 1.37 (s, 6H).  13C (75 MHz): 139.1, 114.6, 108.4, 
83.8, 61.7, 58.9, 33.7, 29.6, 27.8, 25.7, 24.8, 20.1.  HRMS (ESI):  calc for C12H22O3Na: 
237.1467; found: 237.1474 (3 ppm). 
O O
O
 
3,3,5-Trimethyl-5-(undec-10-en-1-yloxy)-1,2-dioxolane (232): 
To a flame-dried vial containing a solution of 107-OTMS (2.5713 g, 12.6 mmol) in 
CH2Cl2 (126 mL) was added sequentially 10-undecen-1-ol (7.6 mL, 37.8 mmol) and 
TsOH (247 mg, 1.3 mmol).  After 4 hrs the reaction was treated with sat. aq. NaHCO3 
(40 mL) and the resulting suspension was extracted with CH2Cl2 (3 x 40 mL).  The 
combined organic layers were subjected to standard drying and purification with 5% 
EA/hex to afford 232 (2.7486 g, 77%). Rf (5% EA/hex): 0.34. 1H NMR (400 MHz): 5.78 
(ddt, J = 17.0, 10.0, 6.9, 1H), 4.97 (m, 2H), 3.59 (m, 1H), 3.43 (m, 1H), 2.53 (d, J = 12.5, 
1H), 2.32 (d, J = 12.5, 1H), 2.05 (m, 2H), 1.58 (2H), 1.47 (s, 3H), 1.42-1.24 (12H), 1.37 
(d, J = 2.5, 6H). 13C (100 MHz): 139.5, 114.2, 108.4, 83.8, 62.0, 58.8, 34.0, 30.2, 29.7, 
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29.6, 29.5, 29.3, 29.1, 27.8, 26.3, 24.8, 20.2.  HRMS (ESI):  calc for C17H32O3Na: 
307.2249; found: 307.2250 (0.3 ppm). 
 
methyl 5-((3,5,5-trimethyl-1,2-dioxolan-3-yl)oxy)pentanoate (233): 
A solution of 231 (501.8 mg, 2.3 mmol) in MeOH (0.5 mL, 12 mmol) and CH2Cl2 
(15mL) was cooled to -78oC in a flame-dried RBF.  A 1% solution of O3/O2 was bubbled 
into the reaction flask until the solution was blue in color.  At this time the reaction 
mixture was purged with O2 for 2 min and allowed to warm to rt.  The contents of the 
flask were concentrated in vacuo and purified by flash chromatography with 40% 
EA/hex.  A solution of the isolated hydroperoxyacetal (473.6 mg, 1.8 mmol) in MeCN 
(7.2 mL) in a RBF was added Ca(OCl)2 (511 mg, 3.6 mmol).  After 20 min the reaction 
was filtered through a pad of silica, concentrated in vacuo, and the residue purified via 
flash chromatography with 20% EA/hex to afford 233 (349.8 mg, 61%). Rf (20% 
EA/hex): 0.45. 1H NMR (400 MHz): 3.63 (s, 3H), 3.58 (m, 1H), 3.42 (m, 1H), 2.49 (d, J 
= 12.6, 1H), 2.33 (at, J = 7.4, 2H), 2.29 (d, J = 12.6, 1H), 1.70 (m, 2H), 1.58 (m, 2H), 
1.43 (s, 3H), 1.33 (s, 6H). 13C (100 MHz):174.3, 108.3, 83.8, 61.1, 58.7, 51.5, 33.8, 29.4, 
27.7, 24.7, 21.8, 20.0.  HRMS (ESI):  calc for C12H22O5Na: 269.1365; found: 269.1353 
(4.5 ppm). 
 
Methyl 10-((3,5,5-trimethyl-1,2-dioxolan-3-yl)oxy)decanoate (234): 
A flame-dried RBF containing a solution of 232 (599.2 mg, 2.1 mmol) in MeOH (0.43 
mL, 10.6 mmol) and CH2Cl2 (14 mL) was cooled to -78oC.  A 1% solution of O3/O2 was 
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bubbled into the reaction flask until the solution was blue in color.  At this time the 
reaction mixture was purged with O2 for 2 min and allowed to warm to rt.  The contents 
of the flask were concentrated in vacuo and the residue was purified by flash 
chromatography with 30% EA/hex.  To a RBF containing a solution of the isolated 
hydroperoxyacetal (398.9 mg, 1.2 mmol) in MeCN (10 mL) was added Ca(OCl)2 (340 
mg, 2.4 mmol).  After 20 min the reaction was filtered through a pad of silica, 
concentrated in vacuo, and the residue purified by flash chromatography with 20% 
EA/hex and with 10% EA/hex to afford 233 (273.5 mg, 41%). Rf (10% EA/hex): 0.25. 1H 
NMR (600 MHz): 3.67 (s, 3H), 3.59 (m, 1H), 3.44 (m, 1H), 2.53 (d, J = 12.4, 1H), 2.35-
2.27 (3H), 1.66-1.51 (4H), 1.47 (s, 3H), 1.38 (s, 3H), 1.37 (s, 3H), 1.39-1.25 (10). 13C 
(150 MHz): 174.5, 108.4, 83.8, 61.9, 58.9, 51.6, 34.3, 30.2, 29.6, 29.5, 29.4, 29.3, 27.8, 
26.3, 25.1, 24.8, 20.2.  HRMS (ESI):  calc for C17H32O5Na: 339.2147; found: 339.2140 (2 
ppm). 
 
3,5,5-trimethyl-3-(4-acetyl-phenylmethoxy)-1,2-dioxolane (236): 
To a flame-dried vial containing a suspension of Re2O7 (8.1 mg, 0.02 mmol) in CH2Cl2 
(10 mL) was added sequentially 107-OTMS (206.6 mg, 1.0 mmol) and methyl 4-
(hydroxymethyl)benzoate (837 mg, 5.0 mmol).  After 5 hrs the reaction was concentrated 
in vacuo and the residue purified sequentially by flash chromatography and HPLC with 
20% EA/hex to afford 236 (174.8 g, 61%). Rf (20% EA/hex): 0.40. 1H NMR (400 
MHz):8.01 (d, J = 8.3, 2H), 7.46 (d, J = 8.3, 2H), 4.79 (d, J = 12.5, 1H), 4.56 (d, J = 12.5, 
1H), 3.91 (s, 3H), 2.66 (d, 12.6, 1H), 2.41 (d, J = 12.6, 1H), 1.57 (s, 3H), 1.41 (s, 6H). 13C 
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(100 MHz): 167.2, 144.4, 129.8, 129.2, 127.4, 108.9, 84.1, 63.7, 58.9, 52.2, 27.9, 24.8, 
20.2.  HRMS (ESI):  calc for C15H20O5Na: 303.1203; found: 303.1219 (3.6 ppm). 
 
3-(Allyloxy)-3,5,5-trimethyl-1,2-dioxolane (237): 
To a RBF containing a solution of 107 (189.0 mg, 1.43 mmol) in CH2Cl2 (15 mL) was 
added sequentially allyl alcohol (0.52 mL, 7.6 mmol) and TsOH (28.5 mg, 0.15 mmol).  
After 24 hrs the reaction was treated with sat. NaHCO3 (5 mL) and the resulting 
suspension was extracted with CH2Cl2 (2 x 10 mL).  The combined organic layers were 
subjected to standard drying and purification with 10% EA/hex to afford 237 (127.5 mg, 
49%).  Rf (5% EA/hex): 0.34. 1H NMR (500 MHz): 5.95 (m, 1H), 5.30 (apparent doublet 
of quartets, J = 17.2, 1.7, 1H), 5.15 (apparent doublet of quartets, J = 10.4, 1.7, 1H), 4.18 
(m, 1H), 4.01 (m, 1H), 2.60 (d, J = 12.6, 1H), 2.37 (d, J = 12.6, 1H), 1.50 (s, 3H), 1.39 (s, 
3H), 1.38 (s, 3H). 13C (MHz): 135.5, 116.3, 108.7, 83.4, 63.3, 58.9, 27.7, 24.7, 20.3.  
HRMS (ESI):  calc for C9H16O3Na: 195.0997; found: 195.1003 (2 ppm). 
 
3-(Allyloxy)-3-methyl-1,2-dioxaspiro[4.5]decane (238): 
To a flame-dried RBF containing a solution of 146 (661 mg, 3.8 mmol) in CH2Cl2 (385 
mL) was added sequentially allyl alcohol (1.3 mL, 19 mmol) and TsOH (72 mg, 0.38 
mmol).  After 17 hrs the reaction was treated with sat. aq. NaHCO3 (20 mL) and the 
resulting suspension was extracted with CH2Cl2 (2 x 20 mL).  The combined organic 
layers were subjected to standard drying and purification with 10% EA/hex to afford 238 
(374 mg, 46%). Rf (10% EA/hex): 0.44. 1H NMR (300 MHz): 5.98 (m, 1H), 5.3 (m, 1H), 
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5.15 (m, 1H), 4.19 (m, 1H), 4.01 (m, 1H), 2.51 (d, J = 12.6, 1H), 2.32 (d, J = 12.6, 1H), 
1.87-1.28 (13H). 13C (75 MHz): 135.5, 116.2, 108.1, 85.7, 63.2, 57.3, 36.5, 34.6, 25.4, 
24.4, 23.4, 20.3.  HRMS (ESI):  calc for C12H20O3Na: 235.1310; found: 235.1304 (3 
ppm). 
 
3-((3,5,5-Trimethyl-1,2-dioxolan-3-yl)oxy)propane-1,2-diol (239): 
To a flame-dried RBF containing a solution of 237 (200.1 mg, 1.2 mmol) and NMO (168 
mg, 1.44 mmol) in acetone (60 mL) was added OsO4 (0.16M in H2O, 0.15 mL, 0.024 
mmol).  After 24 hrs the reaction was treated with sat. NaHSO3 (20 mL) and stirred for 
30 min.  The solution was diluted with sat. aq. NH4Cl (50 mL) and the resulting 
suspension was extracted with CH2Cl2 (10 x 100 mL).  The combined organic layers 
were subjected to standard drying and purification with 100% EA to afford 239 (176.6 
mg, 74%). Rf (100% EA): 0.32. 1H NMR (400 MHz): 3.89-3.54 (5H), 3.10 (s, 0.5H), 2.85 
(ad, J = 6.3, 0.5H), 2.56 (dd, J = 12.6, 5.8, 1H), 2.44 (bs, 0.5H), 2.36 (d, J = 12.6, 1H), 
2.28 (bs, 3H), 1.48 (s, 3H), 1.39 (s, 3H), 1.38 (s, 3H). 13C (100 MHz):108.9, 108.8, 84.4, 
84.3, 70.8, 70.7, 64.3, 64.1, 63.8, 63.0, 58.7, 58.7, 28.0, 27.9, 24.9, 24.8, 19.3, 19.1. 
HRMS (ESI):  calc for C9H18O5Na: 229.1052; found: 229.1042 (4 ppm). 
O O
O
OH
OH
 
3-((3-methyl-1,2-dioxaspiro[4.5]decan-3-yl)oxy)propane-1,2-diol (240):  
To a flame-dried RBF containing a solution of 238 (197.4 mg, 0.9 mmol) and NMO (132 
mg, 1.1 mmol) in acetone (47 mL) was added OsO4 (0.16 M in H2O, 0.12 mL, 0.028 
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mmol).  After 24 hrs the reaction was treated with sat. NaHSO3 (20 mL) and stirred for 
30 min.  The solution was diluted with sat. aq. NH4Cl (50 mL) and the resulting 
suspension was extracted with CH2Cl2 (10 x 100 mL).  The combined organic layers 
were subjected to standard drying and purification with 100% EA to afford 240 (164.1 
mg, 72%). Rf (100% EA): 0.31. 1H NMR (400 MHz): 3.88-3.48 (5H), 3.20 (s, 0.5H), 2.93 
(s, 0.5H), 2.57-2.24 (3H), 1.86-1.32 (13H). 13C (150 MHz):  108.29, 108.27, 86.3, 26.2, 
70.8, 70.7, 64.3, 64.1, 63.8, 63.0, 57.1, 36.7, 36.6, 34.8, 25.2, 25.1, 24.3, 23.3, 19.2,, 19.0.  
HRMS (ESI):  calc for C12H22O5Na: 285.1104; found: 285.1115 (3 ppm). 
 
3,5,5-Trimethyl-3- (3-t-butyl-diphenylsilyloxy-propoxy1,2-dioxolane (242): 
To a flame-dried vial containing a solution of 107-OTMS (508.2 mg, 2.5 mmol) in 
CH2Cl2 (25 mL) was added sequentially 3-[(tert-butyldiphenylsilyl)oxy]-1-propanol (3 g, 
7.3 mmol) and TsOH (48 mg, 0.25 mmol).  After 2 hrs the reaction was treated with sat. 
aq. NaHCO3 (5 mL) and H2O (20 mL) and the resulting suspension was extracted with 
CH2Cl2 (2 x 20 mL).  The combined organic layers were subjected to standard drying and 
purification with 10% EA/hex to afford 242 (704.7 mg, 66%). Rf (10% EA/hex): 0.60. 1H 
NMR (400 MHz): 7.73-7.66 (4H), 7.46-7.35 (6H), 3.85-3.61 (4H), 2.52 (d, J = 12.4, 1H), 
2.32 (d, J = 12.4, 1H), 1.85 (quintet, J = 6.3, 2H), 1.48 (s, 3H), 1.37 (s, 3H), 1.34 (s, 3H), 
1.06 (9H). 13C (100 MHz):135.8, 134.25, 134.21, 129.7, 127.8, 127.7, 108.5, 83.8, 61.1, 
58.7, 33.2, 27.7, 27.0, 24.7, 20.2, 19.4.  HRMS (ESI):  calc for C25H36O4NaSi: 451.2281; 
found: 451.2273 (1.8 ppm). 
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3-((3,5,5-Trimethyl-1,2-dioxolan-3-yl)oxy)propan-1-ol (243): 
To a flame-dried vial containing a solution of 242 (669.8 mg, 1.6 mmol) in THF (16 mL) 
was added TBAF (1M in THF, 1.8 mL, 1.8 mmol).  After 3 hrs the reaction was treated 
with H2O (50 mL) and the resulting suspension was extracted with Et2O (3 x 50 mL).  
The combined organic layers were subjected to standard drying and purification with 
50% EA/hex to afford 243 (242.2 mg, 80%). Rf (50% EA/hex): 0.47. 1H NMR (400 
MHz): 3.87-3.69 (3H), 3.62 (m, 3H), 2.59 (bs, 1H), 2.52 (d, J = 12.6, 1H), 2.34 (d, J = 
12.6, 1H), 1.89-1.70 (2H), 1.48 (s, 3H), 1.37 (s, 6H). 13C (75 MHz): 108.6, 84.2, 61.2, 
60.0, 58.9, 32.0, 27.9, 24.8, 19.4.  IR: 3430, 2940, 2880, 1447.  HRMS (ESI):  calc for 
C9H18O4Na: 213.1103; found: 213.1100 (1.4 ppm). 
 
5-((3-Methyl-1,2-dioxaspiro[4.5]decan-3-yl)oxy)pentan-1-ol (244): 
To a flame-dried vial containing a solution of 147 (504.1 mg, 2 mmol) in CH2Cl2 (10 
mL) was added sequentially 1,5-pentanediol (0.09 mL, 0.87 mmol) and TsOH (16 mg, 
0.087 mmol).  After 2 hrs the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O 
(20 mL) and the resulting suspension was extracted with CH2Cl2 (2 x 20 mL).  The 
combined organic layers were subjected to standard drying and purification sequentially 
with flash chromatography and HPLC with 30% EA/hex to afford 244 (95 mg, 19%). Rf 
(20% EA/hex): 0.08. 1H NMR (400 MHz): 3.72-3.56 (3H), 3.50 (m, 1H), 2.43 (d, J = 
12.5, 1H), 2.28 (d, J = 12.5, 1H), 1.83-1.30 (20H). 13C (75 MHz):107.8, 85.7, 63.1, 61.5, 
 
 
161 
57.3, 36.5, 34.6, 32.5, 29.7, 25.4, 24.4, 23.3, 22.4, 20.0.  IR: 3374, 2933, 2859, 1446.  
HRMS (ESI):  calc for C14H26O4Na: 281.1729; found: 281.1725 (1.4 ppm). 
 
3-(2-(Benzyloxy)ethoxy)-3,5,5-trimethyl-1,2-dioxolane (245): 
To a flame-dried vial containing a solution of 107-OTMS (200 mg, 1 mmol) in CH2Cl2 
(10 mL) was added sequentially 2-(Benzyloxy)ethanol (0.76 mL, 5 mmol) and TsOH (19 
mg, 0.1 mmol).  After 2 hrs the reaction was treated with sat. NaHCO3 (20 mL) and H2O 
(5 mL) and the resulting suspension was extracted with CH2Cl2 (2 x 20 mL).  The 
combined organic layers were subjected to standard drying and purification with 20% 
EA/hex to afford 245 (157.2 mg, 68%). Rf (20% EA/hex): 0.55. 1H NMR (400 MHz): 7.3 
(m, 5H), 4.62 (dd, J = 18.1,12.2, 2H), 3.86-3.61 (4H), 2.64 (d, J = 12.5, 1H), 2.35 (d, J = 
12.5, 1H), 1.51 (s, 3H), 1.40 (d, J = 1.7, 6H). 13C (100 MHz): 138.6, 128.5, 127.9, 127.7, 
102.7, 84.0, 73.3, 69.7, 61.5, 58.7, 27.7, 24.7, 20.2.  HRMS (ESI):  calc for C15H22O4Na: 
289.1416; found: 289.1415 (0.3 ppm). 
 
3,3,5-trimethyl-5-(4-(oxiran-2-yl)butoxy)-1,2-dioxolane (246): 
To a flame-dried vial containing a solution of 231 (501.6 mg, 2.3 mmol) in CH2Cl2 (23 
mL) was added sequentially NaHCO3 (252 mg, 3 mmol) and mCPBA (739.2 mg, 3 
mmol)).  After 24 hrs the reaction was treated with H2O (50 mL) and the resulting 
suspension was extracted with CH2Cl2 (2 x 50 mL).  The combined organic layers were 
washed with sat. aq. NaHSO3 (50 mL) and subjected to standard drying and purification 
with 20% EA/hex to afford 246 (346.7 mg, 65%). Rf (20% EA/hex): 0.50. 1H NMR (300 
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MHz): 3.62 (m, 1H), 3.46 (m, 1H), 2.98-2.88 (1H), 2.75 (dd, J = 4.8, 4.3, 1H), 2.53 (d, J 
= 12.5, 1H), 2.48 (m, 1H), 2.33, (d, J = 12.5, 1H), 1.71- 1.50 (6H), 1.47 (s, 3H), 1.37 (s, 
6H). 13C (75 MHz): 108.4, 83.8, 61.6, 61.4, 58.9, 58.8, 52.5, 52.4, 47.3, 47.2, 32.4, 32.3, 
29.9, 29.8, 27.8, 24.81, 24.8, 22.8, 22.7, 20.1, 20.0. HRMS (ESI):  calc for C12H22O4Na: 
253.1416; found: 253.1409 (2.7 ppm). 
 
3-((3,5,5-Trimethyl-1,2-dioxolan-3-yl)oxy)propanenitrile (247): 
To a flame-dried vial containing a solution of 107-OTMS (202.3 mg, 1 mmol) in CH2Cl2 
(10 mL) was added sequentially 2-cyanoethanol and TsOH (19 mg, 0.1 mmol).  After 1 
hr the reaction was treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and the 
resulting suspension was extracted with CH2Cl2 (2 x 20 mL).  The combined organic 
layers were subjected to standard drying and purification with 10% EA/hex to afford 247 
(121.9 mg, 66%). Rf (30% EA/hex):0.28. 1H NMR (400 MHz): 3.79 (m, 1H), 3.65 (m, 
1H), 2.65 (m, 2H), 2.55 (d, J = 12.6, 1H), 2.33 (d, J = 12.6, 1H), 1.40 (s, 3H), 1.34 (d, J = 
5.9, 6H). 13C (75 MHz): 118.2, 108.7, 84.1, 58.6, 57.0, 27.7, 24.6, 19.6, 19.5.  HRMS 
(ESI):  calc for C9H15O3Na: 208.0950; found: 208.0942 (3 ppm). 
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Chapter 3 
1,2,4-Trioxepanes as potential antimalarials   
 
This chapter details my synthesis of 1,2,4-trioxepanes and their investigation as 
potential antimalarials. 
 
 
Section 1: Previous synthesises 
Section 2: Rationale  
Section 3: Results and Discussion 
Section 4: Antimalarial results 
Section 5: Experimentals 
Section 6: References
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Section 1 
 Previous synthesis 
 When discussing trioxepanes it is important to first understand the nomenclature 
that is used.  There are two isomeric forms of trioxepane peroxides that can exist 
depending on the relative positions of the oxygens in the ring.  The first is a 1,2,4-
trioxepane exemplified by 1.  The second is 1,2,5-trioxepane which is represented by 2.   
  
The synthesis of 1,2,4-trioxepanes is well established in the literature.  All of the 
methods rely upon a similar acid catalyzed ketalization to close the trioxepane ring.  The 
key intermediate employed by all the routes proceed through is typified by 3-
hydroperoxyalkanol 3, which undergoes an acid catalyzed ketalization with ketone 4 to 
afford trioxepane 5.  The difference in individual routes reflects the strategy employed for 
the synthesis of hydroperoxide intermediate 3.  
 
Acid displacement 
The first synthesis of 1,2,4-trioxepanes was described by Adam and Duran in 
1972.1  The diol precursor 6 was formed via a Reformatsky reaction, on the 
corresponding ketone, which is followed by a LiAlH4 reduction on the resulting ester.  
Selective substitution of the tertiary alcohol of 6 with ethereal H2O2 under acidic 
conditions afforded the desired hydroperoxide intermediate 7, which readily undergoes 
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acid catalyzed ketalization to afford 8.  In the course of this study Adam and Durran also 
conducted some initial stability studies on 7 and 8, finding that H2 and Pd/C reduced both 
hydroperoxide 7 and trioxepane 8 to diol 6. 
 
Cobalt-mediated peroxidation 
 To appreciate the usefulness of this approach, it is first necessary to understand 
what makes cobalt peroxidation so different from other methodologies.  The use of cobalt 
for the synthesis of hydroperoxides from alkenes was first reported by Mukaiyama in 
1989.2  In this seminal work Mukaiyama showed that alkene 9 was readily converted to 
peroxide 10 in a variety of solvents in good yield.  Although the reaction is shown here 
only for Co(acac)2 and a terminal alkene the reaction was shown to work with a variety of 
cobalt (II) sources and alkenes.   
 
 In 1990, Isayama was exploring this reaction on styrene and found that the 
reaction required a long initiation time, and proceeded with low conversion.3  He reported 
that the initiation time can be decreased and yield increased with the use a peroxide 
initiator.  This effect was most dramatic for cobalt (II) acetylacetone, Co(acac)2.  Though 
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Isayama did not give a rationale for this peroxide effect, he postulated that the peroxide 
most likely speeds up the initiation reaction. 
 
  CHP = Cumyl hydroperoxide 
 An initial investigation of cobalt peroxide complexes was reported by Weiss in 
1985.4  Weiss drew upon the work of Kochi who had studied cobalt-mediated 
epoxidation of alkenes.5  Weiss found that cyclohexene and ethylbenzene gave large 
amounts of the alkyl peroxides while styrene and norbornene gave the epoxide.  Weiss 
postulated that a radical addition of t-butyl peroxy radical to alkene 13 afforded 
intermediate 14.  As there is no effective hydrogen atom donor, the newly formed radical, 
undergoes SH substitution to generate epoxide 15. 
 
A 2002 mechanistic study by Nojima postulated a mechanism, building upon the 
work of Weiss.6  Nojima initially postulated that there was a cobalt peroxide complex 
present in the reaction.  The support for this came from the work of Isayama 
demonstrating the importance of the peroxide formed, and Weiss’s observation of the 
ability of cobalt peroxide complexes to perform the proposed reaction.  Nojima 
synthesized peroxide complex 17 and reacted it with an excess of alkene 16 under 
standard peroxidation conditions.  Observing that peroxide 18 was formed in very good 
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yield.  In contrast, if 17 was treated with triethylsilane under argon with no alkene 
present, silylperoxide 19 was isolated in high yield, suggesting the intermediacy of a 
cobalt triethylsilane complex. 
 
With this information Nojima proposed a complete mechanism.  The postulated 
key intermediate a hydrido cobalt (II) species (20), which complexes to the alkene and 
delivers a hydride to provide intermediate 22.  Loss of CoII generates radical 23 which 
readily traps O2 to form 25.  Finally, displacement with triethylsilane affords the product 
26 and regenerates 20, restarting the cycle.  O’Neill later provided further support for the 
intermediacy of a carbon radical by performing the reaction with a chiral cobalt catalyst.7  
The lack of asymmetric induction suggests that O2 attacks an achiral intermediate, such 
as 23, after loss of a chiral cobalt catalyst.  
 
 
In 2004, Dussault reported the use of cobalt peroxidation on homoallyl alcohols 
as a different method to synthesize 1,2,4-trioxepanes.8  This work built upon work by Oh 
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who, isolated the triethylsilyl peroxide of 28.9  Unlike what would be expected under 
these conditions, Dussault found that the free hydroperoxide 28 was formed as the major 
product instead of the triethylsilyl analog. Though this peroxidation was performed only 
on alcohol 27, this strategy could be applied to any number of homoallyl alcohols as a 
approach to 1,2,4-trioxepanes.  Dussault found that the ketones with varying electronics 
can be ketalized with 28 to afford trioxepanes 29. 
 
 Dussault became interested in trioxepanes as potential protecting groups for 
carbonyl compounds.  Thus, trioxepane 30 was tested against a variety of reaction 
conditions to determine its stability.  Peroxides are often quite reactive and therefore 
would not be expected to make a good protecting group.  However, Dussault found that 
30 exhibited remarkable stability to various reducing agents.  The exception was n-BuLi 
which caused decomposition even at -78oC.  Dussault reported that deprotection to the 
carbonyl was achieved with a dissolving metal reduction by either Zn/HOAc or 
Mg/MeOH. 
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NaBH4
H2CrO4
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Et3N
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TsOH/MeOH
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>24h
>24h
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>24h
>24h
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0.25h
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30
 
Oxetane opening 
 In 2002, Dussault reported the synthesis of enantiomerically enriched 1,2,4-
trioxepanes that were derived from chiral oxetanes.10  It was found that the oxetane could 
be opened with ethereal H2O2 and a variety of Lewis acids.  The choice of Lewis acid 
was found to be important in that BF3.OEt2, ZnCl2, and MgCl2 produced no reaction, but 
the use of TMSOTf, Yb(OTf)3, and Sc(OTf)3 afforded the desired hydroperoxide, 32, in 
varying yields.  The main issue that was encountered in the opening was the extent of 
inversion of the stereocenter.  The final ketalization step proceeded in moderate yield to 
afford 33.   
 The solvation of the H2O2 was also found to be important to the course of the 
reaction.  When H2O2 in CH2Cl2 was formed by iterative addition and evaporation from 
ethereal H2O2, the inversion product was formed exclusively, even at -78oC.  In contrast, 
the use of H2O2 in CH2Cl2 obtained from direct extraction of H2O2 with CH2Cl2 led to 
elimination giving the homoallyl alcohol.  Dilution of the CH2Cl2-extracted H2O2 with an 
equal volume of ether leads the suppression of inversion.  
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Thiol-Olefin Co-Oxygenation 
The use of thiol-olefin co-oxygenation to synthesize trioxepanes was reported by 
O’Neill in 2006.11  The mechanism for this reaction is reliant upon the generation of a 
thiyl radical.  The reaction is typically initiated by an agent such as AIBN.  The synthesis 
of the 1,2,4-trioxepane was then readily accomplished by ketalization with a variety of 
ketones to afford 1,2,4-trioxepane 38. 
 
 
 In attempts to make more water soluble 1,2,4-trioxepanes a variety of 
manipulations were successfully carried on trioxepane 38.  The oxidation of sulfide 38 to 
the corresponding sulfone and sulfoxide was readily accomplished with mCPBA.  
Treatment of the sulfoxide under Pummerer conditions afforded aldehyde 40.  Aldehyde 
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40 successfully underwent Wittig olefination to afford amide 41 and ester 42.  A 
reductive amination of aldehyde 40 with morpholine was attempted, but led to peroxide 
decomposition. 
 
Singlet oxygen 
 In 2006, Singh reported that singlet oxygenation of homoallylic alcohols is an 
effective method for the generation of a 3-hydroperoxy-4-alken-1-ol 44.12  This route 
starts with alcohol 43, that is readily synthesized in two steps from commercial starting 
materials.  The formation of the final 1,2,4-trioxepanes was accomplished by ketalization 
of 44 with either acetone, cyclopentanone, or cyclohexanone. 
 
 In 2008, Singh synthesized a new series of 1,2,4-trioxepanes in the pursuit of a 
potentially new antimalarial treatment.13  In the course of this work he furthered the 
knowledge of 1,2,4-trioxepanes by performing reactions that are typically not compatible 
with peroxides.  Singh reported successful a reductive amination with a variety of aryl 
amines to form substituted 1,2,4-trioxepanes represented by 47.  This result was 
unexpected given the issues that had been reported by O’Neill on a similar substrate.11  
Though not discussed, the success of this reaction could be due to the use of the less 
active NaBH(OAc)3.  Trioxepane 48 was also stable towards Horner-Wadsworth-
Emmons (HWE) homologation conditions to afford 49.  The low yield for the HWE 
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reaction was not discussed by Singh and it is unclear if the lower yield is inherent to the 
olefination of a ketone or if peroxide decomposition occurred. 
O
OO
Ph
ArNH2, NaBH(OAc)3
benzene, rt
O
O
OO
Ph
NHAr
Ar = Ph
Ar = 4-F-Ph
Ar = 4-CF3-Ph
84%
85%
65%
O
OO
Ph
O
O
P
EtO
EtO
O
OEt
NaH, THF, 58% O
OO
Ph CO2Et
46 47
48 49  
 
Electrophilic cyclization 
Electrophilic cyclization was discussed in full in Chapter 2 Section 2.1.  A brief 
discussion relevant to 1,2,4-trioxepanes follows.  
 In 1996, Dussault reported that it was possible to use electrophilic cyclization of a 
hydroperoxide onto an alkene to afford 1,2,4-trioxepanes.14  The peroxymercuration of 50 
with Hg(OAc)2 was successful, while the corresponding peroxyiodination was not.  
Dussault reported that trioxepane 51 lacked stability, though no explanation was given.  
This lack of stability is possibly due to the hydrogen present in the 7 and the potential for 
E1CB decomposition.  Nojima reported that cyclization of hydroperoxy acetal similar to 
50 with NIS resulted in a low yield and complex mixture of isomers.15 
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Ozonolysis 
 In 1997, Nojima reported that the closure of a hydroperoxy acetal onto an epoxide 
could be used to synthesize 1,2,4-trioxepanes.16  Hydroperoxide acetal 52, which was 
formed through ozonolysis, was subjected to epoxidation conditions to yield 53.  As 
would be expected acidic treatment of 53 resulted in cyclization at the more hindered site 
to give 54.  If 53 was subjected to basic conditions, then cyclization occurred at the less 
hindered site to afford 55.   
 
 Nojima reported in 1997 that the ozonolysis of an alkene in the presence of a 
hydroperoxy acetal would result in intramolecular trapping to give a 7-hydroperoxy-
1,2,4-trioxepane.17  When hydroperoxy acetal 56 is subjected to ozonolysis, 
hydroperoxytrioxepane 57 was produced in good yield.  Nojima found that the choice of 
solvent was important for this reaction.  A 2: 1 mixture of ether/trifluoroethanol gave 
optimal yields, while the use of ether alone resulted in the ozonide of 56 forming as a 
major byproduct.  The use of trifluoroethanol as a solvent resulted in only 57 forming, 
but in decreased yield. 
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Section 2 
 Rationale 
The following work has largely been published.18 
 
Given the high activity of selected 1,2,4-trioxolanes against P. falciparum in situ 
and as potential antimalarial drugs, we became interested in determining the effect that 
ring size has on activity.  This work was done in collaboration of the Vennerstrom group 
at the University of Nebraska Medical Center.  It was decided that I would synthesize 
four 1,2,4-trioxepanes (58 - 61) and their activity against P. falciparum would be 
determined.  The Vennerstrom group would synthesize the corresponding 1,2,4-
trioxolanes and 1,2,4-trioxanes.  The hypothesis is that as the ring size increased the 
peroxide bond would be less accessible and antimalarial activity would diminish.  
Nonetheless it was necessary to synthesize this series to determine if that theory was 
valid. 
 
 Retro-synthetically it was envisioned that a parallel synthesis would be employed, 
using a common hydroperoxyalkanol as a common intermediate and that final 
differentiation between 58/59 and 60/61 would occur at the ketalization step.  Given the 
work that has been done previously, I envisioned that hydroperoxide 63 would be formed 
via a Mukaiyama cobalt peroxidation from an allyl alcohol 64.  In the case of the 
cyclohexyl derivative, is available via a Horner-Wadsworth-Emmons olefination of 
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cyclohexanone.  While in the case of the phenyl propanol derivative, hydroperoxide 63, 
the precursor of 1,2,4-trioxepanes 60 and 61, would be formed from cinnamyl alcohol. 
 
Section 3 
 Results and discussion 
Although the olefination of cyclohexanone to form ester 66 was uneventful, the 
subsequent reduction was found to be problematic.  Initially, LiAlH4 was employed as 
the reducing agent however this led to an inseparable mixture of saturated and 
unsaturated 67. 19  It was found that this issue was readily circumvented by reduction 
with Dibal-H.  Allyl alcohol 67 was then subjected to Mukaiyama cobalt-mediated 
peroxidation using several solvents (1,2-dichloroethane, EtOH) and cobalt complexes 
(Co(acac)2 and Cobalt(II) (2,2,6,6-tetramethyl-3,5-heptanedionate (Co(THD)2).  
However, it was found that all tested conditions gave a poor yield to the desired peroxide 
and always as part of an inseparable mixture.  This outcome is not entirely surprising 
when the earlier Dussault work is considered.8  Alcohol 67 is expected to be a 
problematic substrate which will react to mainly furnish the free hydroperoxide and not 
the triethylsilyl peroxide.  Therefore, it would have been prudent to perform a model 
reaction on a known substrate as a model, but this was not done.      
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Given these synthetic issues I decided that the use of an oxetane as the peroxide 
precursor might be a more successful strategy.  Our lab has previously reported the 
opening of oxetanes similar to 70 with hydrogen peroxide as a route to hydroperoxides 
71.20  It was envisioned that the desired oxetane (70) could be formed by a intramolecular 
nucleophilic displacement of the primary tosylate formed from diol 69. 
 
The synthesis of oxetane 70 began with a Reformatsky reaction of cyclohexanone 
to afford ester 72 which underwent LiAlH4 reduction to provide diol 69.  Closure of the 
oxetane could be accomplished by formation of the primary tosylate followed by an 
intramolecular displacement.  This approach, however, provided the desired oxetane 70 
in poor yield and this route was abandoned. 
 
At this point, I decided that it would be beneficial to employ a modified version of 
the Corey-Chaukovski reaction to obtain the oxetane in one-step from the ketone.  I 
investigated the oxetane in one-step formation of oxetane as reported by Okuma.21  
Though the yield for this reaction is not exemplary, it provided the desired product in a 
one-pot one step procedure. 
 
 
187 
OO
65 70
S+
O I-
56%
 
With the oxetane in hand, I attempted to perform the opening with hydrogen 
peroxide as was previously reported by Dussault.20  However, when I attempted the 
opening I ran into significant trouble with every condition attempted.  The reason for this 
failure is unclear although most of the earlier examples are in acyclic substrates. 
 With these troubles I returned to investigations of the Mukaiyama cobalt-
mediated peroxidation.  I thought that the use of a protecting group on the alcohol might 
improve the outcome of the cobalt-mediated dioxygenation.  Initially, it was planned that 
the TMS or TES ether would be employed, as deprotection and ketalization could be 
accomplished in one-step.    Attempts to form the OTMS ether were unsuccessful, but the 
OTES ether was successfully prepared.  Unfortunately cobalt peroxidation was 
unsuccessful.  In hindsight, the use of the bulkier OTBS ether would have been more 
prudent as it would be less likely to undergo deprotection during the cobalt peroxidation. 
 
 I thought that this strategy merited further investigation using a protecting group 
that would not be labile under cobalt-mediated peroxidation conditions.  A paper by Wu 
reporting the selective reduction of esters in the presence of a dialkyl peroxide 
encouraged me to utilize a ester protecting group.22  To my delight, the acetate derived 
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from alcohol 67 underwent cobalt-mediated peroxidation to yield silyl peroxide 74, 
which underwent Dibal-H reduction to afford the long sought after peroxyalkanol 68. 
Finally, ketalization with either 2-adamantanone or cyclohexanone proceeded in 
moderate yield to afford the desired 1,2,4-trioxepanes 58 and 59 respectively.  
 
The same chemistry was used to prepare the cinnamyl analog (77), the 3-peroxy-
3-phenylpropanol in good yield.  Ketalization of 77 with 2-adamantanone or 
cyclohexanone afforded trioxepanes 60 or 61, respectively in moderate yield. 
O O
O
OH OAc
OOSiEt3
2. Co(acac)2
TESH, 43%
1. Ac2O 89%
OH
OOSiEt3
Ph
O O
O
Ph
75 76
7761 60
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HF, 39% HF, 21%
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Section 4 
 Antimalarial results 
The desired 1,2,4-trioxepanes were subjected to in vitro testing against P. 
falciparum and were compared against structural analogs 1,2,4-trioxolanes and 1,2,4-
trioxoanes (Table 3.1).23,24  There was a decrease in activity as the peroxide ring size 
increased, 5>6>7.  The trioxepanes that I synthesized showed no activity.  Although we 
had expected little activity, we had not expected a complete absence of activity.  Previous 
work showed that the difference in Fe (II) reactivity between 79 and 80 could be 
correlated with the accessibility of the peroxide bond to FeII.25 I believe that this same 
rationale can be extended to the lack of activity for the 1,2,4-trioxepanes.  Our 
collaborators investigated the degradation of trioxepane 58 by soluble Fe(II) and found 
no reaction after 24 hrs, conditions that would have resulted in complete degradation of a 
1,2,4-trioxolane or a 1,2,4-trioxane.  The results show there is a tradeoff between stability 
and activity. 
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Compound IC50 (nM) 
78 >1000 
79 5.3 
80 66 
81 158 
58 >1000 
59 >1000 
60 >1000 
61 >1000 
Table 3.1 
Section 5 
 Experimentals 
All reagents were used as received from commercial vendors, with the exception of 
CH2Cl2, which was distilled from calcium hydride, and THF, which was distilled from 
sodium/benzophenone.  All reactions were conducted under an atmosphere of N2 except 
where noted; “RBF” indicates round-bottom flask.  Thin layer chromatography (TLC) 
was performed on 0.25 mm hard-layer silica G plates; developed plates were visualized 
with a hand-held UV lamp or by staining: 1% ceric sulfate and 10% ammonium 
molybdate in 10% H2SO4 (general stain, after charring); 1% N,N’-dimethyl-p-
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phenylenediamine solution in 1:20:100 acetic acid/water/methanol (specific for 
peroxides);26 1% aq. KMnO4 (for unsaturated compounds).  “Standard drying and 
purification” refers to drying of organic extracts over Na2SO4, removal of solvent under 
vacuum, and purification by flash chromatography using the indicated eluting solvent. 
1H/13C NMR spectra were obtained in CDCl3 unless otherwise indicated; peaks are 
reported as: chemical shift (multiplicity, J couplings in Hz, number of protons).  Infrared 
spectra were recorded as neat ATR films with selected absorbances reported in 
wavenumbers (cm-1). 
CO2Et
 
Ethyl 2-cyclohexylideneacetate (66): 
A suspension containing sodium hydride (2.3g, 57 mmol, 60% in mineral oil) in a flame-
dried RBF was washed with pentane (2 x 20 mL).  The residue was suspended in THF 
(90 mL) and the suspension cooled to 0oC.  Following the drop wise addition of 
triethylphosphonoacetate (13.72 g, 61 mmol), the reaction was allowed to warm to rt and 
stirred at this temperature for 90 min.  Cyclohexanone (5g, 51 mmol) was then added 
drop wise and the reaction allowed to stir overnight.  The reaction was diluted with H2O 
(100 mL) and extracted with Et2O (3 x 100 mL).  The combined organic layers were 
washed with brine (2 x 100 mL), dried with Na2SO4.  The residue obtained upon 
concentration in vacuo was purified by chromatography with 10% EA/hex to afford 66 
(8.0992g, 94 %) as a colorless oil.  Rf (10% EA/hex) = 0.68.  1H NMR (300 MHz): 5.60 
(s, 1H), 4.15 (q, 2H, J=7),   2.83 (apparent t, 2H, J=6), 2.20 (apparent t, 2H, J=6), 1.72-
1.54 (6H), 1.28 (t, 3H, J=7.12).  The NMR spectra matched those previously reported.27 
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OH
 
2-Cyclohexylideneethanol (67) 
In a flame-dried RBF containing a 0oC solution of 5 (7.62 g, 45 mmol) in Et2O 
(150 mL) was added Dibal-H (91 mL, 91 mmol, 1 M).  The reaction was stirred for 2 hrs 
and then was treated with sat. aq. Rochelle’s salt (30 mL) followed by H2O (500 mL).  
The resulting suspension was extracted with Et2O (2 x 500 mL) and the combined 
organic layers were washed with brine (500 mL) and dried with Na2SO4.  The residue 
obtained upon concentration in vacuo was purified via column chromatography with 30% 
Et2O/pent to afford 67 (4.4458 g, 79%) as a colorless oil.  1H (300 MHz): 5.36 (m, 1H), 
4.15 (m, 2H), 2.2-2.03 (4H), 1.62-1.45 (6H), 1.25 (s, 1H). The NMR spectra matched 
those previously reported.27 
 
1-Carboethoxymethyl-1-cyclohexanol (72): 
 Cyclohexanone (5 g, 51 mmol) and ethyl bromoacetate (8.52g, 51 mmol) were 
dissolved in a mixture of benzene (60 mL) and toluene (50 mL) in a RBF.  To a separate 
flame-dried RBF were added sequentially Zn dust (3.31g, 51 mmol) and 25 mL of the 
solution from the other RB.  The reaction was heated to reflux at which point the 
remainder of the first solution was added.  The reaction was held at reflux for 2 hrs after 
which dilute H2SO4 (50 mL) was added and the resulting suspension filtered.  The 
organic layer was washed with brine (2 x 15 mL) and dried with Na2SO4.  The residue 
obtained upon concentration in vacuo was purified by column chromatography with 10% 
EA/hex to afford 72 (4.683 g, 48%). Rf (10 % EA/hex): 0.43. 1H (300 MHz): 4.13(q, J = 
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7.1, 2H), 3.40 (s, 1H), 2.42 (s, 2H), 1.72-1.33 (10H), 1.23 (t, J = 7.1, 3H).  The NMR 
spectra matched those previously reported.28 
 
1-(2-Hydroxyethyl)cyclohexanol (69): 
A suspension of LiAlH4 (306 mg, 38 mmol) in Et2O was cooled to 0oC in a flame-dried 
RBF.  To the suspension was added 72 (500 mg, 2.68 mmol) in Et2O (10 mL).  The 
reaction was stirred for 30 min and then quenched by sequential addition of H2O (0.3 
mL), 10% aq. NaOH (0.3 mL) and H2O (0.9 mL).  The suspension was filtered and the 
aq. layer extracted with Et2O (3 x 15 mL).  The combined organic layers were dried with 
Na2SO4 and the residue obtained upon concentration in vacuo was purified via column 
chromatography with 30% Et2O/hex.  As the subsequent oxetane closure proceeded in 
very low yield, this route was not pursued further. 
O
 
1-Oxaspiro[3.5]nonane (70): 
(Corey-Chaukovski method)21 
To a flame-dried RBF was added sequentianlly trimethylsulfoxonium iodide (8.8 g, 40 
mmol), potassium t-butoxide (4.75 g, 40 mmol), and t-butanol (40 mL).  The slurry was 
allowed to stir at 50oC for 30 min.  A solution of cyclohexanone (1g, 10 mmol) in t-
butanol (10 mL) was added and the reaction was allowed to stir at 50oC for 3 days.  The 
reaction was then treated with H2O (100 mL) and the suspension was extracted with 
pentane (3 x 60 mL).  The combined organic layers were washed with brine (2 x 80 mL) 
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and subjected to standard drying and purification with 7.5% Et2O/pent to afford 70 (706.1 
mg, 56%).    1H NMR (300 MHz): 4.49 (t, J = 7.8, 2H), 2.33 (t, J = 7.8, 2H), 1.90-1.75 
(10H). The NMR contained approximately 10% Et2O but otherwise matched those 
previously reported.21 
 
2-(1-((Triethylsilyl)peroxy)cyclohexyl)ethyl acetate (74): 
To a flame-dried RBF was added sequentially 67 (4.4458 g, 35 mmol), pyridine (50 mL), 
Ac2O (3.88 mL, 52 mmol), and DMAP (437.8 mg, 3.5 mmol).  The reaction was stirred 
for 2 hrs and then quenched by addition of 2N aq. HCl (75 mL).  The suspension was 
extracted with Et2O (3 x 50 mL).  The combined organic layers were washed sequentially 
with 2N HCl (75 mL), sat. aq. NaHCO3 (50 mL), and brine (50 mL).  The organic layer 
was dried with Na2SO4 and the residue upon concentration in vacuo was purified via 
column chromatography with 10 % EA/hex to afford 2-cyclohexylideneethyl acetate 
(5.1477 g, 88%).  Rf (10% EA/hex) = 0.62.  1H NMR (300 MHz): 5.28 (dt, J = 7.3, 1.1, 
1H), 4.57 (d, J = 7.3, 2H), 2.24-2.06 (4H), 2.04 (s, 3H), 1.61-1.44 (6H).  The NMR 
spectra matched those previously reported.29 
To a flame-dried RBF containing Co(acac)2 (437 mg, 1.7 mmol) was added  2-
cyclohexylideneethyl acetate (2.9883 g, 17 mmol) in EtOH (60 mL) and Et3SiH (3.9 g, 
34 mmol).  The reaction was placed under an atmosphere of O2 (balloon) and allowed to 
stir overnight.  The reaction was then concentrated in vacuo and the residue subjected to 
column chromatography with 5 % EA/hex to afford 74 (2.2596 g, 42%). Rf (5% 
EA/hex): 0.44.  1H NMR (300 MHz): 4.19 (t, J = 7.3, 0.8H), 4.1 (t, J = 6.9, 1.2H), 3.69 
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(q, J = 7.0, 1H), 2.03 (d, J = 3.1, 3H), 1.93 (t, J = 1.96, 1H), 1.83-1.08 (13H), 1.06-0.83 
(8H), 0.75-0.53 (4H).   
 
2-(1-((Triethylsilyl)peroxy)cyclohexyl)ethanol (68): 
A flame-dried RBF containing 74 (2.25 g, 6.9 mmol) in CH2Cl2 (60 mL) was cooled to -
78oC and Dibal-H (13.9 mL, 13.9 mmol, 1M) was added.  The reaction was allowed to 
stir for 3 hrs after which the reaction was treated with sat. Rochelle’s salt (60 mL).  The 
suspension was extracted with Et2O (3 x 40 mL) and the combined organic fractions were 
washed with brine (2 x 100 mL) and dried over Na2SO4.  The residue obtained upon 
concentration in vacuo was purified via column chromatography with 30 % Et2O/pent to 
afford 68 (1.2355g, 65%).  Rf (30% Et2O/pent): 0.52.  1H (300 MHz): 3.78-3.61 (3H), 
1.90 (t, J = 6.9, 1H), 1.83-1.09 (14H), 1.04-0.83 (8H), 0.78-0.54 (4H). 13C (75 MHz): 
83.8, 61.0, 58.6, 58.5, 40.6, 39.2, 34.4, 33.54, 33.52, 26.7, 26.4, 22.3, 18.8, 6.9, 6.8, 4.6, 
4.0. 
 
Adamantane-2-spiro-3’-7’-cyclohexyl-1’,2’,4’-trioxepane (58) 
To a flame-dried RBF containing 68 (509.9 mg, 1.83 mmol) in CH2Cl2 (2 mL) was added 
sequentially 2-adamantanone (301 mg, 2 mmol) and HF (48% in H2O, 1 mL).  After 
stirring for 1 hr the reaction was quenched with sat. aq. NaHCO3 (30 mL) and the 
resulting suspension was extracted with CH2Cl2 (3 x 20 mL).  The combined organic 
fractions were washed with brine (2 x 20 mL) and dried with Na2SO4.  The residue 
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obtained upon concentration in vacuo was purified via column chromatography with 10 
% EA/hex.  Subsequent purification through HPLC with 10 % EA/hex afforded the 
desired product 58 (79.5 mg, 15 %).  Rf (5% EA/hex):0.28. 1H NMR (400 MHz): 3.90 
(apparent pentet (probably dt), J = 6.2, 12.2 1H), 3.69 (dt, J = 3.7, 12.4, 1H), 2.40 (br, s, 
1H), 2.15-2.02 (m, 2H), 2.02-1.9 (m, 3H), 1.86-1.30 (20H).  13C NMR (100 MHz, 
CDCl3): 107.5, 81.7, 58.1, 42.3, 37.5, 35.7, 34.6, 34.2, 33.8, 33.8, 33.7, 33.6, 32.9, 27.3, 
26.0, 22.4, 22.0.  HRMS (FAB); calc for C18H29O3: 293.2117; found: 293.2103.  
 
Cyclohexane-2-spiro-3’-7’-cyclohexyl-1’,2’,4’-trioxepane (59) 
To a flame-dried RBF containing 68 (267 mg, 1 mmol) in CH2Cl2 (5 mL) was added 
sequentially cyclohexanone (139 mg, 1.4 mmol) and HF (48% in H2O, 2 mL).  The 
reaction was stirred for 1 hr after which sat. aq. NaHCO3 (30 mL) was added.  The 
suspension was extracted with CH2Cl2 (3 x 20 mL).  The combined organic fractions 
were washed with brine (2 x 20 mL) and dried with Na2SO4.  The residue obtained upon 
concentration in vacuo was purified via column chromatography with 5 % EA/hex.  
Subsequent purification through HPLC with 5 % EA/hex afforded the desired product 59 
(92 mg, 39 %).  Rf (5% EA/hex): 0.48. 1H NMR (400 MHz): 3.60 (m, 1H), 3.66 (m, 1H), 
2.15-2.04 (1H), 1.95-1.72 (21H).  13C NMR (100 MHz): 105.9, 82.0, 58.5, 42.8, 35.9, 
33.4, 32.8, 32.2, 26.0, 25.7, 23.3, 22.9, 22.4, 22.0.  HRMS (EI); calc forC14H24O3: 
240.1725; found: 240.1723.  
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OOSiEt3
 
3-Phenyl-3-(triethylsilylperoxy)propyl acetate (76): 
To a flame-dried RBF containing cinnamyl alcohol (2.46 g, 18.4 mmol) in pyridine (30 
mL) was added sequentially Ac2O (2 mL, 23.6 mmol) and DMAP (226 mg, 1.84 mmol).  
The reaction was allowed to stir for 1 hr after which 2N aq. HCl (40 mL) was added.  The 
suspension was extracted with Et2O (3 x 30 mL) and washed with sat. aq. NaHCO3 (2 x 
40 mL).  The combined organic layers were dried with Na2SO4 and the residue obtained 
upon concentration in vacuo purified via column chromatography with 5% EA/Hex to 
afford cinnamyl acetate (2.8754 g, 89%) as a yellow oil. 1H NMR (300 MHz): 7.75-7.24 
(5H), 6.68 (d, J = 16.4, 1H), 6.30 (dt, J = 15.9, 6.5, 1H), 4.78 (apparent doublet, J = 6.4, 
2H), 2.12 (s, 3H).  13C (75 MHz): 170.9, 136.3, 134.3, 128.7, 128.2, 126.7, 123.3, 65.2, 
21.1. 
To a flame-dried RBF containing Co(acac)2 (146 mg, 0.57 mmol) was added a solution of 
cinnamyl acetate (1.03 g, 5.7 mmol) in EtOH (20 mL) and Et3SiH (1.32 g, 11.3 mmol).  
The reaction was placed under an atmosphere of O2 (balloon) and allowed to stir 
overnight.  The reaction was then concentrated in vacuo and the residue obtained was 
purified via column chromatography with 5 % EA/hex to afford 76 (815.7 mg, 43%). Rf 
(5% EA/hex): 0.43.  1H NMR (300 MHz): 7.41-7.24 (5H), 4.97 (t, J = 6.8, 1H), 4.24-3.98 
(2H), 2.30 (m, 1H), 2.01 (m, 1H), 2.02 (s, 3H), 0.94 (t, J = 7.6, 9H), 0.64 (aq, 6H).  
 
 
 
 
198 
 
3-Phenyl-3-(triethylsilylperoxy)propan-1-ol (77): 
A flame-dried RBF containing 76 (815.7 mg, 2.5 mmol) in CH2Cl2 (20 mL) was cooled 
to -78oC and Dibal-H (5 mL, 5 mmol, 1M) was added.  The reaction was stirred for 3 hrs 
and then treated with sat. aq. Rochelle’s salt (30 mL).  The resulting suspension was 
extracted with Et2O (3 x 40 mL).  The combined organic layers were washed with brine 
and dried with Na2SO4.  The residue obtained upon concentration (672.4 mg, 95%) was 
used in the subsequent reactions without purification. 
O O
O
 
Adamantane-2-spiro-3’-7’-phenyl-1’,2’,4’-trioxepane (60) 
To a flame-dried RBF containing 77 (320.2 mg, 1.13 mmol) in CH2Cl2 (10 mL) was 
added sequentially 2-adamantanone (165 mg, 1.1 mmol) and HF (48% in H2O, 2 mL).  
After stirring for 1 hr the reaction was quenched with sat. aq. NaHCO3 (30 mL) and the 
resulting suspension was extracted with CH2Cl2 (3 x 20 mL).  The combined organic 
fractions were washed with brine (2 x 20 mL) and dried with Na2SO4.  The residue 
obtained upon concentration in vacuo was purified via column chromatography with 7.5 
% Et2O/pent.  Subsequent purification through HPLC with 10 % EA/hex afforded the 
desired product 60 (70 mg, 21 %). Rf (55% EA/Hex):0.65.  1H NMR (400 MHz):7.40-
7.29 (m, 5H), 5.14 (dd, J = 11.5, 3.5, 1H), 4.13 (app t, J = 11.3, 1H), 3.85 (dt, J = 3.4, 
12.2, 1H), 2.4-2.2 (m, 2H), 2.14-1.9 (m, 6H), 1.86-1.79 (m, 2H), 1.75-1.6 (m, 6H).  13C 
NMR (75.5 MHz):138.5, 128.5, 128.4, 127.3, 108.6, 86.1, 76.6, 60.0, 39.4, 37.5, 35.0, 
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34.7, 34.1, 33.9, 33.6, 33.1, 27.2, 27.1.  HRMS (FAB); calc for C19H25O3: 301.1804; 
found: 301.1809.   
 
Cyclohexane-2-spiro-3’-7’-phenyl-1’,2’,4’-trioxepane (61): 
To a flame-dried RBF containing 77 (285.0 mg, 1 mmol) in CH2Cl2 (10 mL) was added 
sequentially cyclohexanone (0.11 g, 1.1 mmol) and HF (48% in H2O, 2 mL).  After 
stirring for 1 hr the reaction was treated with sat. aq. NaHCO3 (30 mL) and the resulting 
suspension was extracted with CH2Cl2 (3 x 20 mL).  The combined organic fractions 
were washed with brine (2 x 20 mL) and dried with Na2SO4.  The residue obtained upon 
concentration in vacuo was purified via column chromatography with 10 % EA/hex.  
Subsequent purification through HPLC with 10 % EA/hex afforded the desired product 
61 (95.5 mg, 39 %).  1H NMR (400 MHz)7.41-7.29 (5H), 5.14 (dd, J = 11.4, 5.15, 1H), 
4.20-4.08 (1H), 3.84 (dt, J = 12.5, 3.4, 1H), 2.37-1.20 (12H).  13C (75 MHz): 138.5, 
128.7, 128.6, 127.5, 106.9, 86.3, 60.5, 39.4, 34.2, 31.9, 25.6, 23.3, 22.9.  HRMS (FAB): 
calc for C15H21O3: 249.1492; found: 249.1489. 
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Chapter 4 
Re (VII) oxide as a catalyst for the generation of stabilized carbocations 
 
This chapter describes my investigation of Re(VII) as a catalyst for the formation 
of stabilized carbocations that are utilized in various displacement of activated alcohols. 
 
 
Section 1: Previous work 
Section 2: Hypothesis 
Section 3: Etherification/acetalization of 3-alkoxy-1,2-dioxolanes 
Section 4: Etherification of lactols 
Section 5: Allylation 
Section 6: Stabilized carbocations 
Section 7: Conclusions 
Section 8: Experimentals 
Section 9: References 
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Chapter 4 includes a description of my application of Re(VII) to the 
transetherification (transacetalisation) of 1,2-dioxolan-3-ols to the corresponding 3-
alkoxy-1,2-dioxolanes.  This chapter will discuss in detail my investigations of the ability 
of Re2O7 to catalyze reactions involving in situ generation of carbocations from alcohols.  
Several reviews on the chemistry of rhenium have been published.1,2 
Section 1 
Previous work 
Isomerization of allylic alcohols by rhenium 
 In 1997, Osborn first reported that ReO3(OSiMe3) or ReO3(OSiPh3) was able to 
catalyze the isomerization of allyl alcohols.3  Osborn’s proposed mechanism (below) 
begins with insertion of rhenium into the C-O bond of 1.  This type of insertion is 
supported by an analogous insertion reported by Wilkinson.4  Complex 3 rearranges to 
the isomerized complex (5) via transition state 4, a pathway supported by the analogous 
work of Chabardes.5  Finally, the catalytic cycle in the presence of 1 and produces 
isomerized alcohol 6. 
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 In 2000, Osborn built upon his earlier work by showing that this allylic 
rearrangement also works for trimethylsilyl ether of 1.6 Osborn also reported that Re2O7 
was able to catalyze this reaction in MeCN, THF, and CH2Cl2.  There is a solvent effect 
on the reaction with a twenty-fold decrease in turnover observed for MeCN or THF 
compared to CH2Cl2.  This was attributed to coordination to the ReO3(OSiMe3) catalyst.  
The rate of the reaction with Re2O7 could not be determined due to the insolubility in 
CH2Cl2. 
 In 2010, Zakarian developed a method to control the regioselectivity of Re2O7-
promoted isomerization of enediols,7 providing one solution to the lack of regioselectivity 
typically encountered in the reactions of simple allyl alcohols.8-10  Transformation of 7 to 
the diol of 8 in the absence of an acetal (9) led to poor conversion (60%) and low 
diastereoselectivity.  The addition of 9 was found to significantly increase both the yield 
of the isomerized product and the diastereoselectivity of the reaction.  The authors 
hypothesized that perrhenic acid catalyzed the conversion of the product regioisomer into 
the benzylidene acetal, which also provided a bias for formation of the 
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thermodynamically preferred 1,3-syn isomer.  A variety of solvents were screened and 
CH2Cl2 was found to be optimal: Re2O7 was shown to be an effective rhenium source.  
This methodology was successfully applied to a variety of substrates.  However, it was 
noted that acid labile groups such as t-butyldiphenylsilyl ethers (TBDPS) and p-
methoxybenzyl ethers (PMB) underwent deprotection upon prolonged exposure (20 hrs) 
but deprotection can be circumvented with the use of a different acetal.  
 
Utilization in Prins cyclization 
 In 2008, Rychnovsky reported using rhenium to catalyze an intramolecular Prins 
reaction.11  The reaction of alcohol 10 and benzaldehyde, 11, afforded tetrahydropyran 12 
utilizing O3ReOSiPh3 as a catalyst.  Rychnovsky postulates that 10 and 11 react to form 
hemiacetal 13, which is then able to undergo rearrangement to give 15.  Exchange with 
Ph3SiOH, formed in the reaction, gives product 12.  Rychnovsky found that this reaction 
works for a variety of alkenes and benzaldehydes.  The reaction was successfully 
performed in several solvent systems but CH2Cl2 was the best.  In 2009, Rychnovsky 
built upon this work by successfully applying this reaction to a more complicated system 
to achieve an intramolecular macrolactonization.12 
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Section 2  
Hypothesis 
The work of Rychnovsky led me to believe that Re (VII) should act as a mild 
catalyst for the acetalization/transetherification of 1,2-dioxolan-3-ols and/or the 
corresponding trimethylsilyl ethers. 
The etherification of 16 under strongly acidic conditions (p-toluene sulfonic acid) 
is likely to involve the formation of cationic intermediate 18 that undergoes trapping by 
an alcohol.  Given the previous work, we anticipated that Re2O7 should be able to insert 
in C-OH bond of 16 to afford an intermediate (17) that could fragment to the same 
carbocation (18), with the difference being that the ionization might occur under much 
milder conditions.  
 
Section 3 
 Etherification/acetalization of 3-alkoxy-1,2-dioxolanes 
To test our hypothesis, I compared the transformation of 20 and 21 in the 
presence of Re2O7 vs. sulfonic acid. (below).  When Re2O7 (10 mol%) was used it was 
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found the yield of 2-phenylethanol was unchanged relative to sulfonic acid (10 mol%).  
In contrast, the yield for etherification with 1-adamantanemethanol increased 
dramatically with Re2O7.  Both of these etherifications proceeded in slightly higher yield 
using only 1 mol% of Re2O7. The use of less than 1 mol% Re2O7 was not investigated, 
but I believe that the reaction could proceed at even lower catalyst loading.  As expected 
the etherification of sterically hindered 1-adamantanol was unsuccessful for either 
catalyst system. 
 
Alcohol PTSA Re2O7 10 mol% 
Re2O7 
1 mol% 
2-phenylethanol 73% (3h) 75 % (1h) 83% (1h) 
1-adamantanemethanol 28% (>12h) 74 % (1h) 78% (2h) 
1-adamantanol Failed Failed Failed 
Table 4.1 
 
I had prepared the dioxolane trimethylsilylether (22) to assist with purification, 
and became interested if the 3-trimethyl-1,2-silyloxydioxolane would be a useful 
substrate for the transetherification.  Gratifyingly the reaction did proceed to afford 21 in 
comparable yield relative to the transetherification on the free alcohol.  The yield of the 
1-adamantylmethyl acetal was slightly depressed compared with the reaction from the 
free alcohol.  The ability to employ trimethylsilyl ethers represents a useful expansion of 
the methodology. 
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Alcohol Re2O7 (1 mol%) 
2-phenylethanol 81% (2h) 
1-adamantanemethanol 65% (>12h) 
1-adamantanol Failed 
Table 4.2 
Given the successful application of Re2O7 to catalyze the etherification of 
anomerically-activated 1,2-dioxolan-3-ols, I became interested in the potential of this 
reagent to catalyze the corresponding etherification (glycosylation) of sugars.  This 
approach was unsuccessful with a variety of glucose pentaacetate derivatives, 23.  Only 
when methanol was employed did any noticeable reaction occur.  
Section 4 
 Etherification of lactols 
 
R X Yield  24 
H CH2CH2Ph Failed 
OAc CH2CH2Ph Failed 
TBS CH2CH2Ph Failed 
H Me 4% 
Table 4.3 
The failure to achieve Re2O7-promoted etherification of sugars could result from 
the presence of strongly electron-withdrawing C-O linkages on the carbons adjacent to 
the hemiacetal.  I therefore decided to screen lactols.  As was expected from earlier work 
with peroxyhemiacetal 20 this reaction proceeded in good yield on the free hemiacetal 
(25).  Unexpectedly, transetherification also proceeded in good yield on the t-
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butyldimethylsilyl (TBS) acetal, 26.  This result was unexpected as the bulkier TBS 
ethers were not expected to undergo insertion of Re(VII) into the C-O bond as had been 
observed for the corresponding trimethylsilyl ethers.  This result broadens the potential 
application of this methodology as the TBS ether is a more widely used protecting group. 
 
Section 5 
 Allylation 
As we postulated that a carbocation intermediate, or something with comparable 
reactivity, was formed in the etherification reaction the next logical step was to explore 
the possibility of achieving C-C bond formation under these conditions.  The allylation of 
25 with allyl trimethylsilane appeared to cleanly furnish one major product (TLC) but 
resulted in low yield (37%) presumably because of volatility.  Therefore, I utilized lactol 
27 which was readily synthesized in two steps from 2-adamantanone.  As was expected 
the allylation of 27 proceeded in excellent yield to afford 28.   
 
 These allylation results made me wonder if it was possible to also perform an 
allylation of 1.2-dioxolan-3-ol using Re2O7.  Previous reports from our group had 
demonstrated successful addition of allylsilane and silyl ketene acetal nucleophiles to 3-
alkoxy-1,2-dioxolanes, however, these reactions were achieved using very powerful 
Lewis acids. 13  I initially investigated the use of allyltrimethylsilane as a nucleophile; 
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however, no reaction was observed.  I therefore investigated the use of more nucleophilic 
allyltributyltin.  The use of the tin compound led to no reaction and a change in reaction 
color, possibly indicating a reaction with Re2O7.   
O O
OH
O O
O
R
Re2O7 (1 mol%)
R = TMS Failed
R = SnBu3 Failed
20 29
 
The etherifications of 20 to 21 have shown that a carbocation intermediate is 
formed, but does not indicate if it is a fully dissociated carbocation.  The failure to 
observe allylation led me to conclude that Re2O7 is not able to convert a 1,2-dioxolan-3-
ol to a carbocation intermediate possessing sufficient reactivity to capture an alkene 
nucleophile.  
Section 6 
 Stabilized carbocations 
I next conducted a brief investigation of the ability of Re2O7 to catalyze other 
reactions involving a stabilized carbocation intermediate.  As an initial target, I chose 
triphenylmethanol, 31, as a substrate capable of forming a relatively stable trityl cation as 
an intermediate.  With the first set of conditions the use of excess nucleophile (5 eq).  I 
found that the reaction was in fact successful, though not in synthetically useful yields 
(Entry 1).  Interestingly, the amount of Re2O7 catalyst and the reaction time could be 
decreased without loss of efficacy (Entry 2).  This led to me rethinking how I approached 
this investigation.  As the trityl group is traditionally used as a protecting group I decided 
to use 31 in excess under more standard conditions.  This change led to a significant 
improvement in the yield (Entry 3).  Alternatively, adding activated 3Å molecular sieves 
in the reaction allowed me to obtain comparable yields in the presence of two equivalents 
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of 31 (Entry 4).  A comparison of entries 4 and 5 demonstrate that the use of Re2O7 
catalysis provides yields comparable to those obtained with a strong acid catalyst.  
 
Entry 30  
(eq) 
31  
(eq) 
Re2O7  
(mol%) 
t 
 (h) 
Sieves 
 (3Å) 
Yield 32  
(%) 
1 5 1 10 5 No 48 
2 5 1 1 3 No 59 
3 1 5 1 3 No 81 
4 1 2 1 3 Yes 84 
5 1 2 PTSA (10) 3 Yes 87 
Table 4.4 
 These results encouraged me to investigate the Re2O7-mediated activation of 
alcohols as a potentially mild method for the synthesis of ethers.  The first alcohol that 
was chosen was 3,4-dimethoxy benzyl alcohol (3,4-DMB) (Entries 1-4).  I found that 
under previously known conditions (Entry 1) the reaction with 2-phenylethanol 
proceeded in moderate yield, but when MeCN, which is able to solubilize both water and 
Re2O7, was used the reaction did not proceed.  It is unknown if the Re2O7 forms a 
complex with MeCN that renders it inactive.  Under more protecting group like 
conditions, an excess of the protecting agent, with the reaction proceeded, but in 
depressed yield (Entry 3).  I decided to use the OTBS analog of 3,4-DMB as I had 
previously demonstrated that Re2O7 was capable of catalyzing the insertion into C-OSiR3 
linkages.  I found that the reaction proceeded in synthetically useful yield (Entry 4).  The 
use of less electron rich 4-methoxybenzyl alcohol (PMB) was successful (Entry 5) and 
proceeded in similar yield to that of 3,4-DMB (Entry 3).  However, when the OTBS 
analog of PMB was employed the reaction was unsuccessful (Entry 6).  The protection of 
cumyl alcohol (cumyl) with 2-phenylethanol also proceeded in moderate yield under the 
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reaction conditions (Entry 7).  As the alcohol became less electron rich and sterically 
hindered formation of the dimer became a serious problem.  For example benzhydrol 
gave predominantly dimer with a very low yield of the desired product.  
 
Entry 30  
(eq) 
R  
(eq) 
X Re2O7 
mol% 
t  
(h) 
Sieves  
(3Å) 
Yield  
(%) 
1 5  3,4-DMB (1) H 10 5 Yes 58 
 2a 5 3,4-DMB (1) H 10 1 Yes NR 
3 1 3,4-DMB (2) H 1 3 Yes 38 
4 5 3,4-DMB (1) TBS 10 1 No 71 
5 1 PMB (2) H 1 3 Yes 40 
6 1 PMB (2) TBS 1 1 No NR 
7 1 Cumyl (2) H 1 3 Yes 46 
Table 4.5 aMeCN used as solvent 
Section 7 
Conclusions 
 Through this work I have shown that Re2O7 is capable of catalyzing a variety of 
reactions.  The first is the synthesis of 3-alkoxy-1,2-dioxolanes from 1,2-dioxolan-3-ols 
in good yield.  Re2O7 is also able to catalyze the etherification and allylation of a lactol 
and its OTBS analog in excellent yield.   
 I have also shown that Re2O7 is able to catalyze the formation of stabilized 
carbocations, potentially providing a new method for the introduction of several alcohol 
protecting groups.  This approach is most successful for the introduction of the trityl 
group, but also showed promise with the 3,4-DMB group.  If this work is to be expanded 
to other ether protecting groups further optimization must be done. 
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Section 8 
 Experimentals 
All reagents were used as received from commercial vendors, with the exception of 
CH2Cl2, which was distilled from calcium hydride, and THF, which was distilled from 
sodium/benzophenone.  All reactions were conducted under an atmosphere of N2 except 
where noted; “RBF” indicates round-bottom flask.  Thin layer chromatography (TLC) 
was performed on 0.25 mm hard-layer silica G plates; developed plates were visualized 
with a hand-held UV lamp or by staining: 1% ceric sulfate and 10% ammonium 
molybdate in 10% H2SO4 (general stain, after charring); 1% N,N’-dimethyl-p-
phenylenediamine solution in 1:20:100 acetic acid/water/methanol (specific for 
peroxides);14 1% aq. KMnO4 (for unsaturated compounds); 3% vanillin in 3% H2SO4 in 
ethanol (general stain after charring).  “Standard drying and purification” refers to drying 
of organic extracts over MgSO4, removal of solvent under vacuum, and purification by 
flash chromatography using the indicated eluting solvent. 1H  /13C NMR spectra were 
obtained in CDCl3 unless otherwise indicated; peaks are reported as: chemical shift 
(multiplicity, J couplings in Hz, number of protons).  Infrared spectra were recorded as 
neat ATR films with selected absorbances reported in wavenumbers (cm-1).  
O
OH
 
Tetrahydro-2H-pyran-2-ol (25): 
To a RBF containing 3,4-dihydro-2H-pyran (3.4204g, 40.7 mmol) neat cooled to 0oC was 
added aq. HCl (8.3 mL, 41.5mmol, 0.2 M).  The reaction was stirred overnight and then 
diluted with H2O (25 mL) and extracted with CH2Cl2 (25 mL).  The combined organic 
fractions were washed with sat. aq. NaHCO3 (25 mL) and subjected to standard drying 
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and purification with 40% EA/hex to 25 (2.297g, 55%).  Rf (50% EA/hex): 0.45. 1H 
NMR (600 MHz): 4.60 (m, 1H), 4.02 (m, 1H), 3.54 (m, 1H), 3.45 (d, J = 4.64, 1H), 1.91-
1.76 (2H), 1.57-1.46 (4H).  The NMR spectra matched those previously reported.15 
 
tert-Butyldimethyl((tetrahydro-2H-pyran-2-yl)oxy)silane (26): 
To a flame-dried RBF containing 25 (501.4 mg, 4.9 mmol) in THF (49 mL) was added 
imidazole (0.4g, 5.9 mmol) and TBSCl (0.9g, 5.9 mmol) as a solution in THF (5 mL).  
The reaction was stirred for 36 hrs, after which it was treated with H2O (30 mL) and 
extracted with Et2O (2 x 30 mL).  The combined organic layers were subjected to 
standard drying and purification with 10% EA/hex to afford 26 (322.9 mg, 31%).  Rf 
(10% EA/hex): 0.52.  1H NMR (300 MHz): 4.93 (m, 1H), 3.97 (m, 1H), 3.49 (m, 1H), 
1.94-1.43 (6H), 0.92 (s, 9H), 0.12 (s, 3H), 0.10 (s, 3H).  13C (75 MHz): 94.3, 63.0, 33.6, 
26.0, 25.7, 19.9, 18.3, -4.1, -5.2. 
 
2-Phenethoxytetrahydro-2H-pyran 
Via etherification of alcohol 
To a flame-dried vial containing 25 (153.1 mg, 1.5 mmol) in CH2Cl2 (15 mL) was added 
sequentially 2-phenylethanol (0.9 mL, 7.5 mmol) and Re2O7 (7.26 mg, 0.015 mmol).   
After stirring for 1 hr, the reaction was concentrated in vacuo and the residue obtained 
was purified via column chromatography with 10% EA/hex to afford 2-
phenethoxytetrahydro-2H-pyran (275.5 mg, 89%).  Rf (10% EA/hex): 0.41.  1H (400 
MHz): 7.36 (m, 5H), 4.63 (t, J = 4.6, 1H), 3.98 (m, 1h), 3.79 (m, 1H), 3.65 (m, 1H), 3.48 
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(m, 1H), 2.95 (t, J = 7.2, 2H), 1.90-1.65 (6H).  13C (100 MHz): 139.3, 129.2, 128.4, 
126.3, 98.9, 68.5, 62.4, 36.6, 30.9, 25.6, 19.7. The NMR spectra matched those 
previously reported.16 
Via etherification of silyl ether 
To a flame-dried vial containing a solution of 26 (216 mg, 1 mmol) in CH2Cl2 (10 mL) 
was added sequentially 2-phenylethanol (0.6 mL, 5 mmol) and Re2O7 (4.8 mg, 0.01 
mmol).  After stirring for 1 hr, the reaction was concentrated in vacuo and the residue 
obtained was purified via column chromatography with 10% EA/hex to afford 2-
phenethoxytetrahydro-2H-pyran (168.5 mg, 82%). 
 
4-Oxatricyclo[4.3.1.13,8]undecan-5-ol (27): 
To a flame-dried RBF containing a solution of 2-adamantanone (3.0 g, 20 mmol) in 
CH2Cl2 (100 mL) was added sequentially m-chloroperoxybenzoic acid (7.15 g, 25 mmol) 
and aq. NaHCO3 (40 mL, 20 mmol, 6.5 M in H2O).  After stirring for 24 hrs, the reaction 
was quenched with Na2SO3 (1g) and washed sequentially with sat. aq. NaHCO3 (20 mL) 
and brine (20 mL).  The combined organic layers were dried with MgSO4, and the 
residue obtained upon concentration in vacuo was purified via column chromatography 
with 60% EA/hex to afford 4-oxatricyclo[4.3.1.13,8]undecan-5-one  (2.8522g, 86%) as a 
white solid.  Rf (60% EA/hex):0.48.  1H (400 MHz): 4.46 (m, 1H), 3.07 (m, 1H), 2.15-
1.68 (12H).  The NMR spectra matched those previously reported.17 
To a flame-dried RBF containing a -78oC solution of 4-
oxatricyclo[4.3.1.13,8]undecan-5-one (2.0 g, 11 mmol) in CH2Cl2 (60 mL) was added 
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Dibal-H (8.3 mL, 12.5 mmol, 1.5M in toluene) dropwise.  The reaction was stirred at -
78oC for 1 hr and quenched with MeOH (0.5 mL).   The reaction was warmed to rt and 
stirred for 45 min.  Sat. aq. Rochelle’s salt (30 mL) was added and the resulting 
suspension was extracted with CH2Cl2 (3 x 40 mL).  The combined organic layers were 
washed with H2O (40 mL), and subjected to standard drying a purification with 40 % 
EA/hex to afford hemiacetal 27 (1.9104g, quant).  Rf (40 % EA/hex): 0.43.  1H NMR 
(400 MHz): 5.29 (d, J = 3.0, 1H), 4.27-4.12 (1H), 2.98 (bs, 1H), 2.35-1.28 (13H).  13C 
(100 MHz): 100.2, 72.4, 38.5, 38.3, 37.4, 25.8, 33.0, 29.4, 26.8, 26.7.  The NMR spectra 
matched those previously reported.18 
O
 
(1R,8S)-5-Allyl-4-oxatricyclo[4.3.1.13,8]undecane (28): 
To a flame-dried vial containing a solution of 27 (168.4 mg, 1 mmol) and Re2O7 (4.8mg, 
0.01 mmol) in CH2Cl2 (10 mL) was added allyltrimethylsilane (0.8 mL, 5 mmol).  The 
reaction was stirred for 1 hr and then treated with sat. aq. NaHCO3 (5 mL) and H2O (5 
mL) and extracted with CH2Cl2 (3 x 20 mL).  The combined organic layers were dried 
with Na2SO4.  The residue obtained upon concentration in vacuo was subjected to column 
chromatography with EA/hex (1 x 10% EA/hex, 1 x 5% EA/hex) to afford 28 (166.5 mg, 
90%).  Rf (10% EA/hex): 0.6. 1H NMR (400 MHz): 5.83 (m, 1H), 5.10-5.00 (2H), 4.18 
(m, 1H), 3.81 (t, J = 6.8, 1H), 2.37 (m, 1H), 2.18 (m, 1H), 2.00 – 1.64 (10H), 1.61 -1.49 
(3H).  13C (100 MHz): 136.6, 116.5, 81.9, 71.8, 41.5, 40.9, 40.0, 26.1, 36.0, 34.6, 30.0, 
26.9, 26.4. 
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Phenylethyl triphenylethyl (trityl) ether (32): 
To a flame-dried RBF containing a solution of trityl alcohol (3.9g, 15 mmol) in CH2Cl2 
(30 mL) was added sequentially Re2O7 (15 mg, 0.03 mmol) and 2-phenylethanol (0.36 
mL, 3 mmol).  The reaction was stirred for 3 hrs, and then treated with sat. aq. NaHCO3 
(10 mL) and H2O (20 mL). The combined CH2Cl2 (3 x 20) extracts were subjected to 
standard drying and purification with 10% EA/hex to afford 112 (879.4 mg, 81%) as a 
white solid.  Rf (10% EA/hex):0.64.  1H NMR (400 MHz): 7.46-7.39 (5H), 7.35-7.20 
(14H), 3.34 (t, J = 7.0, 2H), 2.93 (t, J = 7.0, 2H). 13C (100 MHz): 144.4, 139.5, 129.4, 
128.8, 128.4, 127.9, 127.0, 126.3, 86.8, 65.2, 36.9.   
 
tert-Butyl-(3,4-dimethoxybenzyloxy)-dimethylsilane: 
To a flame-dried RBF containing a solution of imidazole (1.0 g, 15 mmol) and 3,4-
dimethoxybenzyl alcohol (0.73 mL, 5 mmol) in DMF (50 mL) was added  TBSCl (1.1 g, 
7.5 mmol).  The reaction was stirred for 20 hrs and then treated with H2O (100 mL).  The 
resulting suspension was extracted with Et2O (3 x 100 mL).  The combined organic 
layers were subjected to standard drying and purification with (1 x 25% EA/hex and 1 x 
10% EA/hex) to afford tert-butyl-(3,4-dimethoxy-benzyloxy)-dimethyl-silane (1.3845 g, 
98%).  Rf (5% EA/hex):0.46.  1H NMR (300 MHz): 6.91 (s, 1H), 6.84 (s, 2H), 4.69 (s, 
2H), 3.89 (s, 3H), 3.88 (s, 3H), 0.95, 9H), 0.10 (s, 6H).  13C (75 MHz): 149.1, 148.2, 
134.3, 118.4, 111.1, 109.8, 65.0, 56.1, 55.9, 26.1, 18.6, -5.0. 
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1,2-dimethoxy-4-(phenethoxymethyl)benzene 
To a flame-dried RBF containing a suspension of Re2O7 (48 mg, 0.1 mmol) in CH2Cl2 
(10 mL) was added sequentially 3,4-dimethoxybenzyl alcohol (0.15 mL, 1 mmol) and 2-
phenylethanol (0.6 mL, 5 mmol).  The reaction was allowed to stir for 1 hr and then 
treated with sat. aq. NaHCO3 (5 mL) and H2O (5 mL) and extracted with CH2Cl2 (3 x 
20).  The combined organic layers were dried with Na2SO4, and the residue obtained 
upon concentration in vacuo was purified via column chromatography with 20% EA/hex 
to afford 1,2-dimethoxy-4-(phenethoxymethyl)benzene (192 mg, 71%). 
Procedure with TBS analog 
To a flame-dried RBF containing a suspension of Re2O7 (47.5 mg, 0.1 mmol) in CH2Cl2 
(10 mL) was added sequentially tert-butyl-(3,4-dimethoxy-benzyloxy)-dimethyl-silane 
(280.4 mg, 0.99 mmol), 2-phenylethanol (0.6 mL, 5 mmol), and 3A sieves.  The reaction 
was allowed to stir for 5 hrs and was treated with sat. aq. NaHCO3 (5 mL) and extracted 
with CH2Cl2 (3 x 10).  The combined organic layers were subjected to standard drying 
and purification with 20% EA/hex to afford 1,2-dimethoxy-4-
(phenethoxymethyl)benzene (158.9 mg, 58%).  Rf (5% EA/hex):0.42.  1H (300 MHz): 
7.35-7.19 (5H), 6.90 – 6.81 (3H), 4.5 (s, 2H), 3.89 (s, 3H), 3.87 (s, 3H), 3.72 (t, J = 7.0, 
2H), 2.96 (t, J = 7.0, 2H).  13C (75 MHz): 149.2, 148.7, 139.2, 131.1, 129.1, 128.5, 126.3, 
120.2, 111.1, 111.0, 73.0, 71.1, 56.1, 71.1, 56.1, 55.9, 36.5. 
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t-Butyl-(4-methoxybenzyloxy)-dimethylsilane 
To a flame-dried RBF containing imidazole (2 g, 30 mmol) and 4-methoxybenzyl alcohol 
(1.4g, 10 mmol) in DMF (100 mL) was added  TBSCl (2.3 g, 15 mmol).  After 12 hrs the 
reaction was treated with H2O (100 mL) and extracted with Et2O (3 x 75 mL).  The 
combined organic layers were subjected to standard drying and purification with 5% 
EA/hex to afford t-butyl-(4-methoxybenzyloxy)-dimethylsilane (2.4148 g, 96%).  Rf (5% 
EA/hex):0.67.  1H (400 MHz): 7.25 (m, 2H), 6.85 (m, 2H), 4.68 (s, 3H), 3.81 (s, 3H), 
0.94 (s, 9H), 0.10 (s, 6H). The NMR spectra matched those previously reported.19 
 
4-Methoxybenzyl phenethyl ether 
To a flame-dried RBF containing a suspension of Re2O7 (15.2 mg, 0.03 mmol) in CH2Cl2 
(30 mL) was added sequentially 4-methoxybenzyl alcohol (824 mg, 6 mmol), 2-
phenylethanol (0.36 mL, 3 mmol), and 3A sieves.  After 3 hrs the reaction was treated 
with sat. aq. NaHCO3 (10 mL) and H2O (5 mL) and extracted with CH2Cl2 (3 x 20).  The 
combined organic layers were subjected to standard drying and purification with 10% 
EA/hex to afford 4-methoxybenzyl phenethyl ether (291.5 mg, 40%).  Rf (10% 
EA/hex):0.56.  1H (300 MHz): 7.39-7.21 (7H), 7.0-6.89 (2H), 4.52 (s, 2H), 3.85 (s, 3H), 
3.72 (t, J = 7.1, 2H), 2.98 (t, J = 7.1, 2H).  The NMR spectra matched those previously 
reported.20 
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1-Methyl-1-phenylethyl phenethyl ether 
To a flame-dried RBF containing a suspension of Re2O7 (16.6 mg, 0.03 mmol) in CH2Cl2 
(30 mL) was added sequentially cumyl alcohol (816 mg, 6 mmol), 2-phenylethanol (0.36 
mL, 3 mmol), and 3A sieves.  After 3 hrs the reaction was treated with sat. aq. NaHCO3 
(10 mL) and H2O (5 mL) and extracted with CH2Cl2 (3 x 20).  The combined organic 
layers were subjected to standard drying and purification  with 10% EA/hex to afford 1-
methyl-1-phenylethyl phenethyl ether (334.4 mg, 46%).  Rf (10% EA/hex):0.55.  1H (400 
MHz): 7.39-7.16 (10H), 3.41 (t, J = 7.5, 2H), 2.89 (t, J = 7.3, 2H), 1.55 (s, 6H).  The 
NMR spectra matched those previously reported.20 
Section 9 
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